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Abstract  
The prediction and measurement of surgical outcome is difficult. Current 
methods of perioperative risk prediction do not perform particularly well on an 
individual basis with guidelines suggesting a stepwise approach to perioperative 
risk assessment. Part of this stepwise approach is an assessment of functional 
capacity. Cardiopulmonary exercise testing has a body of evidence to support 
its use as a measurement of functional capacity and predictor of perioperative 
risk. In addition grip strength as assessed by handgrip dynamometry has been 
shown to be predictive of surgical outcome. 
This thesis examines the development and testing of a standardised forearm 
handgrip exercise model to predict mortality and morbidity in orthopaedic 
surgical patients.  
This thesis investigates the development of two standardised forearm handgrip 
exercise models, one using an intermittent (cyclical) exercise protocol and the 
other using a static (isometric) protocol. Having established reliable methods of 
using each as a preoperative test, the metabolic output i.e. the measurable 
venous products of metabolism; lactate, SO2, PO2, PCO2, pH and tissue 
oxygenation were compared. The comparison showed that the isometric 
exercise model was the stronger stimulus for anaerobic respiration. Each 
exercise model was also compared to an anaerobic threshold as measured by 
cardiopulmonary exercise testing in the same individuals. The isometric model 
showed a consistent and statistically significant relationship with the anaerobic 
threshold as measured by cardiopulmonary exercise testing but not the cyclical 
model. 
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Finally the isometric forearm exercise model was prospectively tested in a pilot 
study of 21 orthopaedic patients undergoing joint replacement surgery for its 
ability to predict surgical outcome. 
The maximal voluntary contraction from handgrip dynamometry was predictive 
of complications and length of stay and although not statistically significant 
there was a clear trend for those with fewer complications and shorter lengths of 
hospital stay to produce more lactate during isometric forearm exercise testing. 
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SUMMARY	  OF	  THE	  AIMS	  AND	  OBJECTIVES	  OF	  THE	  THESIS	  
All the work contained within this thesis was conducted at the Middlesex 
Hospital, London UK between December 2004 and December 2005. 
Main aims & Objectives 
1) To review the literature on the prediction of surgical outcome. 
2) To highlight from the literature review the role of exercise and functional 
testing in predicting surgical outcome. 
3) To develop a bedside exercise test that could be used to predict surgical 
outcome. 
4) To construct and prove the validity and practicality of a forearm exercise 
model in healthy volunteers. 
5) To compare the relationship between this forearm exercise test and 
established models of assessing whole body functional capacity currently 
used to predict surgical outcome such as cardiopulmonary exercise 
testing. 
6) To identify a suitable test endpoints from the forearm exercise test that 
could be used to predict surgical outcome. 
7) To undertake a prospective study on the ability of the chosen forearm 
exercise model to predict surgical outcome in an elective orthopaedic 
population requiring primary joint replacements. 
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Chapter	  1:	  The	  prediction	  of	  surgical	  outcome	  and	  a	  focused	  
review	  of	  the	  literature	  for	  handgrip	  dynamometry	  and	  
cardiopulmonary	  exercise	  testing	  
 
1.0	   Introduction	  	  
This chapter will briefly discuss the principles of measuring and defining surgical 
outcome and the importance of risk adjusting data. 
I will then discuss current methodology used to predict surgical outcome. 
I will finish the chapter by focusing on functional exercise testing with a specific 
focus on cardiopulmonary exercise testing and handgrip dynamometry. 
Currently there is no perfect method of predicting surgical outcome. Methods of 
prediction to date have often been based on large retrospective populations of 
patients and do not allow for the prediction of an individual’s risk but that of the 
population in which they sit. 
The terms surgical outcome and perioperative outcome are often used 
interchangeably but do not necessarily mean the same thing. Many surgical 
procedures for example a hip replacement have a technical outcome of success 
in terms of restoration of functional capacity or correct alignment of hip 
prosthesis and femoral shaft. The patient may however have suffered a number 
of postoperative events or complications such as a wound infection that delayed 
or made their recovery process prolonged or traumatic and are termed morbid 
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events. This thesis will aim to look at the possibility of predicting surgical 
outcome with regards to morbidity and mortality and not the technical success 
of surgery itself. 
Surgical outcome in this thesis will therefore refer specifically to morbidity 
(complications) and mortality (death) associated with a surgical event unless 
otherwise stated. 
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1.1	   MEASURING	  AND	  DEFINING	  SURGICAL	  OUTCOME	  	  
As mentioned above surgical outcome means different things to different 
people. For the patient it often means curing of a disease, returning to physical 
activity or a job. For the surgeon it may be the technical success of an 
operation, the operative time taken or the rate of post-operative infection. For 
the manager it may be the number of drugs needed or bed days occupied, the 
quantity of equipment used during the operation or the cost the specified 
treatment. What they all have in common however is the desire to objectively 
describe the measure they are interested in and in many cases be able to 
predict and modify that measurement.  
The healthcare burden of surgery is enormous, with recent estimates of major 
surgical operations undertaken worldwide in excess of 234 million 1 
Recently calls for increased clinical safety and accountability following high 
profile healthcare scandals, the drive to give patients a choice between different 
healthcare providers, and the linkage of funding to measured results have 
driven the outcomes reporting agenda forward. Cardiac surgery has led in the 
reporting of outcomes following surgery 2-4, and other surgical specialties are 
now following 2. But these initiatives are limited by the lack of validated 
instruments for describing the variety of outcomes occurring to individual 
patients.  The measures currently used to assess outcome following surgery 
have significant limitations. 
Mortality is the most commonly cited variable but the low event rate following 
elective surgery limits its applicability as a general outcome measure.  Length of 
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hospital stay is known to be affected by medical and non-medical factors and 
therefore functions as a hybrid measure of process and outcome 3-6. Recording 
of perioperative morbidity has hitherto been limited: a recent systematic review 
of the measurement and monitoring of surgical adverse events found 
inconsistency in the quality of reporting of postoperative adverse events limiting 
accurate comparison of rates over time and between institutions 7. A reliable 
and valid index of short-term post-operative morbidity would be of enormous 
value in quality of care, prognostic and effectiveness research. 
The Post-Operative Morbidity Survey (POMS) is the only published prospective 
method for describing short-term morbidity following major surgery 8. The 
POMS (see Table 1.1) contains 18 items that address nine domains of post-
operative morbidity. For each domain either presence or absence of morbidity is 
recorded on the basis of objective criteria. POMS is starting to be used in 
outcomes research 9 and in effectiveness research 10. 
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Table 1.1 The Post Operative Morbidity Survey 
Morbidity type Criteria 
Pulmonary Has the patient developed a new requirement for oxygen or 
respiratory support? 
Infectious Currently on antibiotics and/or has had a temperature of >38°C in 
the last 24 hours. 
Renal Presence of oliguria < 500ml/24hours, increased serum creatinine 
(>30% from pre operative level); urinary catheter in situ.  
Gastrointestinal Unable to tolerate an enteral diet for any reason including nausea, 
vomiting and abdominal distension. 
Cardiovascular Diagnostic tests or therapy within the last 24 hours for any of the 
following: new MI or ischaemia, hypotension (requiring fluid therapy 
>200ml/hr or pharmacological therapy, atrial or ventricular 
arrhythmias, cardiogenic pulmonary oedema, thrombotic event 
(requiring anticoagulation). 
Neurological New focal neurological deficit, confusion, delirium or coma. 
Haematological Requirement for any of the following within the last 24 hrs: packed 
erythrocytes, platelets, fresh-frozen plasma, or cryoprecipitate. 
Wound Wound dehiscence requiring surgical exploration or drainage of pus 
from the operation wound with or without isolation of organisms. 
Pain New post-operative pain significant enough to require parenteral 
opioids or regional analgesia. 
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1.2	   Methods	  used	  to	  predict	  surgical	  outcome	  
There are three major methods currently used to predict surgical outcome: 1) 
Preoperative risk scores, 2) Functional capacity assessment and 3) Adjunctive 
clinical investigations.  Most if not all can be used in a step wise assessment of 
patients prior to surgery as recommended by recent international guidelines 11, 
12.  
1.2.1	   Pre-­‐	  operative	  risk	  scores	  
There are a number of pre and postoperative risk scores and variables that 
have been used to predict morbidity and or mortality in both emergency and 
elective surgery and these are shown in Table 1.2. I will describe and review the 
most commonly used of these scores in this thesis. 
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Table 1.2 Currently available risk scores and variables used in elective and emergency surgery showing information source required and prediction for 
morbidity and mortality 
 Information Source Prediction  
Risk Score / Variable Preoperative Postoperative Morbidity Mortality Discussed in 
Thesis 
Age *  * * YES 
American Society of Anesthesiologists Physical Status Classification (ASA-PS) 13 *  * * YES 
Boersma 14 *   * YES 
Boey Score 15 *   * NO 
Charlson comorbidity index 16 *   * YES 
Cleveland Colorectal Model 17 * *  * NO 
Detsky 18 *  *  YES 
Donati Score 19 *  *  NO 
Fitness Score 20 * *  * NO 
Glasgow Aneurysm Score 21 *   * NO 
Goldman 22 *  * * YES 
Hardman Index 23 *   * NO 
Lee 24 *  * * YES 
National Surgical Quality Improvement Program (NSQIP) 25 * * * * YES 
Physiological and Operative Severity for the Enumeration of Mortality and 
Morbidity (POSSUM) & (P-POSSUM) 26, 27 
* * * * YES 
Reiss Index 28 * *  * NO 
Sickness Assessment 29 *   * NO 
Surgical Risk Score (SRS) 30 * *  * YES 
VA Pneumonia Prediction Index 31 *  *  YES 
VA respiratory Failure Score 32 *  *  YES 
Veltkamp Score 33 *  *  NO 
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1.2.1.1	   American	  Society	  of	  Anesthesiologists	  (ASA)	  
The American Society of Anesthesiologists (ASA) physical status classification 
(ASA-PS) was originally developed in 194113 by the American Society of 
Anesthetists and later revised in 196334 to a form close to that used today (see 
Table 1.3). It was designed to provide a simple and concise summary of a 
patient’s global preoperative health status and consists of six different 
subjectively differentiated categories, with an ASA grade of VI being reserved 
for brain dead patients, awaiting organ harvesting. There have been modifiers 
added to the score such as “G” for gravid 35, and “E” for emergency in an 
attempt to reduce the inconsistency of the score 36, but it’s most widespread 
use remains as a five point grading classification from ASA 1 – V. 
It was never intended or expected to be a good predictor of surgical outcome on 
an individual basis, but was expected to provide a description of “anaesthetic 
risk”, that could be clearly communicated and provide a uniform system for 
statistical and epidemiological purposes. It lacks the sensitivity and specificity to 
predict on individual patients, not least because it does not take into account 
the severity of the surgical procedure itself and doe not quantify surgical risk. 
Many authors have however used it and minor modifications of it to predict 
outcome from surgery, as described in the following paragraphs. 
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Table 1.3 American Society of Anesthesiologists Physical Status Score 201037 
 
ASA	  
Grade	   Criterion	  I	  	   A	  normal	  healthy	  patient	  II	   A	  patient	  with	  mild	  systemic	  disease	  III	   A	  patient	  with	  severe	  systemic	  disease	  IV	   A	  patient	  with	  severe	  systemic	  disease	  that	  is	  a	  constant	  threat	  to	  life	  V	   A	  moribund	  patient	  who	  is	  not	  expected	  to	  survive	  without	  the	  operation***	  
VI	   A	  declared	  brain‐dead	  patient	  whose	  organs	  are	  being	  removed	  for	  donor	  purposes	   	  
 
There is however a clear evidence of it’s effectiveness in being able to predict a 
broad range of surgical outcomes from mortality to perioperative complications 
and length of stay in a diverse group of patients from those with cirrhosis 
through to trauma 38-49. 
 
1.2.1.2	   Surgical	  Risk	  Score	  
In 2002 the American Society of Anesthesiologists Physical Status 
Classification was combined with an urgency of surgery score from the National 
confidential Enquiry into Patient Outcome and Death (NCEPOD) categories and 
a measure of surgical severity using the British United Provident Association 
(BUPA) operative severity scores 30 (see Table 1.4) 
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Table 1.4 Surgical Risk Score (Sutton 2002) 
CEPOD Criteria Score 
Elective  
Routine booked non‐urgent case, e.g. 
varicose veins or hernia 1 1 
Scheduled  
Booked admission, e.g. cancer of the colon or 
AAA 2 2 
Urgent 
Cases requiring treatment within 24±48 h of 
admission, 3 
Emergency 
Cases requiring immediate treatment, e.g. 
ruptured AAA 4 4 
      
BUPA     
Minor 
Removal of sebaceous cyst, skin lesions, 
oesophagogastric duodenoscopy 1 
Intermediate  
Unilateral varicose veins, unilateral hernia 
repair, colonoscopy 2 2 
Major Appendicectomy, open cholecystectomy 3 3 
Major plus 
Gastrectomy, any colectomy, laparoscopic 
cholecystectomy 4 4 
Complex major 
Carotid endarterectomy, AAA repair, limb 
salvage, anterior resection, oesophagectomy 5 
      
ASA 
     
I No systemic disease 1 1 
II Mild systemic disease 2 2 
III Systemic disease affecting activity 3 3 
IV Serious disease but not moribund 4 4 
V Moribund, not expected to survive 5 5 
 
The resultant score comes from a simple summing of each scored category. For 
patients undergoing high risk surgery the receiver operating curves were not 
significantly different to either Physiological and Operative Severity for the 
Enumeration of Mortality and Morbidity (POSSUM) or Portsmouth-Physiological 
and Operative Severity for the Enumeration of Mortality and Morbidity (P-
POSSUM) for predicting mortality 50. For patients undergoing lower risk surgery 
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the SRS score was significantly predictive for mortality and unlike POSSUM did 
not appear to over predict mortality for low risk procedures 30. 
1.2.1.3	   Physiological	  and	  Operative	  Severity	  for	  the	  Enumeration	  of	  Mortality	  
and	  Morbidity	  (POSSUM)	  
In 1991 a Urology Surgeon named Graham Copeland described a scoring 
system for surgical audit that he called the Physiological and Operative Severity 
for the Enumeration of Mortality and Morbidity and used the abbreviated 
acronym (POSSUM) to label his system 26. 
The system uses an 18 component scoring system comprised of 12 variables 
from a preoperative physiological assessment and 6 variables from the 
operative severity assessment (See Tables 1.5 & 1.6). Originally 48 
physiological variables and 12 perioperative variables were scrutinised by 
multivariate analysis for their ability to predict morbidity and mortality rates up to 
30 days post surgery. Those 18 variables with the highest predictive ability were 
then included in the final score as described above. 
The percentage risk of either mortality or morbidity is calculated by categorising 
the variables on an exponential scale and then putting the summed product of 
the two component scores into a logistic regression equation. Mortality and 
morbidity are calculated from two different equations and both produced 
significant equations for mortality and morbidity prediction 26. 
Copeland’s original study also produced a prospective validation cohort, which 
was analysed for observed versus expected rates of mortality and morbidity. 
The observed rates did not differ significantly from the expected rates derived 
from the calculations 26. 
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Many studies have confirmed the utility of POSSUM in predicting postoperative 
mortality and or morbidity 50-55. There are however some criticism of POSSUM 
in that it may significantly overestimate risk for those with a predicated risk of 
death of less than 10% 56. Other studies have also shown it and some of it’s 
derivative systems to significantly overestimate perioperative risk 57-66. This may 
be because of the inherent use of logistic regression equations in that if all the 
Variables in POSSUM are normal i.e summed to 12, then there is still a 
calculated risk of death of 1.08% 56. 
In 1998 David Prytherch reworked Copeland’s POSSUM scoring system and 
published the Portsmouth-POSSUM (P-POSSUM) 27. He used the same 
variables as Copeland but modified the regression equation using a large local 
dataset. His new system in a limited number of studies appears to calculate risk 
better than the original POSSUM score 27, 50, 61, 66-68, but still has a propensity to 
significantly overestimate risk 59, 64, 68-71 and in some cases even underestimate 
risk 50, 72-74. He did not however produce a score for morbidity at the time of 
publication. 
Many surgical specialities have now developed surgical specific POSSUM risk 
models, which have the obvious advantage of introducing data specific to the 
surgery being undertaken and allowing for better calibration and have been 
shown to be better at risk prediction than the original POSSUM. There are 
scores available for vascular 52 , colorectal (Cr-POSSUM) 59, 72, 74-77, 
oesophageal 69, 78, 79 and orthopaedic surgery 80, but again there is evidence to 
suggest they may not be precise enough for accurate risk prediction 59, 79, 81-83. 
POSSUM was originally intended as a tool for audit and surgical comparison 
and caution must be exercised in predicating individual risk, given the various 
imprecisions in its measurement.  
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Table 1.5 Physiological scoring table for POSSUM score, scored at the time of surgery 
(Copeland 1991) 
 Score 
 1 2 4 8 
Age (years) ≤60 61-70 ≥71  
Cardiac signs 
Chest 
radiograph 
No failure 
Diuretic, digoxin, 
antianginal or 
hypertensive 
therapy 
Peripheral 
oedema; warfarin 
therapy, 
Borderline 
cardiomegaly 
Raised jugular 
venous 
pressure 
Cardiomegaly 
Respiratory 
history Chest 
radiograph 
No dyspnoea 
Dyspnoea on 
exertion Mild 
COAD 
Limiting 
dyspnoea (one 
flight) Moderate 
COAD 
Dyspnoea at 
rest (rate 
>30/min) 
Fibrosis or 
consolidation 
Blood pressure 
(systolic) 
(mmHg) 
110-130 100-109, 131-170 ≥171, 90-99 ≤89 
Pulse 
(beats/min) 50-80 81-100, 40-49 101-120 ≥121, ≤39 
Glasgow coma 
score 15 12-14 9-11 ≤8 
Haemoglobin 
(g/100 ml) 13-16 
11.5-12'9 16.1-1 
7.0 
10.0-11.4 17.1-
18.0 ≤9.9, ≥18.1 
White cell count 
(x 10'*/1) 4-10 10.1-20 , 3.1-4 ≥20.1, ≤3  
Urea (mmol/l) ≤7.5 7.6-10 10.1-15 ≥15.1 
Potassium 
(mmol/l) 3.5-5 3.2-3.4, 5.1-5.3 2.9-3.1, 5.4-5.9 ≤2.8, ≥6 
Sodium 
(mmol/l) ≥136 131-135 126-130 ≤125 
Electro-
cardiogram Normal  
Atrial fibrillation 
(rate 6-90) 
Any other 
abnormal 
rhythm or >5 
ectopics/min Q 
waves or ST/T 
wave 
COAD=chronic obstructive airways disease 
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Table 1.6 Operative severity score for POSSUM score, scored after surgical procedure 
(Copeland 1991). 
 Score  
 1 2 4 8 
Operative 
severity*  Minor  Moderate  Major  Major +  
Multiple 
procedures  1   2 >2  
Total blood 
loss (ml)  ≤ 100  101-500  501-999  ≥1000 
Peritoneal 
soiling  None  
Minor 
(serous 
fluid)  
Local pus  
Free bowel 
content, pus 
or blood  
Presence of 
malignancy  None  
Primary 
only  
Nodal 
metastases  
Distant 
metastases  
Mode of 
surgery  Elective    
Emergency 
resuscitation 
of >2 h 
possible, 
Operation <24 
h after 
admission 
Emergency 
(immediate 
surgery <2 h 
needed)  
 
1.2.1.4	   Charlson	  comorbidity	  index	  
The Charlson index was originally developed and validated in 1987 as a 
weighted index method for classifying comorbid conditions which may affect the 
risk of dying in longitudinal medical studies 84. It was modified and evaluated 
seven years later to incorporate age in a small group of 226 hypertensive and 
diabetic patients undergoing elective surgery, who were followed up for 5 years 
from hospital discharge 16. The study confirmed it’s ability to be a valid predictor 
of death in patients undergoing elective surgery 16. Subsequent studies using 
the original Charlson index and the age-comorbidity index have shown 
inconsistent results in predicting mortality, which has limited its incorporation 
into clinical practice. The both appear to be able to reasonably predict long term 
(5 year) survival in diabetics 85 undergoing elective surgery and for patients 
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having lung resections for carcinoma 86-88, yet they perform less well for those 
with urological carcinoma 89-91. 
As an index like many others it was designed to predict the outcome of 
populations and not that of individuals. 
1.2.1.5	   Cardiac	  risk	  and	  non-­‐cardiac	  surgery	  
There has been a steady evolution of risk scores to predict adverse 
cardiovascular outcomes since the original work by Goldman et al in 1977 22. 
Each has seen an improvement on its predecessor in its predictive ability. 
1.2.1.5.1	   Goldman	  
The Goldman index is a 9-point multifactorial index combining clinical 
examination, investigations and surgical severity with a disproportionate score 
assigned to each variable within in it, (see Table 1.7). It soon found widespread 
use due to it’s simplicity and proved to be more predictive than the ASA score 
for predicating perioperative cardiovascular morbidity 92, but less good at 
predicting mortality 47. The combination of the ASA score with Goldman’s index 
did however improve the prediction of mortality 93. 
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Table 1.7 The Goldman cardiac risk index (abbreviated 1977) 
Clinical Variable Score 
Third heart sound 11 
Elevated jugular venous pressure 11 
Myocardial infarction within 6 months 10 
ECG: premature atrial contractions or non-sinus rhythm 7 
ECG: >5 premature ventricular contractions/minute 7 
Age > 70 years 5 
Emergency procedure 4 
Intra-thoracic, intra-abdominal or thoracic surgery 3 
Poor general status, metabolic or bed ridden 3 
 
There are a number of problems with the Goldman index that centre around the 
subjective nature of the clinical variables. For instance there is considerable 
intraobserver variability in recognition of a raised jugular venous pressure and 
the presence of a third heart sound, both of which are integral components of 
the index. The same is true for components such as “poor general status”, 
which have a strongly subjective nature to their categorisation and thus on the 
overall index score. The subjective nature of these observations are not unique 
to the Goldman index and affect almost all of the scores described in this thesis. 
Although unlikely to be the sole cause of their inability to consistently predict 
risk, subjectivity of assessment almost certainly plays an important part.  
 40 
1.2.1.5.2	   Detsky	   	  
In 1986 Detsky modified the Goldman index by using a Bayesian statistical 
approach, but using the same clinical variables and presented the risk index in 
the form of a simple nomogram 18. It did not prove to be any more superior to 
the ASA score or the Goldman index in predicting perioperative cardiovascular 
complications 94. 
1.2.1.5.3	   Lee	  (Revised	  cardiac	  Risk	  Index)	  
Twenty-two years after Goldman described his index, Lee introduced the 
revised cardiac risk index 24. The original paper describes the derivation and 
subsequent validation cohorts and uses a simple six point scoring system to 
apportion cardiac risk in non-cardiac surgery, (see Table 1.8). It combines data 
from the patient’s preoperative comorbid state and type of surgery undertaken. 
It is probably the most widely used risk scoring system in current clinical 
practice and remains the best validated of the current scoring systems. It is 
used by the most recent American College of Cardiology / American Heart 
Association guidelines on perioperative cardiac risk as the basis for a clinical 
evaluation system to determine who is likely to benefit from preoperative testing 
and intervention 11. It was originally designed to predict any of five 
complications, myocardial infraction, pulmonary embolism, ventricular 
fibrillation, cardiac arrest and complete heart block. In a recent systematic 
review by Ford et al it’s ability to discriminate between those at high and low risk 
of cardiac events after non-cardiac surgery was confirmed 95. In the same 
review however, the authors also highlight the fact that it did not perform as well 
in predicting cardiac events in vascular surgery or in predicating death, with 
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many studies being heterogeneous clinically and statistically and of low 
methodological quality 95.  
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Table 1.8 a) The Lee index (Lee 1999) and b) Points scoring and risk of perioperative 
complications 
 
a) 
Clinical variable Score 
High risk surgery 1 
Coronary heart disease 1 
Congestive heart failure 1 
Cerebrovascular disease 1 
Diabetes mellitus on insulin 1 
Serum creatininie >2 mg/dl 1 
 
b) 
Points Class Risk Complications 
0 I Very low 0.4 % 
1 II Low 0.9 % 
2 III Moderate 6.6 % 
3 IV High >11 % 
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1.2.1.5.4	   Boersma	  
The latest adaptation of the revised cardiac risk index (Lee index) is by 
Boersma et al, who broadened the surgical categories to 4, introduced variables 
for open vs. laparoscopic surgery, elective vs. emergency surgery and added 6 
age categories 14. The main strength for this scoring system is that it is derived 
from 9 years of retrospective surgical outcome data from non-cardiac surgery 
operations containing 108,593 patients and performed better than the original 
Lee index in predicting cardiovascular mortality 14. It has not however been 
prospectively tested in a surgical population outside of the Netherlands. 
 
1.2.2	   Age	  
Age is a fundamental component of many of the scoring systems described in 
this chapter, but is rarely used alone for prediction of surgical outcome. Age 
alone has been shown to be a poor predictor of mortality, morbidity and length 
of stay in multivariate analysis 96.  For any given age however, an individual has 
a statistical chance of dying (see Figure 1.1 and Table 1.9) that has lessened in 
the last 25 years as both male and female life expectancy have increased, with 
male life expectancy having risen to 77.2 years.  
As the population ages the number of comorbidities rises per individual and any 
individual of the same age but with differing degrees of comorbidity will have a 
different life expectancy. For example if we take two 71 years old male patients, 
a) has diabetes mellitus, ischaemic heart disease and renal failure and b) has 
no demonstrable comorbidity, it is b) that has a significantly higher chance of 
dying at anytime point irrespective of surgery. So age will always have a 
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powerful effect on any risk score that incorporates it, but it may be nothing more 
than a surrogate marker of comorbidity. 
Recently perioperative risk calculators have been proposed in the guidelines on 
perioperative assessment by AAGBI which build on the statistical chance of 
dying and incorporate surgical severity and patient comorbidity 97. They are yet 
to be tested in large prospective studies however, but age is always likely to 
remain a core component of any risk prediction model. 
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Figure 1.1 Rise in average life expectancy at birth for males and females 1980 – 2006 
(http://www.statistics.gov.uk/cci/nugget.asp?id=168) 
 
Table 1.9 Average life expectancy for each decade of life - 2006-2008 
 Average period expectation of life at given age 
Age Males Females 
0 77.40 81.63 
10 67.93 72.09 
20 58.12 62.20 
30 48.52 52.37 
40 39.05 42.65 
50 29.85 33.21 
60 21.29 24.26 
70 13.77 16.05 
80 7.79 9.18 
90 3.98 4.48 
100 1.95 2.17 
 
Adapted from Interim Life Tables, United Kingdom 2006-2008 (www.statisitcs.gov.uk -accessed Auhst 17th 
2010) 
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1.2.3	   National	  Surgical	  Quality	  Improvement	  Program	  (NSQIP)	  
The Veterans Affairs (VA) hospitals in the United States have been mandated 
by law to report surgical outcome since 1986. As part of this program between 
1991 and 1993 they prospectively collected data on over 117,000 major 
surgical procedures and from this data constructed 30 day mortality and 
morbidity risk adjustment models for 9 surgical specialities 25. Eight of these 
surgical specialities are reviewed annually using logistic regression analysis to 
create and enhance existing models for each speciality, with upwards of 23 
individual components related to preoperative morbidity and surgical care 4. 
The system is used predominantly for national audit comparison and 
epidemiological research, but has been translated into non-VA hospitals 98 and 
the private sector successfully 99. The size, complexity and broad coverage of 
surgical specialities and hospitals put the NSQIP model in a unique position and 
have led to some fascinating insights into the long term outcome from surgery. 
In 2005 Khuri et al using the NSQIP database reported on the long term 
outcome of over 105,000 patients undergoing surgery 100. What they found was 
that the occurrence of a postoperative complication within 30 days of surgery 
was more important in predicting the long term survival of surgical patients than 
any preoperative patient risk or intraoperative factor 100. Hamel et al using the 
same dataset looked at surgical outcome in an elderly population of over 
590,000 patients, finding the NSQIP mortality risk model to perform well on 
patients over 80, but postoperative complications in those over 80 were 
associated with a high 30 day mortality 101.  
It is most likely that models built on large local datasets of patients represent the 
direction of travel for perioperative risk calculators and have significantly 
enhanced traditional scoring systems such as the revised cardiac risk index 14. 
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It is somewhat disappointing that the United Kingdom with a centralised and 
government funded healthcare system such as the NHS has nothing like this for 
comparison. Much of the data available in the UK is from hospital episode 
statics data that is independently risk adjusted by agencies such as Dr Foster 
and fed back to hospitals and healthcare agencies, but does not have the 
complexity or intent of systems such as NSQIP to help us better understand 
perioperative risk assessment and modification. 
1.2.4	   Functional	  exercise	  testing	  
The objective assessment of exercise capacity is a core component of most 
preoperative consultations and an integral component of many more 
sophisticated risk assessment programs. Deriving an assessment of exercise 
capacity however from subjective patient based questionnaires or from formal 
exercise testing is possible and desirable. These will be described below. 
Table 1.10 Summary table of functional exercise testing 
Evidence Test Cost 
+ Stair Climbing Cheap 
+ Subjective exercise 
questionnaires 
Cheap 
++ Cardiopulmonary exercise testing Expensive 
+ Shuttle testing Moderate 
 
 
1.2.4.1	   Stair	  climbing	  
The four most recent studies to prospectively evaluate stair climbing for patients 
undergoing thoracic surgery, all suggest that an inability to climb 2 flights of 
stairs is a good predictor of increased perioperative mortality 102-105. The most 
recent and largest of which, however suggests it may not be a good 
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discriminator of morbidity 104. In a small study of high risk patients by Reilly et al 
the inability to climb 2 flights of stairs was associated with a positive predictive 
value of 82% for post-operative complications 106. Many/all of the studies 
evaluating stair climbing to date have included thoracic surgery patients. 
Pulmonary function has an obvious and crucial role in recovery from thoracic 
surgery, with the FEV1 being the best predictor of survival after lung resection 
surgery 107. If one excludes thoracic surgery patients, it is clear stair climbing is 
not a good discriminator for perioperative mortality and does not induce a 
sufficient enough stress response 107, 108. There are in addition many problems 
of standardising stair climbing with respect to stair height, speed of assent and 
the inability of claudicating patient to perform such exercise. A standardisation 
of these would possibly improve the test significantly. 
1.2.4.2	   Subjective	  exercise	  questionnaires	  and	  assessment	  
Although most preoperative questioning by anaesthetists will involve an enquiry 
as to the patients reported exercise tolerance it is rarely standardised and 
simply reported as good, adequate or poor. 
Reilly et al showed the merit in this in 1999 by looking at symptom limited 
exercise capacity as reported by the patient and found it to be a reasonable 
predictor of in hospital risk 106. 
Partially in an attempt to standardise the subjective assessment of exercise and 
correlate it to exercise capacity Htalky et al developed a 12 item scale that 
correlated with peak oxygen uptake. Their original cohort consisted of 50 
patients from which they developed the index and called it the Duke Activity 
Status Index (DASI), (See Table 1.11)109 They used an empirical equation to 
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then estimate peak oxygen uptake (Estimated peak oxygen uptake = (0.43 * 
(DASI)) + 9.6) from the sum of the values for all 12 items 109. 
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Table 1.11 Self administered, 12 point Duke Activity Status Index (Hlatky et al 1989) 
Item  Activity  Yes  No 
1 Can you take care of yourself (eating dressing bathing or using the toilet)?  2.75 0 
2 Can you walk indoors such as around your house?  1.75 0 
3 Can you walk a block or two on level ground?  2.75 0 
4 Can you climb a flight of stairs or walk up a hill?  5.5 0 
5 Can you run a short distance?  8 0 
6 Can you do light work around the house like dusting or washing dishes?  2.7 0 
7 Can you do moderate work around the house like vacuuming sweeping floors or carrying in groceries?  3.5 0 
8 
Can you do heavy work around the house like 
scrubbing floors or lifting and moving heavy 
furniture?  
8 0 
9 Can you do yard work like raking leaves weeding or pushing a power mower?  4.5 0 
10 Can you have sexual relations?  5.25 0 
11 
Can you participate in moderate recreational 
activities like golf bowling dancing doubles tennis or 
throwing a baseball or football?  
6 0 
12 
Can you participate in strenuous sports like 
swimming singles tennis football basketball or 
skiing?  
7.5 0 
 
The scores are based on the estimated metabolic equivalent for that particular 
activity (1 MET = 3.5 mls/Kg/min), which is the resting oxygen consumption of a 
70 Kg male at rest. Despite being widely used it has been show to be less 
predictive of outcome compared to simples scores e.g. the ASA score 110. For 
this reason it is more commonly used as part of a broader assessment of 
patients such as in the American College of Cardiology/American Heart 
Association guidelines on perioperative cardiac risk prevention 11, where in the 
absence of formal exercise testing it is a useful surrogate. 
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1.2.4.3	   Cardiopulmonary	  exercise	  testing	  
The epidemiological evidence that physical activity confers sustained health 
benefits, not only by reducing the event rate of cardiovascular disease but also 
in he prevention of certain types of cancer and reduction in type 2 diabetes 
continues to grow 111. There is conflicting evidence with regards to the intensity 
of exercise undertaken. Vigorous regular exercise has clear benefit as does 
moderate levels of regular activity such as walking, which may be more 
appropriate as the population ages and the ability to undertake vigorous 
exercise is diminished and more sedentary forms of exercise are undertaken 
112.What is also clear is that a sedentary lifestyle has a strong predisposing 
influence on cardiovascular and metabolic diseases e.g. obesity, coronary 
artery disease, stroke and hypertension and mortality 113. 
Cardiologists have used treadmill exercise testing to detect coronary artery 
disease for many years, by looking for inducible ischaemia through incremental 
levels of exercise (such as the Bruce protocol), with a reasonable degree of 
sensitivity and specificity 114. Even in populations with high levels of coronary 
artery disease such as vascular patents, using the same technology and 
techniques to identify coronary ischaemia and then relate them to perioperative 
outcome was initially unsatisfactory, when compared to conventional nuclear 
imaging techniques 115. What was clear from early attempts however was that it 
was consistently possible to associate poor patient outcome with poor exercise 
performance, but many of the studies failed to reach statistical significance and 
were small studies 116-119. For instance the study by Bonow et al looked at 45 
patients with symptomatic aortic regurgitation and found exercise capacity to be 
a poor predictor of postoperative mortality and imprecise in assessing 
preoperative left ventricular dysfunction, but useful in predicting long term 
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survival after the operation 116. In a slightly larger study of 200 patients over 40 
undergoing major elective non-cardiac surgery Carliner et al were unable to 
demonstrate that exercise testing added substantially to the preoperative risk 
assessment with the only statistically significant predicator in multivariate 
analysis being the preoperative ECG 117. 
The 1980’s also saw the emergence of cardiopulmonary exercise testing which 
soon established itself as a well validated and repeatable measure of exercise 
capacity 120. In essence cardiopulmonary exercise testing consists of 
continuous expired and inspired gas analysis at the mouth, pulse oximetry, non-
invasive blood pressure measurement and recording of a continuous 
electrocardiogram whilst progressing through an incremental (ramped) exercise 
protocol on a bicycle ergometer or treadmill. Full details of measurement 
possibilities and analysis techniques are available in Chapter 5, but the two 
measurements of relevance to perioperative risk estimation are the maximum 
oxygen consumption (VO2 peak) and the anaerobic threshold (AT). 
Anaerobic threshold is a submaximal and objective marker of aerobic capacity 
and is reached significantly earlier in exercise than VO2 peak and as such is 
relatively independent of patient motivation. It is reached when the contribution 
from anaerobic respiration becomes significant and oxygen supply to the 
muscles cannot meet its demands. There are tables for VO2 peak that are 
based on age, height and gender to which values from cardiopulmonary 
exercise testing can be compared and is a very reproducible marker of 
cardiorespiratory fitness 121, 122. 
It wasn’t until 1993 that the first of two studies by Pauls Older’s group in 
Australia confirmed the correlation between exercise capacity and perioperative 
outcome 123. In a study of 187 elderly patients undergoing major surgery they 
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showed that an anaerobic threshold of <11 mls/Kg /min was associated with a 
mortality of 18% compared with the overall study mortality of 7.5% and a 
mortality rate of 0.8% for those with an anaerobic threshold of > 11 mls/Kg/min 
123. Furthermore for those with an At < 11 mls/Kg/min and preoperative 
ischaemia during testing the mortality increased to 42%, but preoperative 
ischaemia with a high anaerobic threshold i.e. > 11 mls/Kg/min had a mortality 
rate closer to 4% 123. 
In 1999 a second study by the same group additionally reported on a series of 
448 patients > 60 years of age undergoing major intrabdominal surgery in 
whom they used cardiopulmonary exercise testing to stratify care to an ICU, 
HDU or ward level postoperatively based on evidence of myocardial ischaemia 
and anaerobic threshold during cardiopulmonary exercise testing and the 
expected oxygen demand of the surgical procedure being undertaken 124. Again 
they found that an anaerobic threshold <11 mls/Kg/min was predictive of poor 
outcome, but equally important was that in those patients deemed fit for surgery 
and ward based care there were no deaths, compared to a study mortality of 
3.9% 124.  
In all eleven studies have looked at the utility of cardiopulmonary exercise 
testing to predict perioperative risk 123-133 of which the most recent systematic 
review includes nine studies 134. Two studies have looked at it’s utility in 
abdominal aortic aneurysm repair 125, 131 the first of which by Nugent et al used 
VO2 peak in 30 patients and found no association with postoperative 
complications in the 12 months of study follow up, but a trend towards more 
complications in those with a VO2 peak < 20/mls/Kg/min 131. Carlsile et al 
however found a stronger association in 130 patients with anaerobic threshold, 
VO2 peak and the Ventilatory equivalent for oxygen ( VE/ VO2  ) for survival, with 
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VE/ VO2 being the strongest predictor of 30 day and mid term survival 125 . The 
addition of the revised cardiac risk index to the cardiopulmonary exercise 
testing variables further enhanced the predictive ability of testing 125. 
Only one study has looked at 59 hepatic transplantation patients and grouped 
them retrospectively into survivors and non-survivors 126. They conclude that 
survivors were significantly more likely to have a VO2 peak < 60% of predicted 
and a VO2 – anaerobic threshold of <50% of predicted 126. 
Four studies have looked at upper gastrointestinal surgery patients 127-130. The 
first paper by Nagamatsu et al in 1994 in 52 patients found significantly more 
cardiopulmonary complications in the group with low VO2 max and anaerobic 
threshold 130. In their second paper in 2001 of 91 patients they retrospectively 
grouped patients with moderately advance oesophageal cancer into two groups 
according to the presence or absence of cardiopulmonary complications after 
oesophagectomy 129. They confirmed the finding of lower VO2 max values in 
those with complications but were unable to find the same association with 
anaerobic threshold 129. The study by Forshaw et al showed similar results in 78 
patients undergoing oesophagectomy, with significantly lower VO2 peak values 
in those with complications and although significant, relatively poor receiver 
operating characteristics curves of 0.63 (95% CI o.50 – 0.76) and 0.62 (95% CI 
0.49 – 0.75) for VO2 peak and anaerobic threshold respectively 127. The last 
upper GI study is by McCullogh et al in 109 bariatric patients undergoing 
laparoscopic bypass surgery 128. They used a slightly different approach by 
grouping patients into tertiles based on their VO2 peak and found a significant 
difference in complications for those with a VO2 peak of < 15.8 mls/Kg/min and 
for those with a VO2 peak > 15.8 mls/Kg/min of 16.6% and 2.8% respectively 
128. In addition despite recording anaerobic threshold it was not analysed as a 
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postoperative indicator but hospital length of stay and 30 day readmission rates 
were highest in those in the lower tertile for VO2 peak 128. 
Of the four studies looking at major elective surgery 123, 124, 132, 133, the two by 
Older et al have been described above 123, 124. The two studies by Wilson et al 
and Snowden et al are not only the largest (847 and 171 patients respectively) 
of the described studies but looked at mortality and complications respectively 
and used slightly differing thresholds for anaerobic threshold, (<10.9 mls/Kg/min 
vs. 10.1 mls/Kg/min) 132, 133. The largest study by Wilson et al of 847 patients 
were analysed retrospectively for clinical risk factors and cardiopulmonary 
exercise testing data to determine their relationship with all cause mortality after 
surgery. They found a clinical history of ischaemic heart disease, and anaerobic 
threshold <10.9 mls/Kg/min and a VE/ VO2 of >34 to be predictive of hospital 
and 90 day mortality, with anaerobic threshold having the highest risk ratio (RR) 
of 6.8 (95% CI 1.6 – 29.5) 133. Of interest is the elevation in the RR to 10.0 (95% 
CI 1.7 – 61) for those with no documented history of ischaemic heart disease 
133. Snowden and colleagues performed a prospective study on 171 patients 
using a algorithm based activity assessment, the Veterans Activity 
Questionnaire index (VASI), and cardiopulmonary exercise testing to look at 
complications on day 7 using the Post operative Morbidity Survery 132. In 
addition to the VASI being predictive of outcome they too found anaerobic 
threshold to be predictive of outcome with those having ≥ 1 complication having 
lower a lower anaerobic threshold (9.1 vs. 11.9 mls/Kg/min, P=0.001), that was 
accurate with an area under the curve of 0.85, a sensitivity of 88% and a 
specificity of 79% at an optimum anaerobic threshold of 10.1 mls/Kg/min 132. 
They conclude by stating “preoperative anaerobic threshold significantly 
improved outcome prediction when compared to the use of VASI alone” 132 
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It is clear from the studies described here that both VO2  peak, VE/ VO2 and 
anaerobic threshold are reproducible, accurate and capable of predicting 
perioperative mortality and morbidity. Furthermore CPET may have the ability to 
individualise risk prediction.	  
There is however a continued debate as to the exact physiological basis of 
anaerobic threshold 135, mainly because there is accruing evidence to suggest 
that hypoxia may not be the driving force for lactate production and that 
anaerobic threshold may be nothing more than a marker of exercise capacity. 
This theme will be examined in more detail later on in this chapter under 
metabolic performance on pages 62-69. 
The balance of evidence from the most recent systematic review suggests that 
VO2 peak and anaerobic threshold are useful markers to predict surgical 
outcome, with the evidence slightly favouring VO2 peak 134. Despite the fact that 
cardiopulmonary exercise testing has been used as a tool to predict surgical 
outcome and stratify surgical care for over 35 years, there have only been 2,308 
patients studied and published in peer reviewed clinical trials worldwide with 
nearly 1,000 of those published as recently as 2010 132, 133. This is in stark 
contrast to the fact that in 2009 over 10,000 cardiopulmonary exercise tests 
were estimated to have been done preoperatively in the UK alone as part of a 
preoperative assessment 136. There has always been a strong biological 
plausibility to cardiopulmonary exercise testing and it has been adopted widely 
throughout the UK despite a relatively light body of evidence to support it. 
Furthermore there is some disagreement and debate within the 
cardiopulmonary exercise testing fraternity as to which is the best marker of 
exercise capacity to use for preoperative testing with oxygen pulse, ventilatory 
equivalents, anaerobic threshold and VO2 peak all having protagonists and 
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detractors. One also needs to remember that not everybody can do an exercise 
test such as those with severe musculoskeletal pain or claudication. There are a 
number of prospective randomised clinical trials ongoing that will undoubtedly 
add to our understanding, but there is still a considerable setup and running 
cost to cardiopulmonary exercise testing coupled with its infancy and relatively 
small evidence base that has to borne in mind when evaluating it as a 
preoperative test. 
No currently published study has looked exclusively at cardiopulmonary 
exercise testing in orthopaedic patients to predict perioperative risk. 
1.2.4.4	   Shuttle	  testing	  
Shuttle walk testing has been validated shown to be an extremely reproducible 
test 137, 138. It requires patients to move on flat ground between two fixed points 
in a fixed amount of time that decreases as the test progresses. The more times 
the points are reached the greater the distance walked and the higher the 
assessment value. It is however more of a screening test for patients unlikely to 
need further investigation, with patients achieving in excess of 400m needing 
little or none and patients achieving less than 250m being referred on for further 
testing 137, 138.  
1.2.5	   Other	  Investigations	  
This section will focus on echocardiography and clinical guidelines. 
1.2.5.1	   Echocardiography	  and	  Clinical	  Investigations	  
No non-invasive or invasive clinical investigation is capable of predicting 
outcome alone. For the main part they are used as adjunctive tests in step wise 
assessment of perioperative risk as seen in the American College of Cardiology 
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/ American Heart Association guidelines on prevention of perioperative cardiac 
risk 11. Poldermans et al showed a highly significant reduction in mortality by 
instigating perioperative beta blockade for patients undergoing non-cardiac 
surgery, determined at risk by a positive Dobutamine Stress echocardiography 
(DSE) 139. As a test DSE has a high negative predictive value, but modest 
positive predictive value. Myocardial perfusion scintigraphy however has a high 
sensitivity but poor specificity and was found in a recent meta-analysis in 
vascular patients to be the less good test 140.  
The majority of adjunctive testing is however aimed at identifying occult 
coronary artery disease or stratifying known ischaemic and valvular heart 
disease. The main controversy in using these tests to predict perioperative risk 
is that they simply identify a treatable cardiac condition that may not improve 
perioperative risk if dealt with preoperatively. For instance the recent coronary 
artery revascularisation before major vascular surgery study, reports no benefit 
in stable coronary artery disease if prophylactically revascularised prior to 
surgery 141. Of note were the exclusion of patients with left main stem disease 
and unstable angina. With percutaneous coronary artery intervention comes the 
added complexity of the stents used i.e. bare metal or drug eluting and the 
optimum timing of surgery and stopping of antiplatelet agents designed to stop 
in stent thrombosis. The most recent European guidelines provide some 
guidance on the timing of surgery after such events with elective surgery being 
postponed for up to a year minimum for patients with new drug eluting stents 12, 
which further complicates the perioperative risk evaluation.  
 59 
1.2.5.2	   Handgrip	  dynamometry	  
The use of handgrip dynamometry to assess grip strength is not new and It has 
found widespread use in the fields of sport and exercise medicine. 
There are a wide variety of tests available to measure and analyse muscle 
strength and of these tests handgrip dynamometry is not only the simplest to 
apply, but also the most widely studied. Handgrip exercise also primarily affects 
only two flexor muscles, the flexor digitorum profuns and the flexor digitorum 
superficialis muscles. Consequent to this there is a large dataset available 
which describes the normal range of handgrip strength in normal and abnormal 
populations, enabling deviations from these to be objectively calculated. 
Handgrip strength has been shown to be a valid surrogate of overall muscular 
strength and is commonly used for this purpose 142, 143.  
In addition low handgrip strength has repeatedly been shown to be associated 
with disability, mortality, cognitive decline and adverse surgical outcomes 144. 
The most common use for handgrip dynamometry is as a test of strength and 
muscular function but there are studies that describe it’s use as an exercise 
therapy for instance the use of isometric exercise using handgrip dynamometry 
has also shown benefit in reducing systolic and diastolic blood pressure 145 
The most often studied groups are the elderly and surgical populations and in 
these it is grip strength that is most commonly cited as the predominant test 
value.  
1.2.5.2.1	   Normal	  values	  
The range of normal values for handgrip dynamometry is well-established 146-
150. Males have a higher average grip strength than females (mean (± SD) for 
30-34 year olds, 55 (7.1)N vs. 33.8 (5.9)N) 151, which declines with age (mean 
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(± SD) for 70 – 74 year olds, 41.7 (8.9)N vs. 26.4 (6.8)N 151. It is most probable 
that grip strength is stronger in the dominant hand than the non-dominant, but 
this may not be true for left handed people with some studies suggesting the 
non-dominant hand to be up to 22.6% stronger 152. 
 
The following section will describe the association of grip strength studies with 
clinically important outcomes. 
1.2.5.2.2	   Grip	  strength	  
Grip strength is the most commonly used test endpoint of handgrip 
dynamometry. 
1.2.5.2.2.1	   Postoperative	  outcomes	  
There are eighteen studies that directly relate handgrip strength to perioperative 
outcomes in the literature, (see Table 1.12) 153-169. The most common 
perioperative outcome predicted by limited grip strength is postoperative 
complications. The finding is not universal however with some authors finding 
no relationship between low grip strength and postoperative complications 154-
156. There are a number of clear advantages to using such a simple technology 
when compared to cardiopulmonary exercise testing in that a bicycle ergometer 
and metabolic cart are not needed, the result is on the whole very objective and 
can be performed by those bed bound such as with fractured neck of femur 
patients or patients undergoing emergency surgery. 
Most recently Beloosesky et al looked retrospectively at 105 patients who had 
been operated on for a fractured neck of femur and found a reasonable 
correlation between handgrip strength 1 week postoperatively and functional 
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recovery at 6 months 153. Three other studies have also looked at fractured neck 
of femur patients who represent a particularly frail group with common 
nutritional and mobility deficiencies 157, 167, 169. The largest of which in 205 
female post neck of femur fracture patients only showed a moderate correlation 
with functional outcome compared to Beloosesky 169. Visser et al report a 
similar story by following up 90 women for 1 year and showing that the group 
that lost almost 29% of their grip strength had a poorer functional recovery 167. 
Only one study was performed on coronary artery bypass patients and failed to 
show any benefit in predicting length of stay or compilations 155.  
Of the two studies in liver transplant patients, handgrip testing was done as part 
of a nutritional assessment preoperatively 158, 164. The study by Figueiredo in 53 
patients did not demonstrate any correlation with complications, but did show 
lower grip strength to be significantly associated with a longer ICU stay 158. In 
the slightly larger study by Le Cornu in 82 patients there was a significant 
association with major perioperative complications, sepsis and length of stay for 
those with a grip strength <85% of normals 164. The remaining studies can be 
divided into four categories: Abdominal surgery (n=4), Major surgery (n=4), 
Vascular surgery (n=1) and Maxillofacial surgery (n=1). The studies by Brenner 
and Dannhauser in major and abdominal surgery respectively did not show any 
correlation between handgrip strength and perioperative outcome 154, 156. In 
addition to doing preoperative handgrip strength testing Griffith et al also tested 
on days 1,3,5 and 7 postoperatively in 61 vascular patients. Grip strength per se 
was not predicative of mortality for the six patients that died, but the decrease in 
grip strength from the first to the 7th day was predictive for the seven patients 
who developed complications 159. The one maxillofacial study found a value of 
preoperative grip strength <85% of controls to be highly predictive of 
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postoperative complications (48% vs 18%, P=0.004) 160. Mahalakshmi used 
four predictive parameters to predict perioperative complications in 100 
abdominal surgery patients and found maximal grip strength to be better than 
serum albumin but worse than clinical nutritional scoring in predicting 
complications 165. Kidjian in a similar group of 102 abdominal surgery patients in 
whom 87% developed complications found handgrip strength to be the most 
sensitive test in predicting complications compared to standard biochemical 
nutritional variables 163. Similarly Kalfarentzos found handgrip dynamometry to 
be more sensitive (77.78 vs 66.6%), more specific (86.11% vs 65.28%) and 
have a higher positive predictive value (58.33% vs 32.4%) for predicting 
postoperative mortality and morbidity than their standard prognostic nutritional 
index, with dynamometry being 100% sensitive for mortality 163. Hunt used grip 
strength as part of a preoperative nutritional status indicator in a group of 205 
surgical patients with a complications rate of 14% and found it to be the most 
sensitive single parameter in predicting postoperative complications 161. Webb 
et al derived control data from 247 healthy volunteers and found a grip strength 
of less than 85% to be the best cut off value for predicting postoperative 
complications with a sensitivity of 74% 168.  Finally Schroeder et al found a weak 
but significant (r2=0.352, P=0.01) correlation between grip strength and 
postoperative fatigue in 84 patients undergoing surgery 166. 
What the vast majority of these studies have in common is that they were done 
as part of or instead of a nutritional assessment, reflecting the fact that elderly 
surgical patients often represent a potentially frail malnourished group at high 
risk of perioperative complications and death. It is entirely possible that 
publication bias may have altered the balance of this review with only 3 of the 
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studies reporting negative results, but there is a strong biological plausibility to 
strength and recovery and likely represents a true result. 
As alluded to earlier in this thesis the concept of handgrip dynamometry to 
predict surgical outcome is very appealing for a number of reasons. Firstly there 
is a vast wealth of literature from which to draw normal values for populations 
for comparison. Secondly the technique is both repeatable and easy to 
standardise with most available equipment being easy to calibrate and most 
equipment being eminently portable. Thirdly the result of a maximal voluntary 
contraction or an average of three attempts provides a relatively succinct 
endpoint for the test that is easily quantifiable. Fourthly the cost of equipment is 
very cheap, as are the running costs and the interpretation of the test does not 
need such advanced training as that needed to interpret a cardiopulmonary 
exercise test. Fifthly the forearm lends itself very well to scientific study with the 
majority of exercise being done by 2 muscles, the fact that it has predominantly 
one artery to supply it and the ability to sample venous effluent from exercising 
muscle from the antecubetal fossa where most of the deep veins drain and it’s 
accessibility. Lastly unlike whole body exercise such as running or cycling, 
exercise by the forearm muscle does not rely so heavily on large increase in 
cardiac output by the heart and lungs and is thus relatively independent from 
the cardiopulmonary system, allowing relatively moribund patients to perform 
the test. 
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Table 1.12 Perioperative handgrip exercise studies used to predict postoperative outcome 
Study Year Number of 
patients 
Type of surgery Conclusions & test Predicated Significant 
Beloosekyet al 2010 105 Fractured neck of femur Lower grip strength 1 week post hip fracture 
Motor function at 6 
months yes 
Brenner et al 1989 249 Major surgery Lower preoperative grip strength 
Increased frequency of 
complications no 
Cook et al 2001 200 Coronary heart bypass surgery Maximum grip strength Complications, LOS no 
Dannhauser et al 1995 52 Abdominal surgery Preoperative grip strength Part of prognostic model no 
Davies et al 1984 76 Female Hip fractures Grip strength < 15 Kg Complications yes 
Figueirdo et al 2000 53 Liver Transplant Lower preoperative grip strength ICU LOS yes 
Grffith et al 1989 61 Vascular Surgery Reduced preoperative grip strength Complications yes 
Guo et al 1996 127 Oral and maxillofacial cancer Preoperative grip strength<85% of controls Complications yes 
Hunt et al 1985 205 Surgery Preoperative grip strength<85% of normal Complications yes 
Kalfarentzous 1989 95 Gastrointestinal cancer Preoperative grip strength<85% of normal Mortality, morbidity yes 
Klidjian et al 1980 102 Abdominal surgery Preoperative grip strength<85% of normal Complications yes 
Le Cornu et al 2000 82 Liver Transplant Preoperative grip strength<85% of normal 
LOS, Complications, 
Sepsis yes 
Mahalakshmi et al 2004 100 Abdominal surgery Strength =<85% control mean Complications, LOS yes 
Schroeder et al 1993 84 Major surgery Lower preoperative grip strength Postoperative fatigue yes 
Visser et al 2000 90 Female hip fractures Loss of grip strength Poor mobility recovery yes 
Webb et al 1989 90 Major surgery Preoperative grip strength<85% of normal Complications, LOS yes 
Wehern et al  2005 205 Female fractured neck of femur Lower Grip strength Functional outcome yes 
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1.2.5.2.2..2	   Mortality	  
Low levels of physical inactivity lead to low muscle mass and associated 
low muscle strength. In a longitudinal study of 1071 men over a 25 year 
period Metter et al showed a clear link between grip strength and 
mortality 170. They found that a low and declining muscle strength was 
associated with mortality but was independent of muscle mass or 
physical activity 170. Furthermore for those <60 years old it was the rate of 
loss of strength that proved most predictive, whereas in those > 60 years 
old strength itself was more important. 
Recently Ling et al published a series of 555 Dutch subjects who were 
followed up over 9.5 years in a subset analysis of the Leiden 85-plus 
study. Four hundred and forty four (80%) of these patients died during 
this time, with an elevation of all cause risk for mortality in those in the 
lowest tertile at 85 years of age ([HR] 1.35) and those in the lowest two 
tertiles at 89 years of age ([HR] 2.04) 171. 
1.2.5.2.2.3	   Cognitive	  decline	  
In a 7 year follow up study of 2160 Mexican Americans, Alfaro-Acha et al 
showed an association between those subjects in the lowest quartile for 
handgrip strength and their decline in cognitive function over time 172. 
With those in the upper quartile having relatively well preserved cognitive 
function over the course of the study 172.  
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1.2.5.2.2.4	   Causality	  
There is unlikely to be a causal link between grip strength and outcome, 
moreover grip strength reflects function or the nutritional state of the 
patient. However in a large scale study of 919 moderately and severely 
disabled women Rantanen et al suggest that handgrip strength is a 
powerful predicator of all cause mortality and an indicator of overall 
muscle strength, but “may predict mortality through mechanisms other 
than those leading from disease to muscle impairment” 173. 
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1.3	   Metabolic	  performance	  and	  exercise	  physiology	  relevant	  to	  this	  
thesis	  
The release of muscle metabolites during exercise evokes potent 
cardiovascular reflexes to increase blood pressure and vasoconstrictor 
responses to counteract local vasodilatation, increasing sympathetic 
discharge to active and in active muscle 174. Furthermore there is 
evidence that these responses may be attenuated or modified by 
exercise training 175. Intensive handgrip exercise does not however 
significantly challenge the cardiorespiratory system in healthy individuals. 
Muscles cells and their mitochondria derive oxygen from the arterial 
system through the dissociation of oxygen from haemoglobin and 
diffusion across the capillaries to the cell 176. Under conditions of intense 
exercise such as a 100m sprint the cellular demand for oxygen outstrips 
its capacity for delivery resulting in hydrogen ions release through 
adenosine triphosphate (ATP) hydrolysis, which are not effectively 
buffered by mitochondrial ATP production. The result is a net transport 
out of the cell via the lactate/H+ transporter and the H+/Na+ exchanger 
and diffusion into the blood 177, 178. It is however difficult to study the 
cellular process directly, but studies with intramuscular catheters have 
given us some insights 179, as have nuclear magnetic resonance 
scanning 180, 181. 
The traditional concept of lactic acidosis occurring when the supply of 
oxygen to the tissue does not meet it’s demands, may not be entirely 
correct 182. Glycolysis is the metabolic pathway by which glucose is 
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converted into glucose and pyruvate. The energy release during this 
process is converted into high energy compounds such as ATP and 
reducing compounds such as nicotinamide adenine dinucleotide (NADH). 
Under aerobic (oxygen dependent) conditions this is a highly effective 
pathway liberating 34 moles of ATP via further aerobic reactions utilising 
pyruvate and NAD+, but under anaerobic conditions (oxygen 
independent) only two molecules of pyruvate are produced and two 
molecules of ATP. The net result of anaerobic respiration is a greater flux 
of substrate through the pathway, which can quickly exhaust available 
substrate and is therefore limited in its longevity. Under aerobic 
conditions oxygen acts as the final electron acceptor in the respiratory 
chain. There are four main steps to the process: 1) The pyruvate formed 
from the glycolysis of glucose is converted into acetyl-CoA and CO2 
within the mitochondria, 2) The acetyl CoA enters the enters the Krebs 
Cycle or the citric acid cycle where it is fully oxidised to carbon dioxide 
and water with net NADH production, 3) The NADH is oxidised to NAD+ 
by the electron transport chain, creating a hydrogen ion gradient across 
the inner membrane of the mitochondria and 4) The proton gradient 
drives oxidative phosphorylation to produce ATP. Under anaerobic 
conditions it is much simpler with the pyruvate produced from glucose 
acting as the main oxidiser and in the process being converted to lactate. 
This results in the oxidation of NADH back to NAD+ (see Figure 1.2) 
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Figure 1.2 The conversion of pyruvate to lactate. 
 
Pyruvate + NADH + H+  Lactate + NAD+ 
NADH = Nicotinamide adenine dinucleotide 
 
The acidosis that occurs in exercise and is associated with lactate is 
predominantly derived from the cleavage of ATP to release hydrogen 
ions. Under anaerobic conditions it is anaerobic metabolism that 
produces most ATP as it is capable of producing it at a high rate and 
hence the associated acidosis as the buffering systems of the cell are 
overwhelmed. This has theoretical physiological advantage in that it 
encourages oxyhaemoglobin to dissociate and release oxygen from he 
blood to tissues. 
There is continued controversy however, about the role that a lack of 
oxygen plays in the stimulus to produce first pyruvate and then lactate, 
with increasing evidence to suggest that oxygen availability is only one of 
several factors that may cause an increase in muscle and blood lactate 
during exercise 183-185. The normal range for lactate in venous blood is 0.5 
– 2.2 mmol/L 186, 187, with lactate being produced at rest by glycolysis in 
the presence or absence of oxygen 188. Exercise physiologists have long 
since used the concept of a “lactate threshold” to evaluate athletes and 
help design training programs, but its definition is not clearly defined and 
is often used interchangeably with anaerobic threshold which may be 
technically incorrect, although they both represent a spectrum of 
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metabolic change. Connett best described the lactate threshold as “The 
point during exercise of increasing intensity at which blood lactate begins 
to accumulate above resting levels, where lactate clearance is no longer 
able to keep up with lactate production” 184. During low intensity exercise 
lactate levels do not become elevated and remain close to normal levels, 
but rise quickly as the intensity of exercise increases, commonly showing 
a sharp upward inflection point 189, 190. The accumulation of lactate 
however simply reflects the ratio of production to clearance at that 
particular point in time and does not tell us anything about the availability 
or non-availability of oxygen, hence using the terms anaerobic or aerobic 
threshold may be misleading. As the concentration of blood lactate rises 
above 4 mmol/L there is an accumulation of lactate referred to as the 
onset of blood lactate accumulation, which is often used in preference to 
the lactate threshold as it can be hard to identify with certainty 191, 192. The 
best indicator of performance however is probably the maximal lactate 
state when the rate of lactate clearance equals the rate of lactate 
production 193, 194. Lactate threshold is commonly expressed as a 
percentage of maximal oxygen consumption (VO2 peak/max) with elite 
athletes having lactate thresholds at 70-80% of VO2 peak/max and 
untrained individuals operating closer to the 50-60% mark 195, 196. Even if 
two people have the same VO2 peak/max it does not necessarily mean 
they will have the same lactate threshold, and the one with a higher 
lactate threshold will generally perform better in endurance type exercise 
196. It is possible to improve an individuals lactate threshold through 
training. For instance Costill et al showed a peak lactate level of 
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approximately 12 mmol/L could be reduced to approximately 6 mmol/L in 
200m swimmers with a dedicated training program over 25 weeks 197 but 
there is debate as to whether this is through decreased production 198 or 
through increased clearance of lactate 199.  
As shown above the generation of lactate allows for the continued 
processing of carbohydrates into ATP through glycolysis and although 
traditionally though of as a waste product of metabolism it is a functional 
part of the energy supply chain. There is clear evidence that lactate is 
passed from cell to cell as two carbon fragments to allow for processing 
in different cells and organs via the lactate shuttle as described by Brooks 
in 1984 200. Lactate that is not oxidised in the muscle diffuses into the 
blood where it is transported to the liver in a process known as the Cori 
cycle, where it can be converted back into pyruvate in the presence of 
oxygen, which can then recreate glucose through gluconeogenesis. 
Furthermore Lactate is the preferred source of fuel for the brain, heart 
and most slow twitch muscle fibres 201-203. 
Peak levels of lactate can reach over 30 mmol/L, but more commonly 20-
25 mmol/L is normal 204, with peak levels occurring in the blood up to 5 
minutes after the cessation of exercise 186. Of considerable interest is the 
fact that trained individuals are not only capable of generating higher 
levels of lactate at the point of failure, but can perform similar levels of 
work with lower levels of lactate than untrained individuals 205. 
Although overly simplistic the effects of exercise training are essentially 
twofold. Firstly there is an improvement in VO2 peak and although this is 
largely genetically determined an untrained individual can improve their 
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VO2 peak by as much as 20% 188, 206. Much of this increase comes from 
improvements in cardiorespiratory performance with enhanced gas 
exchange and blood flow through the lungs, increased cardiac output and 
enhanced blood flow to skeletal muscle, organs and tissues hence 
improving oxygen delivery. Secondly there are peripheral adaptations at 
the muscular and cellular level resulting in better exercise efficiency and 
fuel utilisation. As described above the lactate threshold may rise or the 
point at which lactate begins to acumulate can certainly be improved 207, 
208. These peripheral adaptations are however complex and not 
completely understood. At a musculoskeletal level there is an increase in 
the size and density of mitochondria, an increase in oxidative enzyme 
activity, increases in myoglobin concentrations and increased capillaries 
in muscle. There also appears to be a change in the metabolic 
characteristics of muscle fibres with endurance training. Elite endurance 
athletes have a high proportion of type I muscle fibres which have a high 
mitochondrial density and enzyme capacity allowing most energy 
production to be derived from aerobic metabolism 209, 210. Whilst training 
does not appear to change the muscle type (i.e. Type II to type I), it does 
make them metabolically more efficient 211, 212. The culmination of these 
changes mean that the body is better able to produce energy via aerobic 
metabolism and to utilise and tolerate better the end products of 
anaerobic metabolism.  
The exercise physiology of patients with comorbidities may not be so 
straightforward but does appear to be in keeping with the mechanisms 
described above. Studies in patients with chronic heart failure have 
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shown that low level exercise can improve exercise tolerance, not 
through improvements in central cardiac performance i.e. cardiac output 
and stroke volume but mainly through peripheral adaptations, with an 
increase in mitochondrial density and thus an improvement in oxidative 
capacity 213. This is an important observation and is in keeping with other 
studies that suggest improvements in functional capacity with training are 
primarily dependent on peripheral changes 214, 215. 
It is clear in healthy individuals that training improves central cardiac 
performance and thus the ability to deliver and utilise oxygen in 
exercising tissues as well as raising an individual’s tolerance to 
academia, lactate accumulation and possibly their ability to utilise lactate 
more effectively. Fitter patients may also benefit from these advantages 
when undergoing surgery, but the picture is less straightforward. The 
balance of evidence suggests that artificially raising an individual’s 
oxygen delivery by manipulation of central haemodynamics with fluids 
and positive inotropes to levels around 600 mls/min/m2 decreases both 
mortality and morbidity in moderate and high risk surgical patients 216. 
Whilst others have shown that it is the rate of lactate clearance that 
predicts survival and not the raising of oxygen delivery itself 217. Indeed 
high levels of lactate and the inability to clear them have long been seen 
as bad prognostic markers in the critically ill, with lactate simply reflecting 
early energy failure and an imbalance between supply and demand 218. 
Peripheral adaptations of the oxidative system have not been consistently 
proven with the artificial manipulation of central haemodynamics in 
perioperative care and it is likely the benefit from such short therapy, (1 – 
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12 hours) is through the prevention of organ under perfusion, but this 
remains a very controversial area. 
Cardiopulmonary exercise testing is capable of identifying the anaerobic 
threshold of an individual at submaximal exercise and is strongly reliant 
on both the central cardiorespiratory performance i.e. oxygen delivery, as 
well as the peripheral cellular performance of that individual i.e. 
mitochondrial density and efficiency. The identification of the anaerobic 
threshold by cardiopulmonary exercise testing has been shown to be 
predicative of surgical outcome. Short-term intense exercise in the 
forearm is however likely to be much more reliant on the peripheral 
cellular performance than it is on the central cardiorespiratory 
performance. It is plausible therefore that identification of the anaerobic 
threshold or a surrogate thereof of a small muscle group in the forearm in 
a forearm exercise model may be equally predictive of surgical outcome 
as that identified by cardiopulmonary exercise testing, accepting the fact 
that it is more reliant on peripheral cellular performance.  
1.3.1	   Rhythmic	  isometric	  exercise	  (Cyclical)	  
Rhythmic or cyclical exercise implies a repetitive cycle of muscle 
contraction and release. Exercise can be both isometric and rhythmic. 
The forearm has been a popular organ to study due to its simplicity of 
access and it’s supply from one predominant artery. Despite this, exact 
values of oxygen, acid base and lactate for exercising muscle are not 
always reported. 
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Soller et al looked at the influence of increasing maximal voluntary 
contraction on intramuscular and venous values of oxygen and acid base 
status of exercising muscle 179. They used rhythmic isometric handgrip 
exercise at increasing levels of MVC with a 2s on and 1 second off 
pattern. They were able to demonstrate that intramuscular oxygen had 
reached close to 0 Kpa with maximal voluntary contractions of 30% and 
45%, although it was clearly possible to demonstrate changes in both 
venous and intramuscular values from 15% of maximal voluntary 
contraction 179. Interestingly they observed an approximately 50% 
reduction in venous PO2 which began to plateau out as exercise 
continued but found intramuscular PO2 continued to drop to near zero 
levels 179. They also observed reduction in pH and elevations on PCO2 as 
exercise progressed and that as the exercise intensity increased the 
separation between intramuscular and venous values increased, with 
intramuscular levels continuing to rise at a faster rate 179. 
Sogol et al used increasing transmural pressure to mimic ischaemic 
conditions or a mismatch in the oxygen supply/demand balance using 
three different models of exercise that varied in maximal voluntary 
contraction, contraction patterns per minute and the pressure applied to 
the exterior of the forearm in a sealed tank to assess the effects of 
training on pressor responses 175. They showed a positive effect of 
training by having to increase the level of transmural pressure applied to 
produce a similar but attenuated metabolic response including lactate and 
pH changes. They were not however able to demonstrate changes in 
venous oxygenation change with training 175. 
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There is an increase in blood flow following muscle contraction during the 
relaxation phase as local metabolites cause vasodilatation and for 
intermittent isometric exercise it is most likely that muscle oxygenation is 
maintained as oxygenated blood is returned to the exercising muscles 219. 
 
1.3.2	   Static	  isometric	  exercise	  (Isometric)	  
There are far fewer studies that report static handgrip exercise with 
concomitant measurement of muscle metabolites. Cui et al used lactate 
as a surrogate marker of cellular metabolites when trying to deduce the 
effect of muscle metabolites on mechanorecptor mediated muscle 
sympathetic activity. They used a static isometric exercise regime at 30% 
of MVC until fatigue, by sampling lactate from the antecubital vein they 
were able to show a significant increase in lactate above basal levels with 
venous lactate levels of 2- 3 mmol/L 220. 
In an effort to understand the contribution of aging to metaboreceptor 
induced sympathetic response to hypoxia, Houssiere et al were able to 
demonstrate significant changes from baseline for lactate by using a 
regime of 30% MVC for 3 minutes, but do not report mean and standard 
deviations for the quantity of lactate released 221. 
During isometric exercise there is a consequent rise in intramuscular 
pressure and a reduction in blood flow in the microcirculation because of 
vessel compression 222. The compression leads to a rapid ejection of 
blood from these vessels and in turn restricts the arterial flow of blood to 
the exercising muscle 219. Sustained isometric exercise (>30% maximal 
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voluntary contraction) is always accompanied by an increase in 
intramuscular pressure and consequently causes substantial and 
sustained ischaemia to the exercising muscle 223-225. These observations 
suggest that sustained isometric exercise should create favourable 
conditions to stimulate anaerobic metabolism in the exercising forearm 
muscles and produce a proportionate metabolic response. The study by 
Katayama et al go some way to confirming this hypothesis 226. They used 
a sustained and intermittent model of isometric exercise to look at the 
effects of hypoxia on muscle deoxygenation. They found as hypothesised 
that hypoxic conditions had no discernable effect on the sustained 
isometric model but did on the intermittent isometric model with respect to 
muscle deoxygentation, suggesting that sustained isometric forearm 
exercise produces more hypoxic conditions 226.  
Both an intermittent and sustained isometric forearm exercise model will 
be taken forward as candidate models for forearm exercise to predict 
surgical outcome and will be the main theme of this thesis. 
I would hypothesise that the isometric forearm exercise model is likely to 
produce a model with a greater stimulus to anaerobic metabolism and 
give a stronger and clearer signal. The cyclical model however may be 
more tolerable due to partial replenishment of the blood supply in the 
relaxation phase of it’s cycling resulting in more work being done over 
time with the potential to produce a larger metabolic signal, which may be 
more useful in a patient population. 
There is to my knowledge no study that has looked at the metabolic 
output i.e. the measurable venous products of metabolism; forearm 
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lactate, SO2, PO2, PCO2, pH and tissue oxygenation (STO2) of a 
standardised handgrip exercise model to predict surgical outcome. 
Throughout this thesis the term metabolic output will refer to the 
measureable markers of anaerobic metabolism in venous blood i.e.; 
forearm lactate, SO2, PO2, PCO2, pH and tissue oxygenation (STO2) as 
measured by near infrared spectroscopy. 
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1.4	   Hypothesis	  
Cells that are deprived of oxygen have to utilise anaerobic respiration to 
produce energy rich compounds capable of sustaining cellular function. 
Exercise above an individual’s anaerobic threshold results in 
proportionally more anaerobic respiration and the production of end 
products of metabolism such as lactate, Hydrogen ions and CO2.  
There is a reasonable body of evidence to suggest that assessing an 
individuals anaerobic threshold through cardiopulmonary exercise testing 
may help in predicting surgical outcome and stratifying perioperative care 
and that handgrip dynamometry has been shown to be capable of 
predicting surgical outcome through grip strength determination. 
This thesis will set out to explore a number of hypotheses: 
1) There is a fundamental difference in the metabolic output i.e the 
measurable venous products of metabolism; forearm lactate, SO2, 
PO2, PCO2, pH and tissue oxygenation (STO2) between a rhythmic 
isometric (Cyclical) handgrip exercise model and a static isometric 
(Isometric) handgrip exercise model. 
2) The metabolic output from exercising forearm muscle i.e the 
measurable venous products of metabolism; forearm lactate, SO2, 
PO2, PCO2, pH and tissue oxygenation (STO2) or cumulative 
markers thereof of a standardised handgrip exercise model will 
have a direct relationship to the anaerobic threshold in the same 
individual as measured by cardiopulmonary exercise testing. 
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3) The metabolic output from exercising forearm muscle i.e. the 
measurable venous products of metabolism; forearm lactate, SO2, 
PO2, PCO2, pH and tissue oxygenation (STO2) or cumulative 
markers thereof of a standardised handgrip exercise model will be 
able to identify those patients at risk of a poor surgical outcome 
and thereby allow it to be used as a preoperative test instead of 
cardiopulmonary exercise testing, or for those patients unable to 
perform a cardiopulmonary exercise test. 
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1.5	   Plan	  of	  investigation	  
This thesis will firstly examine the practicality and metabolic response of 
two different standardised forearm exercise models to look at the impact 
of different exercise regimes (cyclical and isometric) on muscle and 
cellular function in healthy volunteers (Chapters 2,3 & 4). 
The performance of each standardised forearm exercise model will then 
be benchmarked against formal cardiopulmonary exercise testing in the 
same group of healthy volunteers to identify a candidate standardised 
forearm exercise model and test endpoint (Chapter 5). 
The standardised forearm exercise model will be prospectively trailed in a 
pilot cohort of orthopaedic patients undergoing joint replacement for its 
ability to predict postoperative outcome (Chapter 6).  
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Chapter	  2:	  THE	  DEVELOPMENT	  OF	  A	  CYCLICAL	  HANDGRIP	  
EXERCISE	  MODEL	  
2.0	   INTRODUCTION	  
Exercising muscle uses oxygen to produce high-energy compounds such 
as ATP that help sustain muscular activity. Oxygen delivery to the 
exercising muscle is crucial in bringing enough oxygen to sustain aerobic 
respiration and the efficient production of large quantities of ATP for each 
molecule of glucose used. Most often physical performance is limited by 
the amount of oxygen that can be delivered per unit time, otherwise the 
muscles rely on inefficient anaerobic respiration to supply energy. This 
process cannot continue indefinitely and there is a large variation in the 
population in their ability to sustain aerobic respiration. Elite endurance 
athletes most commonly have high anaerobic thresholds which can be 
improved with training 196. 
A forearm model has been used before to look at the expression of 
cytokines and muscle metabolism during exercise and is a useful model 
because it is easily accessible, amenable to blood sampling and simple to 
quantify work done or a force applied to it.  
There are two principle methods of exercising the muscles of the forearm. 
The first is a sustained contraction, so called “Isometric exercise” and the 
second is cyclical or “repetitive isometric”. Each has a number of 
strengths and weaknesses as a model as outlined in Chapter 1.  
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The forearm model was chosen to explore further the relationship 
between oxygen utilisation, tissue oxygenation and metabolism in the 
exercising muscle. In Chapter 5 a comparison is made between isolated 
muscular exercise and whole body exercise with regards to oxygen 
utilisation.  
This chapter will look at the development of a forearm exercise model 
based on a cyclical pattern of isometric work and rest and examine it’s 
effect on local markers of aerobic and anaerobic metabolism. 
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2.1	   Effects	  of	  venous	  occlusion	  
Effect of venous occlusion for cannulation on venous blood gas variables 
It is most probable that the venous occlusion required for cannulation of 
the antecubital fossa will have an effect on the metabolism of the forearm 
muscle secondary to venous blood stagnation and oxygen utilisation. 5 
healthy volunteers were studied to determine the time required for venous 
blood gas variables to return to normal values after 60 seconds of venous 
occlusion. A tourniquet was applied to the upper arm to achieve venous 
occlusion during which a 20G cannula was inserted into the antecubital 
fossa of the same arm, to which a 3-way tap was connected. The 
tourniquet was released after a total of 60 seconds. Uncuffed sequential 
venous sampling was undertaken at 30-second intervals for 5 minutes 
thereafter via the cannula and analysed on a Radiometer series 700 for 
pH, PCO2, PO2,  SO2 and lactate. The dead space of the cannula was 
discarded prior to each sample being drawn and flushed with 5 mls of 
0.9% saline after each sample was drawn. 
2.1.1	   Results	  
For the majority of subjects there was a return to steady state of the blood 
gas variables by 180 seconds. All of the subjects had returned to steady 
state (Less than 5% variability) by 210 seconds (see Figure 2.1). 
To ensure the effects of venous occlusion did not influence the results, 
based on the observations in the healthy volunteers a period of 5 minutes 
was set between venous cannulation and the drawing of samples for 
baseline data. 
 85 
Figure 2.1 Graph of forearm lactate decline to a steady state after venous cuffing 
for cannulation. Each line represents a single subject, with samples taken at 30 second 
intervals. 
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2.2	   MATERIALS	  AND	  METHODS	  
2.2.1	   Subjects	  
Healthy adult individuals were recruited by local advertisement. All 
subjects gave written informed consent to the study as had been 
previously agreed by the local research ethics committee of University 
College London Hospitals. All subjects were screened as healthy by 
questionnaire and medical examination by the study investigator prior to 
participating in the study. 
2.2.2	   Equipment	  
2.2.2.1	   Near	  Infrared	  spectroscopy	  measurement	  of	  tissue	  oxygenation.	  
Near infrared spectroscopy (NIRS) uses fibre-optic light in the near 
infrared light spectrum to measure the percentage of oxygen saturation in 
haemoglobin and associated chromophores based on spectrophotmetric 
principles 227. NIRS has been used successfully for many years to 
measure tissue oxygenation in human and animal muscle under static 
and exercising conditions with variable degrees of accuracy depending 
on methods used, site of measurement and size of probe used (a 
surrogate of tissue penetration)225-239. A new generation of NIRS machine 
was used to monitor tissue oxygenation saturation (STO2), because of an 
increase in it’s accuracy due to algorithm development 227. The NIRS 
machine uses single depth attenuation measurements at 680, 720, 760 
and 800 mm and uses second derivative spectroscopy to reduce light 
scattering effects. It differs predominantly from previous methods by 
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using a wide 40 mm wavelength gap to improve sensitivity to 
oxyhaemoglobin 227. NIRS measures arterial and venous oxyhaemoglobin 
at the microcirculatory level and is a reflection of both oxygen delivery 
and oxygen consumption 240, 241. The light emitted from a probe attached 
to the surface of the skin is reflected back from the tissues that underlie it 
to give an average of absorbance which is recorded by the machine to 
give an indication of the ration of oxygenated and deoxygenated blood. 
Near infrared spectroscopy was used to measure tissue oxygen 
saturation in the exercising forearm muscle using an Inspectra™ Tissue 
spectrometer model 325. The Inspectra™ was attached to a computer 
running Inspectra™ software version 2.0 via an Inspectra™ Optolink™ 
RS232 Optical converter. This provided real time acquisition of data at 3-
second intervals, which was stored on the computer for later analysis. 
Prior to each experiment the Inspectra™ was calibrated using the 
Inspectra™ calibrator and checked using the Inspectra™ system check 
for high and low point calibration checks. A self-adhesive foam pad used 
to house the 15 mm probe of the Inspectra™ was placed on the belly of 
the exercising forearm muscle prior to any exercise for 5 minutes to allow 
stabilisation of the signal. 
2.2.2.2	   Handgrip	  dynamometry	  setup	  
An alloy pinch grip transducer (MIE medical research Ltd, Leeds, UK) 
was attached to a digital analyser (MIE medical research Ltd, Leeds, UK), 
which in turn was connected to computer running WINCAS software (MIE 
medical research Ltd, Leeds, UK) (see Appendix for software screen 
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shots). The computer stored real time analogue data for the duration of 
the experiment for later analysis. In addition to data storage the WINCAS 
software provides a visual and audible feedback system to the subject. 
The width of the prongs on the pinch grip analyser was adjusted to the 
individual’s hand size as per manufacturer’s instructions. The pinch grip 
transducer was factory calibrated before testing and as per 
manufacturer’s guidelines and only needs calibrating at 12 monthly 
intervals thereafter. The pinch grip apparatus was software calibrated 
before each individual experiment. Subjects were instructed to grip the 
transducer below the red marks, ensuring accurate force transduction. If 
necessary the subject’s position was adjusted to keep the forearm 
parallel to the desk on which it rested and the transducer held in an 
upright position to ensure each subject used the same muscle groups -
see Figures 2.2 a) & b). 
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Figure 2.2 a) Photograph of apparatus set-up. b) Schematic representation of 
total setup including near infrared spectroscopy (NIRS) probe on exercising forearm 
muscle group. 
 
a)  
 
 
b)  
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2.2.3	   Protocol	  
Each subject had their maximal voluntary contraction established by 
taking the highest value from 3 maximal force exertions prior to 
cannulation or exercise and were allowed to rest for 10 minutes. A 20G 
indwelling intravenous cannula was inserted into the non-dominant 
forearm of the subject. The non-dominant arm was used because there is 
some evidence to suggest a reduced grip strength compared to the 
dominant arm and the muscles may not be as aerobically conditioned as 
the dominant arm, which may produce a more pronounced metabolic 
response 152. A 3-way tap was attached and flushed with 5mls of 0.9% 
saline. Samples where then withdrawn at specified time intervals by first 
aspirating the dead space of the 3-way tap without any cuff occlusion and 
then aspirating into a blood gas syringe. A minimum of 5 minutes was 
given before the first sample was withdrawn to negate any effects of 
venous cuffing on muscle metabolism of oxygen use. 
For cyclical exercise the subjects were asked to exert a maximal 
voluntary contraction (MVC) for 2 seconds then to relax for 3 seconds. 
This cycle was repeated for 300 seconds i.e. 60 cycles, followed by 300 
seconds of rest before the final measurements were taken. Audible 
metronomic instructions were given by the computer to “squeeze” and 
“relax” coupled with visual strain gauges prompting the subjects when to 
squeeze and when to relax (see Figure 2.2).  
Subjects were asked to rate the intensity of the exercise using the Borg 
scale, which is an asymmetric scale starting from 0 through to 20 (See 
Table 2.1)242. 
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Table 2.1 Borg Scale rating- Subjective assessment of the intensity of 
exercise by subject. 
  
Scale Effort 
6 20% effort 
7 30% effort - Very, very light (Rest) 
8 40% effort 
9  50% effort - Very light - gentle walking 
10 55% effort 
11 60% effort - Fairly light 
12 65% effort 
13 70% effort - Somewhat hard - steady pace 
14 75% effort 
15 80% effort - Hard 
16 85% effort 
17 90% effort - Very hard 
18 95% effort 
19 100% effort - Very, very hard 
20 Exhaustion 
 
During exercise and the rest period venous samples were taken from the 
indwelling venous catheter at fixed time points of 0,60,120,180,300 and 
600 seconds. Each time the dead space of the cannula was discarded 
and then flushed with 5mls of 0.9% saline after the sample had been 
withdrawn into a blood gas syringe. The samples were analysed 
immediately on a Radiometer 7200 blood gas analyser, which has 
excellent precision with 0.1% variability between sample measurements. 
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2.2.4	   Statistical	  analysis	  
All analyses were done using Graphpad Prism 5 for Macintosh 
(Graphpad software, San Diego, California). All data are expressed as 
means (± standard deviation) where normally distributed unless otherwise 
stated. Statistical significance was set at p<0.05. 
The study was powered on the assumption that a significant (P<0.05, 
double sided testing) correlation coefficient >=0.6 between anaerobic 
threshold and lactate production would require >=10 subjects. 
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2.3	   RESULTS	  
2.3.1	   Demographics	  
Ten subjects were enrolled into the study all of which completed the 
protocol in full. Eight of these subjects were male and two were female. 
They had a median age of 34 (28.5-36.5) years, a median height of 184 
(175.5-187.25) cm, a median weight of 86 (70.25-88.5) Kg and a median 
exercise time per week of 195 (0-420) minutes, (see Table 2.2), with 3 
subjects taking no exercise each week. 
Table 2.2 Healthy volunteer demographics 
 
Subject Sex Height Weight Age Exercise time per week 
1 M 182 86 24 420 
2 M 179 100 36 100 
3 M 179 71 35 0 
4 M 188 88 40 180 
5 M 196 90 32 420 
6 F 165 68 20 420 
7 M 186 78 38 420 
8 M 186 87 34 210 
9 F 160 47 30 0 
10 M 187 86 34 0 
 
Exercise time per week=Regular exercise undertaken per week in minutes, M=Male, F=Female 
Height=cms, Weight=Kgs, Age=years, Exercise time per week=minutes 
 
2.3.2	   Handgrip	  dynamometry	  
The performance data from handgrip dynamometry shows a large range 
of strength and work done with a mean maximum strength value of 213.2 
(± 68.17) N and mean work done of 28678 (± 8742) Ns (Table 2.3), but 
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relatively little variation in the Borg rating assigned by subjects with a 
mean rating of 13(± 1.25)(Table 2.3). There was no significant 
relationship between the Borg scale rating and the work done (r2=0.05, 
p=0.52). 
Table 2.3 Individual handgrip dynamometry values for all subjects and Borg rating 
 
Subject  
 Max 
value (N) 
 Fatigue 
rate 
 Work done  
(Ns)  Borg rating 
1 215.29 24.61 43627.84 13 
2 296.57 59.79 29321.94 12 
3 133.15 9.05 22361.13 12 
4 201.23 46.83 35701.16 11 
5 197.2 56.87 32785.22 13 
6 157.82 35.47 15921.33 14 
7 357.53 111.95 35228.88 14 
8 164 37.03 28977.22 15 
9 176.39 40.43 16580.47 14 
10 232.94 65.58 26277.11 12 
  
Max value=N, Fatigue rate=the average  of the curve between max value and end of contraction, Work 
done=Ns, Borg rating=subjective assessment of exercise intensity-see Table 2.x 
 
There was however a significant relationship between the maximum 
voluntary contraction of each subject and the maximum value they 
obtained during the cyclical exercise testing-see Figure 2.3 a). The 
maximum strength value achieved in the test was significantly lower than 
maximal voluntary contraction (MVC 350 ± 82.14 vs. MSV 218.32 ± 
68.17, p = 0.0007). Each individual however had a higher maximal 
voluntary contraction than they did a maximal strength value-see Figure 
2.3 b). 
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Figure 2.3 a) Linear regression plot of maximum value obtained during exercise 
and maximum voluntary contraction as tested prior to protocol commencement. b) 
Before and after plot of maximal strength value and corresponding maximal voluntary 
contraction for each individual 
 
a) 
 
b) 
 
MSV = Maximal Strength Value, MVC = Maximal Voluntary Contraction 
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The fatigue rate is a marker of reduction in strength over the course of the 
exercise, but again showed wide variation with a mean of 48.76 (± 27.91) 
and no significant relationship to work done (r2=0.06, p=0.48). In addition 
the maximum grip strength achieved showed no clear relationship to total 
work done (r2=0.21, p=0.18). There was however, a significant 
association with maximum strength achieved and the fatigue rate 
(r2=0.77, p=0.0009) showing subjects with high maximum strength values 
fatiguing quicker (see Figure 2.4). 
 
Figure 2.4 Relationship of fatigue rate and maximum strength achieved. 
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2.3.3	   Metabolic	  performance	  
2.3.3.1	   Fixed	  time	  sampling	  points	  
A graphical representation of the forearm lactate response to cyclical 
forearm exercise is shown in Figure 2.5. 
The graph illustrates that for the majority of subjects forearm lactate 
values were falling by the termination of the test. For subject 2 there was 
no change in forearm lactate between sample times at 300 and 600 
seconds, for subject 8 there was a paradoxical rise in forearm lactate 
from 300 to 600 seconds. All subjects had ceased exercise and were in a 
resting state by 300 seconds. 
 
Figure 2.5 Forearm lactate curves for each subject, showing sampling points at 
0,60,120,180,300 and 600 seconds. 
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Box and whisker summary plots of all subjects for forearm lactate, SO2, 
PO2, PCO2, pH and STO2 are shown in Figure 2.6 
There were significant changes from baseline (time 0) for all measured 
blood gas variables (Forearm lactate, SO2, PO2, PCO2, pH) but not for 
tissue oxygenation (STO2). Only forearm lactate showed significant 
changes at all time points when compared to baseline. Forearm lactate 
and PO2 values were significantly higher than baseline by the termination 
of sampling. The SO2, pH and PCO2 variables had returned to near 
baseline values by the last sampling time of 600 seconds. 
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Figure 2.6 Box and whisker plots of metabolic markers of metabolism plotted 
over 6 discrete sampling times for all 10 subjects. 
 
 
*=Significant results showing deviation from baseline (0 seconds), one way ANOVA, p<0.05   
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2.3.3.2	   Summary	  measures	  of	  metabolic	  performance	  
Markers of the performance of the model were evaluated through the 
static, dynamic and cumulative summary endpoints. Chapter 2: Appendix 
shows detailed calculations and explanations for all endpoints. The pH 
variables were transcribed into their equivalent [H+] for ease of 
computational analysis. 
Performance summary measures for forearm lactate and CO2 showed the 
most significant association with work done (see Tables 2.4 & 2.5 and 
Figures 2.7 & 2.8 respectively). Baseline levels showed no significant 
association with work done except for STO2 (r2=0.45, p=0.03)-see Figure 
2.9 b). For CO2 all performance endpoints were significant. For forearm 
lactate all expect (Lactate peak % change over baseline) were significant. 
Significance was just reached for hydrogen ion performance summary 
measures with ([H]+ cumulative-baseline) (r2=0.4, p=0.049)-see Figure 2.9 
a). 
All other performance measure summaries showed no significant 
association with work done and are shown in tabular form in Chapter 2: 
Appendix for completeness. 
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Table 2.4 Forearm lactate – Linear regression vs. Work done 
Lactate n=10 r² P value 
Lactate baseline median(IQR) 0.95(0.875-1.325) 0.0727 0.4512 ns 
Lactate peak  mean(SD) 3.24(0.7891) 0.5973 0.0088 * 
Lactate peak-
baseline mean(SD) 2.09(0.6173) 0.5781 0.0107 * 
Lactate peak % 
change over 
baseline 
mean(SD) 203.8(82.05) 0.1296 0.3069 ns 
Lactate 
cumulative mean(SD) 1602(398.9) 0.6951 0.0027 * 
Lactate 
cumulative -
baseline 
mean(SD) 912(315) 0.6212 0.0068 * 
Lactate 
cumulative/sec mean(SD) 2.67(0.6649) 0.6951 0.0027 * 
* = Significant  result (p<0.05), IQR=Interquartile range, SD=standard deviation 
 
Figure 2.7 Significant linear regression plots Forearm lactate vs. Work done: a) 
Peak, b) Peak-Baseline, c) Cumulative, d) Cumulative-baseline, e) Cumulative/Second     
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Table 2.5 CO2 – Linear regression vs. Work done 
CO2 n=10 r² P value 
 CO2 baseline median(IQR) 5.75(5.63-6.005) 0.1018 0.3688 ns 
CO2 peak mean(SD) 8.244(0.8187) 0.7136 0.0021 * 
CO2 peak -
baseline mean(SD) 2.378(0.5724) 0.918 < 0.0001 * 
CO2 peak  % 
change over 
baseline  
mean(SD) 40.55(9.62) 0.8107 0.0004 * 
CO2 cumulative mean(SD) 931.2(316.8) 0.624 0.0066 * 
CO2 cumulative -
baseline mean(SD) 810.5(301.9) 0.5101 0.0203 * 
CO2 
cumulative/sec mean(SD) 7.217(0.7437) 0.4566 0.032 * 
* = Significant  result (p<0.05), IQR=Interquartile range, SD=standard deviation 
 
Figure 2.8 Significant linear regression plots CO2 vs. Work done: a) Peak, b) 
Peak-Baseline, c) Peak % change over baseline, d) Cumulative, e) Cumulative-baseline, 
f) Cumulative/Second 
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Figure 2.9 Significant linear regression plots of a) [H+] cumulative-baseline, b) 
STO2 baseline 
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2.4	   DISCUSSION	  
The main aims of this study were to test a) if a cyclical approach to 
forearm exercise was practical and possible and b) if a proportionate 
biological response could be achieved that would clearly differentiate 
subjects. 
As a bedside test it was clearly practical with all subjects managing to 
complete the testing. There were however a number of calibration issues 
and computer interface problems with the near infrared spectroscopy 
equipment that caused delay in testing for 3 of the subjects. These were 
easy to overcome and did not affect the overall result, but could be an 
issue in a busy ward setting if taken forward as a bedside test, but would 
present less of a problem in an outpatient setting such as a preoperative 
assessment clinic. There were also a number of adhesion issues of the 
near infrared spectroscopy probe to the skin which was resolved with 
additional adhesive tape to ensure no ambient light entry. 
The test produced a clear biological response for all measured blood gas 
variables over time but not for near infrared spectroscopy. There was a 
wide range of values for STO2 amongst individuals and relatively little 
difference between baseline and nadir values, which brings into question 
its ability and sensitivity to track changes in tissue oxygenation in this 
model.  There are however a number of confounding aspects of the 
technique which may account for this. Firstly the degree of subcutaneous 
fat the light has to travel through will affect the depth the readings are 
taken from and it is likely that this was different across the individual 
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subjects. In addition although the emitted light frequencies are designed 
to detect oxy and deoxy haemoglobin the other structures such as bone, 
fat and skin all contribute to a variability that cannot be accounted for in 
such a fixed device. It also has to be remembered that NIRS gives an 
average of the readings and at any single time point there will be a 
balance of arterial and venous blood as well as tissue that will contribute 
to the readings at any given point. One would expect the consumption of 
oxygen and ATP (not measured in this model) to exhibit significant falls in 
measures of oxygen content 179. There were indeed falls in both PO2 and 
SO2, which reflect the consumption of oxygen by exercising muscles. If 
the rate of supply of oxygen to the exercising muscle is sufficient to 
maintain aerobic metabolism, there should in theory be little change in 
these values. It is clear however that the muscles were using a mixture of 
aerobic and anaerobic metabolism as evidenced by the significant 
amounts of forearm lactate being produced during exercise. Lactate is 
predominantly an end intermediary of anaerobic respiration, with glucose 
being converted first to pyruvate with the liberation of 2 molecules of ATP 
and then to lactate. Hence it is reasonable to assume that near infrared 
spectroscopy lacked the sensitivity to track these changes in tissue 
oxygenation. Chudalla et al however provide a different explanation and 
suggest there is no relationship between PO2 and venous lactate release 
in a forearm exercise model 243. Furthermore they suggest that 
sympathetic stimulation as evidenced by epinephrine release also has no 
effect on lactate release 243.  
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Blood sampling form the 20G cannula inserted into the antecubital fossa 
represents sampling of blood from the deep forearm veins which drain 
blood almost exclusively from the forearm muscle both at rest 244, 245 and 
during exercise 246  but it is impossible to prove that in our model. 
The forearm lactate levels at the termination of exercise were still 
significantly higher than those at the beginning of testing, as were the 
PO2 values. It is most probable that this reflects ongoing anaerobic 
metabolism and release of lactate in the now resting muscle and reactive 
hyperaemia as blood flow is increased due to end products of metabolism 
causing local vasodilatation. We did not measure flow in our model but 
others have looked extensively at flow mediated brachial artery dilatation 
after forearm ischaemia and shown reactive hyperaemia to be a true 
phenomenon 220. 
Because the test was based on fixed time point blood sampling a set of 
summary measures of the test were calculated to allow comparison of the 
overall output of the model amongst individuals. It is a potential weakness 
of this model and having the ability to sample the venous end products of 
metabolism continuously would have been advantageous and is being 
looked at in future work. 
The subject group itself despite being predominantly male was 
reasonably well matched for age, weight and height but differed 
considerably in their routine exercise regime per week with 30% of 
subjects taking no regular exercise. Regular exercise has a considerable 
positive effect on cardiovascular and endothelial function and may have 
bearing on the performance during the forearm exercise, but our study 
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numbers were too small to be able to clearly discern that. Chapter 5 does 
however look at the anaerobic performance of each individual. 
Despite that fact that there was a wide range of maximum strength and 
work done across the group the subjective rating of the intensity of the 
exercise using the Borg scale failed to reflect that. The scale is a 15 point 
scale designed in an asymmetric way (scores 6 – 20) to reduce the 
chance of bias 242. It has been shown in athletes to correlate with their 
perceived rate of exertion and physiological variables such as heart rate, 
lactate levels and oxygen consumption 247, but there are known 
inconsistencies with it’s use 247 and does not appear to be valid in 
discriminating exercise quantity in this model. 
Due to the prolonged nature of the test it is not surprising that the 
maximal strength value achieved in the test was significantly less than the 
maximal voluntary contraction achieved in one off testing, as individuals 
switch psychologically to endurance rather than short term intensity. The 
Borg rating as already stated is clearly not useful to standardise the effort 
each individual puts into the test and it does not have the sensitivity to 
discriminate. For any exercise test it is important to be able to standardise 
the test so as to be able to apply it to a larger population. Using a 
maximal voluntary contraction to do this is well documented in the 
literature 179, 243, 248, 249. In our study there is a clear relationship between 
MSV and MVC in that MVC is higher than MSV for all subjects. However 
the difference between MVC an MSV is not consistent with some subjects 
increasing their MVC by 2-3 times whilst others only increase by 20-30%. 
The impact of psychology on exercise performance is well known and is 
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difficult to control for during experimentation. All subjects however were 
given the same verbal and visual feedback and encouraged by me to 
work as hard as possible throughout the experiment. This has to be 
acknowledged as a potential weakness of this exercise regime. 
The endurance capacity of each individual is clearly different as 
evidenced by their being no clear relationship between the MSV and work 
done. The test itself is a combination of grip strength and the ability to 
apply that overtime (endurance). Those subjects with higher grip 
strengths did fatigue earlier, reflecting their inability to maintain high 
intensity over time. 
The forearm lactate curves for each subject as shown in Figure 2.5 show 
a relatively homogenous response with all subjects increasing their 
forearm lactate production over time and with the exception of subject 8, 
all showed a fall in forearm lactate in the resting period. The fact that the 
response was homogenous is good in that it suggests the input to the test 
is capable of eliciting a definable response, but less useful in that it does 
not clearly discriminate between individuals. For a test like this to be 
useful it must be able to separate individuals. It is possible that our 
subjects are too similar and the test simply reflects their homogeneity. It 
is interesting to speculate what the results would have been if I had 
repeated the experimental design in a group of elderly patients with 
multiple comorbidities in whom I am sure the I would have found more 
heterogeneity. This thesis did not examine that elderly population with 
this model and is a weakness that will be addressed in future work. 
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2.5	   Conclusion	  
As a potential bedside test the model performed well. The setup of the 
test and the instructions given to subjects were easy to follow and no 
subject failed to finish the test. Fixed time point sampling was easy to 
achieve and to concurrently analyse. 
It was easy to measure the input to the test in terms of the forces applied 
which were significantly and not surprisingly less than a one off test of 
strength (the maximal voluntary contraction), but made the test more 
difficult to standardise. There was also a wide variability amongst 
individuals in terms of grip strength and work done. 
The test was equally successful in stimulating anaerobic metabolism with 
clear rises in lactate and falls in PO2 and SO2. It was clearly capable of 
producing well defined endpoints throughout the test that were 
significantly different from baseline for all variables for the majority of 
sampling points except for tissue oxygenation (STO2). The continuous 
nature of STO2 measurement was hoped to have given more time 
specific information but it’s variability between subjects was too high, 
probably as a result of diference with subcytaneous tissue depth and 
differences in tissue structure below the probe. 
It was also encouraging that the work done during the test was correlated 
to a number of markers of muscle metabolism seeing increasing amounts 
of lactate and PCO2 as the workload increased.  
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2.6	   Chapter	  2	  appendix	  
Isometric	  test	  example	  of	  dynamometer	  graph	  screen	  shot	  
Example of typical strength graph after single grip application and 
associated calculations (reproduced with permission from WINCAS 
manual MIE medical research Ltd) 
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Cyclical	  test	  example	  of	  dynamometer	  graph	  screen	  shot	  
Example a typical repeated (cyclical) strength endurance test 
(reproduced with permission from WINCAS manual MIE medical research 
Ltd) 
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Calculations	  and	  definitions	  for	  summary	  test	  endpoints	  
1) Baseline 
a. The value at 0 seconds 
2) Peak 
a. The highest recorded value during the test 
3) Peak-baseline 
a. The highest recorded value during the test minus the value 
at 0 seconds 
4) Peak % change over baseline 
a. (The peak or nadir value minus the baseline value) divided 
by the baseline value and multiplied by 100. 
5) Cumulative 
a. The area under the curve for sampling points 0 to 600 
6) Cumulative-baseline 
a. The area under the curve for sampling points 0 to 600 
minus (the baseline value multiplied by 600) 
7) Cumulative/sec 
a. The area under the curve for sampling points 0 to 600 
divided by 600 
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Summary	  performance	  measures	  
Summary statistics and linear regression results for summary test 
endpoint variables vs. Work done, illustrated in full for completeness. 
Hydrogen ion concentration 
[H]+ n=10 r² P value 
[H]+ baseline mean(SD) 0.00000004124 (1.616E-09) 0.0421 0.5696 ns 
[H]+ peak median(IQR) 0.00000005795 (5.228E-08-5.677E-08) 0.01164 0.7668 ns 
 [H]+ peak-baseline median(IQR) 0.00000001241 (9.862E-09-1.661E-08) 0.007292 0.8146 ns 
[H]+ peak % change over 
baseline 
median(IQR) 29(23.25-41.36) 0.005708 0.8357 ns 
[H]+ cumulative median(IQR) 0.0000303 (0.00002848-0.00003108) 0.1973 0.1984 ns 
[H]+ cumulative-baseline mean(SD) 0.000004856 (0.00000175) 0.4016 0.0492 * 
[H]+ cumulative/sec mean(SD) 0.00000004933 (3.414E-09) 0.1973 0.1984 ns 
 
Partial pressure of oxygen (kPa) in venous blood 
PO2 n=10 r² P value 
PO2 baseline mean(SD) 4.986(1.072) 0.0004927 0.9515 ns 
PO2 nadir mean(SD) 3.738(0.4258) 0.07618 0.4402 ns 
PO2 nadir-baseline mean(SD) -1.248(0.9714) 0.01044 0.7788 ns 
PO2 peak % change over 
baseline 
mean(SD) -22.85(13.21) 0.07289 0.4506 ns 
PO2 cumulative  mean(SD) 1290(103.3) 0.003925 0.8635 ns 
PO2 cumulative-baseline mean(SD) -1702(555) 0.0001976 0.9693 ns 
PO2 /sec mean(SD) 2.149(0.1721) 0.003925 0.8635 ns 
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Dynamometer derived variables 
Dynamometer n=10 r² P value 
Maximum strength value 
(N) mean(SD) 213.2(68.17) 0.2131 0.1793 ns 
Fatigue rate mean(SD) 48.76(27.91) 0.06434 0.4795 ns 
Borg rating mean(SD) 13(1.247) 0.05822 0.5019 ns 
 
Saturation of oxygen (%) in venous blood 
SO2 n=10 r² P value 
SO2 baseline mean(SD) 69.15(11.33) 0.01422 0.7428 ns 
SO2 nadir mean(SD) 46.58(6.236) 0.1405 0.2859 ns 
SO2-baseline median(IQR) -21.4(-27.08-(-16.6)) 0.01695 0.72 ns 
SO2 peak % change over 
baseline 
mean(SD) -32.1(6.137) 0.03934 0.5828 ns 
SO2 cumulative  mean(SD) 16425(1621) 0.06475 0.478 ns 
SO2 cumulative -baseline mean(SD) -25065(5462) 0.00532 0.8413 ns 
SO2/sec mean(SD) 27.37(2.702) 0.06475 0.478 ns 
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Near infrared spectroscopy derived summary test performance 
variables. 
STO2 n=10 r² P value 
STO2 baseline mean(SD) 79.1(12.4) 0.446 0.0348 * 
STO2 nadir mean(SD) 56(15.28) 0.008362 0.8016 ns 
STO2 nadir-baseline mean(SD) -23.1(15.29) 0.2026 0.1917 ns 
STO2 peak % change over 
baseline  
mean(SD) -28.56(17.94) 0.1064 0.3577 ns 
STO2 cumulative  mean(SD) 20847(3479) 0.1825 0.2182 ns 
STO2 cumulative-baseline mean(SD) 720.1(559.7) 0.01231 0.7603 ns 
STO2 /sec mean(SD) 79.32(8.196) 0.04714 0.5468 ns 
NIRS STO2 slope mean(SD) 33.63(35.91) 0.05549 0.5124 ns 
NIRS THI average mean(SD) 11.24(2.382) 0.2929 0.1062 ns 
NIRS V02 mean(SD) 355(344.8) 0.009359 0.7903 ns 
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Chapter	  3	  -­‐	  The	  development	  of	  a	  isometric	  handgrip	  
exercise	  model	  
 
3.0	   INTRODUCTION	  
In chapter 2 I demonstrated that the using a handgrip exercise model 
based on cyclical (intermittent) isometric exercise was practical to 
perform, stimulated anaerobic metabolism and that the endpoints of the 
test the measurable venous products of muscle respiration i.e. lactate 
and PCO2 correlated well with work done by the model. 
There are fundamental differences however between isometric 
(resistance) and cyclical (rhythmic) exercise. This chapter will aim to 
evaluate the use of an isometric exercise strategy to produce a 
standardised forearm handgrip exercise model. 
The overall setup and use of equipment is similar between the two 
forearm exercise models and has been described already in Chapter 2. 
Where there are significant differences these will be highlighted in the 
method section.  
 117 
3.1	   MATERIALS	  AND	  METHODS	  
3.1.1	   Subjects	  
Healthy adult individuals were recruited by local advertisement. All 
subjects gave written informed consent to the study as had been 
previously agreed by the local research ethics committee of University 
College London Hospitals. All subjects were screened as healthy by 
questionnaire and medical examination by the study investigator prior to 
participating in the study. 
3.1.2	   Equipment	  
3.1.2.1	   Near	  Infrared	  spectroscopy	  measurement	  of	  tissue	  oxygenation.	  
This setup has already been described in Chapter 2, see pages 81-82. 
3.1.2.2	   Handgrip	  dynamometry	  setup	  
The overall setup of the equipment has already been described in 
Chapter 2, see pages 82-84. 
3.1.3	   Protocol	  
A 20G indwelling intravenous cannula was inserted into the non-dominant 
forearm of the subject. A 3 way tap was attached and flushed with 5mls of 
0.9% saline. Samples where then withdrawn at specified time intervals by 
first aspirating the dead space of the 3 way tap without any cuff occlusion 
and then aspirating into a blood gas syringe. A minimum of 5 minutes 
was given before the first sample was withdrawn to negate any effects of 
venous cuffing on muscle metabolism of oxygen use. 
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Subjects were seated and the apparatus set up as described in Chapter 
2. A maximal voluntary contraction (MVC) was established prior to a 
baseline venous gas sample was taken, by asking the subject to briefly 
grip the transducer as hard as possible. This was repeated 3 times and 
the average reading taken as the subjects true MVC, subjects were then 
rested for 10 minutes. The MVC was recorded by the computer and a 
target zone set as 50% of that MVC with a tolerance of +/-5%, (see 
Figure 3.1). Subjects were given visual feedback from a graphical force 
transducer graph on the computer screen and received audible 
encouragement from myself. Subjects were then rested for a minimum of 
5 minutes and their STO2 reading had returned to baseline.  
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Figure 3.1 Demo screen shots illustrating recording of MVC and setting of 50% 
MVC target with ±5% tolerance band, (reproduced with permission from WINCAS 
manual MIE medical research Ltd), a) Recording of MVC b) target values and tolerance 
bands 
a) Recording of MVC 
 
b) Screenshot of test showing target value and ±5% tolerance bands 
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Once each subject had been rested and was seated and positioned 
correctly they were asked to grip the transducer so as to exert a force 
equivalent to 50% of their MVC. To assist them they were shown a visual 
bar graph of force applied that contained a green target area with a 5% 
tolerance band (see Figure 3.1). They were instructed to keep the within 
the green area for as long as possible or until exhaustion. If they exerted 
too little or too much force the bar turned red indicating they were outside 
of the target zone and they were given audible instructions to alter the 
force of their grip to return to the green zone. If they strayed outside this 
tolerance zone for more than 3 seconds the test was automatically 
terminated. 
The study lasted for 10 minutes from the onset of exercise. During this 
time multiple venous sampling was made at specified time points of 
60,120,180,300 and 600 seconds after exercise had started and NIRS 
readings recorded at 3 second intervals onto a computer as described in 
Chapter 2. Prior to each venous sample being taken a dead space 
volume of 2 mls was discarded from the venous effluent cannula after 
which the venous blood gas sample was taken. The cannula was then 
flushed with 2 mls of 0.9% saline to prevent blockage of the cannula. 
Once exercise had finished due to patient fatigue, readings and blood 
sampling continued for the full 10 minutes of the study, subjects were 
asked to rest after cessation of exercise to prevent further voluntary 
muscle contraction.  
 121 
3.1.4	   Statistical	  analysis	  
All analyses were done using Graphpad Prism 5 for Macintosh 
(Graphpad software, San Diego, California). All data are expressed as 
means (± standard deviation) where normally distributed unless otherwise 
stated. Statistical significance was set at p<0.05. Linear regression. 
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3.2	   RESULTS	  
3.2.1	   Demographics	  
Eleven subjects were enrolled in the study, ten of which had already 
completed the cyclical forearm exercise study in a previous sitting. All 
subjects completed the study without any problems. There were nine 
male and two female subjects. 
Group demographics were obviously broadly similar to those of Chapter 
2. They were 34 (30-36) years old, had a median height of 183(179-187) 
cm, a median weight of 86 (71-88) Kg and a median exercise time per 
week of 210 (0-420) minutes.  
The demographics for the group are shown below in Table 3.1. 
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Table 3.1 Healthy volunteer demographics 
 
Subject Sex Height Weight Age Exercise time per week 
1 M 182 86 24 420 
2 M 179 100 36 100 
3 M 179 71 35 0 
4 M 188 88 40 180 
5 M 196 90 32 420 
6 F 165 68 20 420 
7 M 186 78 38 420 
8 M 186 87 34 210 
9 F 160 47 30 0 
10 M 187 86 34 0 
11 M 183 85 35 420 
 
Exercise time per week=average exercise undertaken per week in minutes 
 
3.2.2	   Handgrip	  dynamometry	  
The performance data from handgrip dynamometry shows a large range 
of strength and work done with a mean MVC of 355.6 ( ± 80.07) N and 
mean work done of 26257 ( ± 11388) Ns (see Table 3.2), but relatively 
little variation in the Borg rating assigned by subjects with a high mean 
rating of 15.91 (± 2.43), (see Table 3.2). There was no significant 
relationship between the Borg scale rating and the work done (r2=0.15, 
p=0.24). 
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Table 3.2 Individual handgrip dynamometry data for all subjects with Borg ratting 
 
Subject ID MVC Work done  Exercise time  Borg rating 
1 352.88 29797.49 185.76 16 
2 438.66 34708.62 164.72 18 
3 250.02 9226.31 68.88 14 
4 308.16 25371.17 183.89 15 
5 466.31 41554.4 190.33 13 
6 264.66 8675.61 72.64 16 
7 438.25 39390.4 196.7 18 
8 307.35 25206.91 173.81 18 
9 265.07 19114.8 147.92 12 
10 408.98 19258.47 102.72 15 
11 411.02 36526.41 183.88 20 
 
Exercise time=seconds, Work done=NS 
 
As expected there was a significant association of MVC and work done 
(r2=0.73, p=0.0008), but no significant relationship between the Borg 
rating and exercise time. 
 
3.2.3	   Metabolic	  performance	  
3.2.3.1	   Fixed	  time	  sampling	  points	  
There was a relatively wide and heterogeneous variation in the pattern of 
forearm lactate production between subjects (See Figure 3.2). All 
subjects had ceased to exercise by 190.33 seconds and all but one 
(subject 4) showed declining levels of forearm lactate from 300-600 
seconds. 
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Figure 3.2 Forearm lactate curves for each subject, showing sampling points at 
0,60,120,180,300 and 600 seconds. 
 
Box and whisker summary plots of all subjects for forearm lactate, SO2, 
PO2, PCO2, pH and STO2 are shown in Figure 3.3. 
There were significant changes from baseline (time 0) for all sampling 
points for forearm lactate, but not for PO2 or STO2. The first sampling 
point at 60 seconds was significantly less than baseline for SO2, as were 
sampling points at 120 and 180 seconds when compared to baseline pH. 
When compared to baseline, PCO2 at 180 seconds was significantly 
higher. All other variables and sampling points showed no significant 
changes when compared to baseline, (see Figure 3.3). 
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There was no significantly detectable difference from baseline by the 
termination of the tests for any of the variables except for Forearm 
lactate, which remained significantly higher, (see Figure 3.3). 
3.2.3.2	   MVC	  
There was no significant relationship between MVC and any fixed time 
point sample or of summary measures of metabolic performance for 
forearm lactate, SO2, PO2, PCO2, pH or STO2. 
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Figure 3.3 Box and whisker plots of metabolic markers of metabolism plotted 
over 6 discrete sampling times for all 11 subjects. 
 
*=Significant results showing deviation from baseline (0 seconds), one way ANOVA, p<0.05   
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3.2.4	   Summary	  measures	  of	  metabolic	  performance	  
Markers of the performance of the model were evaluated through the 
static, dynamic and cumulative summary endpoints. Chapter 2: Appendix 
shows detailed calculations and explanations for all endpoints. The pH 
variables were transcribed into their equivalent [H+] for ease of 
computational analysis. 
3.2.4.1	   Forearm	  lactate	  
The only significant association with work done was for cumulative minus 
baseline lactate, with more lactate being produced at higher workloads, 
(see table 3.3 and Figure 3.4). 
3.2.4.2	   PCO2	  
There was a significant variability between subjects for baseline PCO2, 
with a median of 6.58(0.72) kPa and although a weak association with an 
r2 value 0f 0.27 those with higher levels of baseline PCO2 appear to do 
more work-see Table 3.4 and Figure 3.5 a). 
There were significant and stronger relationships between PCO2 
cumulative and PCO2 cumulative per second versus work done, with 
higher levels of both being associated with more work having been done-
see Table 3.4 and Figures 3.5 b) & c). 
3.2.4.3	   Hydrogen	  ion	  concentration	  
With the exception of baseline values the only significant associations 
were similar to PCO2 with cumulative and cumulative per second [H]+ 
having stronger associations with r2 values of 0.77, (see Table 3.5 and 
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Figures 3.6 a) & b) respectively). More work done was associated with a 
higher measurable concentration of [H]+ and consequently a lower pH. 
3.2.4.4	   SO2	  
The values for oxygen saturation followed a similar pattern to both PCO2 
and [H]+ with cumulative and cumulative per second variables being 
significantly associated with work done. The more work done the greater 
the drop in cumulative SO2 and the lower the SO2 per second-see Table 
3.6 and Figures 3.7 a) & b). 
3.2.4.5	   Dynamometry	  &	  Borg	  scale	  ratings	  
There was no significant association between the Borg rating given by 
each subject to the amount of work done during the exercise, (see Table 
3.7). 
Not surprisingly however there were significant associations for MVC and 
exercise time versus work done, (see Table 3.7 and Figures 3.8 a) & b) 
respectively). 
3.2.4.6	   STO2	  and	  PO2	  
There were no significant associations with work done and either STO2 or 
PO2, (see Tables 3.8 & 3.9 respectively). 
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Table 3.3 Summary statistics and linear regression results for Forearm lactate derived variables vs. Work done 
Lactate n=11 r² P value 
Lactate baseline median(IQR) 1.409(0.6057) 0.1754 0.6755 ns 
Lactate peak  mean(SD) 4.336(1.419) 0.544 0.0692 ns 
Lactate peak-baseline mean(SD) 2.927(1.336) 0.3523 0.0885 ns 
Lactate peak % change over baseline mean(SD) 246.2(170.9) 0.04469 0.2955 ns 
Lactate cumulative mean(SD) 2036(686.3) 0.7475 0.0623 ns 
Lactate cumulative -baseline mean(SD) 1190(560) 0.6206 0.0435 * 
Lactate cumulative/sec mean(SD) 3.393(1.144) 0.7475 0.0623 ns 
 
• = Significant result (p<0.05), IQR=Interquartile range, SD=standard deviation 
 
Figure 3.4 Linear regression plot for cumulative lactate-baseline Vs. Work done. ---- = 95% confidence intervals 
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Table 3.4 Summary statistics and linear regression results for PCO2 derived variables Vs. Work done. 
PCO2 n=11 r² P value 
PCO2 baseline median(IQR) 6.582(0.7222) 0.2723 0.0345 * 
PCO2 peak mean(SD) 9.49(2.19) 0.3624 0.1687 ns 
PCO2 peak -baseline mean(SD) 2.908(2.017) 0.2178 0.4473 ns 
PCO2 peak  % change over baseline  mean(SD) 44.39(31.04) 0.1792 0.5466 ns 
PCO2 cumulative mean(SD) 4181(528.1) 0.5337 0.0059 * 
PCO2 cumulative -baseline mean(SD) 232.1(426.2) 0.1403 0.3677 ns 
PCO2 cumulative/sec mean(SD) 6.969(0.8802) 0.5337 0.0059 * 
* = Significant result (p<0.05), IQR=Interquartile range, SD=standard deviation 
 
Figure 3.5 Significant Linear regression plots for PCO2 derived variables vs. Work done. ---- = 95% confidence intervals a) PCO2 baseline, b) PCO2 
cumulative c) PCO2 cumulative/sec 
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Table 3.5 Summary statistics and linear regression results for [H]+derived variables Vs. Work done. 
[H]+ n=11 r² P value 
[H]+ baseline mean(SD) 0.00000004458(3.26E-09) 0.2687 0.296 ns 
[H]+ peak median(IQR) 0.00000006018(9.305E-09) 0.4351 0.2838 ns 
[H]+ peak-baseline median(IQR) 0.0000000156(9.345E-09) 0.2265 0.4912 ns 
[H]+ peak % change over baseline median(IQR) 35.38(21.74) 0.1952 0.4952 ns 
[H]+ cumulative median(IQR) 0.00002973(0.000002753) 0.7721 0.0394 * 
[H]+ cumulative-baseline mean(SD) 0.000002981(0.000002211) 0.404 0.1422 ns 
[H]+ cumulative/sec mean(SD) 0.00000004954(4.589E-09) 0.7721 0.0394 * 
* = Significant result (p<0.05), IQR=Interquartile range, SD=standard deviation 
 
Figure 3.6 Significant Linear regression plots for [H]+derived variables vs. Work done.  ---- = 95% confidence intervals. a) [H]+ cumulative, b) [H]+ 
cumulative/sec 
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Table 3.6 Summary statistics and linear regression results for SO2 derived variables Vs. Work done. 
SO2 n=11 r² P value 
SO2 baseline mean(SD) 68.69(19.63) 0.1827 0.2046 ns 
SO2 nadir mean(SD) 39.4(36.5-48.8) 0.5034 0.2753 ns 
SO2-baseline median(IQR) -23.34(17.76) 0.01053 0.6261 ns 
SO2 peak % change over baseline mean(SD) -31.03(19.93) 0.05404 0.6574 ns 
SO2 cumulative  mean(SD) 44975(4740) 0.4947 0.0063 * 
SO2 cumulative -baseline mean(SD) 3761(9226) 0.03393 0.6874 ns 
SO2/sec mean(SD) 74.96(7.9) 0.4947 0.0063 * 
* = Significant result (p<0.05), IQR=Interquartile range, SD=standard deviation 
 
 
Figure 3.7 Significant Linear regression plots for SO2 vs. Work done.   ---- = 95% confidence intervals a) SO2 cumulative, b) SO2/sec 
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Table 3.7 Summary statistics and linear regression results for Borg & Dynamometer derived variables Vs. Work done. 
Dynamometer n=11 r² P value 
MVC (N) mean(SD) 355.6(80.07) 0.7324 0.0008 * 
Exercise time (seconds) mean(SD) 151.9(47.89) 0.1974 0.0002 * 
Borg rating mean(SD) 15.91(2.427) 0.001378 0.2406 ns 
 
*= Significant result (p<0.05), IQR=Interquartile range, SD=standard deviation 
 
 
Figure 3.8 Significant Linear regression plots for Dynamometer derived variables vs. Work done.  ---- = 95% confidence intervals. a) MVC, b) Exercise 
time 
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Table 3.8 Summary statistics and linear regression results for STO2 derived variables Vs. Work done. 
 
STO2 n=11 r² P value 
STO2 baseline mean(SD) 80.09(9.428) 0.0199 0.0743 ns 
STO2 nadir mean(SD) 60.27(15.23) 0.009659 0.1345 ns 
STO2 nadir-baseline mean(SD) -19.82(11.32) 0.0002181 0.5926 ns 
STO2 peak % change over baseline  mean(SD) -25.31(16.53) 0.0005629 0.336 ns 
STO2 cumulative  mean(SD) 47768(4702) 0.1455 0.1792 ns 
STO2 cumulative-baseline mean(SD) -286.4(3268) 0.09284 0.3095 ns 
STO2 /sec mean(SD) 81.25(79.25-82.55) 0.1455 0.1792 ns 
NIRS STO2 slope mean(SD) 11.94(6.481-41) 0.02826 0.0507 ns 
NIRS THI average mean(SD) 11.33(2.495) 0.09253 0.0723 ns 
NIRS V02 mean(SD) 152.8(62.16-475.4) 0.03315 0.0598 ns 
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Table 3.9 Summary statistics and linear regression results for PO2 derived variables Vs. Work done. 
 
PO2 n=11 r² P value 
PO2 baseline mean(SD) 6.9(4.054) 0.001522 0.5608 ns 
PO2 nadir mean(SD) 3.43(3.25-5.44 0.1342 0.182 ns 
PO2 nadir-baseline mean(SD) -1.64(-5.36-(-0.23)) 0.008611 0.7987 ns 
PO2 peak % change over baseline mean(SD) -29.83(22.2) 0.004594 0.7035 ns 
PO2 cumulative  mean(SD) 4265(911.8) 0.00447 0.1093 ns 
PO2 cumulative-baseline mean(SD) 782.7(-1343-1476) 0.0003852 0.9793 ns 
PO2 /sec mean(SD) 7.108(1.52) 0.00447 0.1093 ns 
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3.3	   DISCUSSION	  
This study was designed as was the cyclical model in Chapter 2 to test a) 
if an isometric approach to forearm exercise was practical and possible 
and b) if a proportionate biological response could be achieved that would 
clearly differentiate subjects. It was clearly practical to perform and 
measure static isometric and in many ways easier than cyclical isometric 
exercise due to the simplicity of the exercise regime used. The pattern of 
response for individuals was heterogeneous as shown in Figure 3.2 for 
the forearm lactate curves, which may have the added benefit of 
differentiating individuals. The group as a whole exhibited a broad range 
of static strength (MVC) and work done, which may be responsible for the 
differences in forearm lactate patterns seen. The subjective rating of 
exercise using the Borg scale showed more variation than in Chapter 2 
but no association with the actual work done or exercise time. This 
suggests that there was not a significant difference in perception of how 
hard the exercise was between individuals, but was poor at predicting the 
final amount of work done. This is not entirely surprising in that it is an 
individual and subjective measure of exercise intensity and there was a 
large variation in the MVC and exercise time between individuals, which 
had the most significant bearing on the amount of work done. MVC being 
the largest of the components making up work done was significantly 
associated with work done, but did not show any significant relationship 
wit exercise time. Strength (MVC) and endurance however are two 
separate exercise entities and one does not necessarily belie the other. A 
difference in muscle fibre types may explain why individuals with slow 
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twitch fibres may be more adapted to endurance exercise whilst those 
with type 1 or fast twitch may be more suited to short term intense 
exercise. My model was a mixture of the two entities, but we cannot 
comment further as no histological analysis of muscle fibre was 
undertaken. 
All subjects had ceased to exercise by 190 seconds but over half the 
group continued to see rises in forearm lactate after the cessation of 
exercise. This reflects the ongoing respiration in the muscle with 
regeneration of high-energy compounds and is consistent with other 
models of intense exercise. All subjects apart from one had falling 
concentrations of forearm lactate by the termination of the test, which 
may have a number of explanations, 1) due to measurement error 2) an 
increase in lactate production or 3) an increase in lactate clearance as 
blood flow is restored to the forearm. Explanations 1) and 3) are the most 
likely.  
The test produced significant changes in all variables from fixed time 
point samples except PO2 and STO2. It is likely that exercise occurred in 
predominantly anaerobic conditions as evidenced by the rise in forearm 
lactate, PCO2 and hydrogen ion concentration along with data from other 
authors 179. Soller et al show that even during exercise changes in 
venous measures for SO2 and PO2 may not reflect absolute changes at 
the cellular level and it is most probable that our model reflects that. The 
early drop in SO2 may reflect acute use of venous oxygen stores to fuel 
aerobic respiration, but it is difficult to explain why this was restored within 
60 seconds during the exercise period. The failure of STO2 to track 
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changes may in part be due to the wide variation in readings between 
individuals despite the changes in median values and probably reflects 
the inaccuracy in the monitor – which can be affected by probe depth, 
size and placement. The placement of the probe probably varied between 
subjects, as does the amount of subcutaneous fat, which may have led to 
the variability in readings.  
It is disappointing not to find a relationship between MVC and any of the 
fixed time point samples or the summary measures of performance. 
Strength, however, is only one aspect of exercise as mentioned above 
and endurance as measured by work done may be the better variable to 
measure. This is borne out by relating work done to the summary 
measures of performance that showed significant relationships for 
forearm lactate, PCO2, hydrogen ion concentration and SO2. Fixed time 
point sampling in my model has some disadvantages in that it can only 
give an approximation of metabolic flux at certain points in time as the 
sampling frequency was at best 60 seconds. Changes that occur 
between these points will be missed and have to be extrapolated which 
has obvious potential for error. Alternative approaches have been used 
such a placing continuous catheters in muscle 179, but the aim of the 
model was to keep it simple as a bedside test and insertion of such 
catheters would have negated that benefit. The strongest associations 
were seen in hydrogen ion concentration with r2 values of up to 0.77. 
Sustained forearm exercise above 30% of MVC is known to cause 
anaerobic respiration and as explained in Chapter 1, acidosis is the main 
waste product of anaerobic respiration with hypoxia being only one of 
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many stimuli for the release of forearm lactate production. This adds 
weight to the argument that the model effectively induced anaerobic 
respiration in exercising muscle. 
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3.4	   CONCLUSION	  
The static isometric model again performed well and was simpler to setup 
due to the reduced complexity of the instructions given than the cyclical 
isometric model. 
Standardisation of the test worked well with each subject achieving 
results comparable to an age matched control group and the input of an 
individual was easy to calculate from the test apparatus. 
Fixed time point sampling was possible and analysis straightforward. 
The endpoints of the test were easily definable with significant changes 
from base line for venous markers of anaerobic respiration i.e. lactate, 
hydrogen ion concentration and PO2, but less significant changes from 
baseline were seen most probably due to the decreased duration of 
exercise in this test compared to the cyclical model. 
Again the model showed good correlation with work done and the 
measureable venous summary endpoints of anaerobic respiration. 
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CHAPTER	  4	  -­‐	  A	  COMPARISON	  OF	  ISOMETRIC	  AND	  CYCLICAL	  
HANDGRIP	  MODELS	  
4.0	   INTRODUCTION	  
In chapter 2 I showed that a cyclical forearm exercise model was practical 
to perform and produced a measurable and reproducible metabolic 
response, with clearly identifiable endpoints and relationship to work 
done. The metabolic response of individual was relatively homogenous. 
In chapter 3 I showed that an isometric forearm exercise model was also 
practical to perform and produced a measurable and reproducible 
metabolic response, with clearly identifiable endpoints and relationship to 
work done. The metabolic response of individual was in contrast relatively 
heterogeneous. 
This chapter will compare and contrast the performance, the input and 
the metabolic output of the isometric and cyclical forearm exercise 
models. It will establish identifiable endpoints for each model, which will 
be compared with the anaerobic threshold measured by formal 
cardiopulmonary exercise testing in the same group of subjects in 
Chapter 5. 
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4.1	   MATERIALS	  AND	  METHODS	  
4.1.1	   Handgrip	  dynamometry	  
Both method and experimental setup have been described in Chapters 2 
& 3 in full. I will briefly outline each test again here for the sake of clarity. 
The cyclical forearm exercise test consisted of a maximal voluntary 
contraction for 2 seconds followed by a relaxation phase of 3 seconds. 
This was repeated 60 times and the exercise part of the test terminated at 
300 seconds. 
The isometric forearm exercise test was simpler with subjects asked to 
exert a maximal voluntary contraction and then sustain a contraction 
rated at 50% of that maximal voluntary contraction for as long as possible 
or until exhaustion. 
Both exercise tests had visual and auditory feedback and venous 
sampling was performed at 0,60,120,180,300 and 600 seconds with 
STO2 measurements recorded every 3 seconds. 
4.2	   Results	  
Comparison results will be presented below. 
4.2.1	   Comparison	  of	  isometric	  and	  cyclical	  forearm	  exercise	  models	  
4.2.1.1	   Demographics	  
These have been described in full chapters 2 & 3. There were no 
significant differences between the two groups for age, height, weight or 
exercise time per week. 
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4.2.1.2	   Work	  done	  
Work done by each exercise model was calculated as the integrated area 
under the force time curves. Table 4.1 shows the respective work done 
and Borg rating for each subject by exercise model. 
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Table 4.1 Comparison of work done and Borg scale for isometric and cyclical 
handgrip models. 
 Isometric Cyclical 
Subject Work done (N)  Borg rating 
Work 
done (N)  Borg rating 
1 29797.49 16 43627.84 13 
2 34708.62 18 29321.94 12 
3 9226.31 14 22361.13 12 
4 25371.17 15 35701.16 11 
5 41554.4 13 32785.22 13 
6 8675.61 16 15921.33 14 
7 39390.4 18 35228.88 14 
8 25206.91 18 28977.22 15 
9 19114.8 12 16580.47 14 
10 19258.47 15 26277.11 12 
11 36526.41 20   
 
Figure 4.1 shows a comparison between each exercise model with 
respect to the subjective rating of the intensity of the exercise they 
experienced according to the Borg rating scale. There is a clearly 
significant difference between the two models with subjects finding the 
isometric model harder. There was also a wider variation in the rating of 
the intensity of the exercise than the cyclical model, (mean Borg cyclical 
13 (± 1.25) vs. mean Borg isometric 15.91 (± 2.43). 
Figure 4.2 however demonstrates that there was no significant difference 
between the total amounts of work done by subjects for each exercise 
model, despite the Borg rating suggesting that the isometric exercise was 
harder. 
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There was however a significant difference in the MVC in the isometric 
model and the MSV in the cyclical model, (mean ± (SD), MVC (ISO) 
355.6 (80.07) vs. 213.2 (68.17), P=0.0003). 
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Figure 4.1 Comparison of Borg scale rating (difficulty of exercise-subjective 
rating) for each handgrip model.  
 
*indicates significant difference between groups, 2 tailed unpaired t test p=0.003. 
 
 
Figure 4.2 Vertical scatter plot of work done by isometric and cyclical exercise 
models respectively. Individual subject plots with Mean and SD bar indicators. 
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4.2.1.3	   Metabolic	  performance	  
Metabolic performance has been described in chapter 1 and refers to the 
measurable venous products of metabolism i.e. Forearm lactate, SO2, 
PO2, PCO2 and pH at fixed time points and a their cumulative summary 
analysis. 
4.2.1.3.1	   Fixed	  time	  point	  sampling	  
This section will describe the results of handgrip dynamometry from the 
fixed sampling points i.e. 0,60,120,180,300 and 600 seconds. 
4.2.1.3.1.1	   Pattern	  of	  forearm	  lactate	  production	  
Overall both models were able to elicit a metabolic response as 
evidenced by the production of lactate measured in venous blood during 
exercise. As can be seen from Figure 4.3 however the pattern of 
production was subtly different. The cyclical model produced a more 
homogenous pattern of production, with less differentiation between 
subjects. The isometric model on the other hand shows more variation in 
forearm lactate production with sharp and higher rises in at least 4 of the 
subjects but over differing time scales, with 7 of them reaching peak 
lactate levels by 300 seconds in comparison to 5 in the cyclical model. 
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Figure 4.3 Comparison of forearm lactate production by sampling point for each 
individual a) Cyclical, b) Isometric. 
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4.2.1.3.1.2	   Release	  patterns	  for	  all	  blood	  gas	  variables	  and	  STO2	  
Figure 4.3 suggests that there may be a difference between the way 
forearm lactate is released over time by each respective model. Figure 
4.4 a) also suggests that forearm lactate release is higher at each time 
point for the isometric exercise, this is however untrue as there is no 
statistical difference between each respective time point from 0 to 600 
seconds.  
The same observation is true for all other variables measured except for 
SO2 and PO2 which both show significant differences between the two 
exercise models at 300 seconds, with the isometric having higher SO2 
and PO2 values-see Figures 4.4 b) & c). 
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Figure 4.4 Box and whisker plots (min to max) of venous blood gas variables and 
tissue oxygen saturations (STO2) at all sampling points. Comparison of isometric and 
cyclical models. 
 
     = Isometric model,      = Cyclical model 
*=Significant difference between groups by one way ANOVA analysis (p<0.05), i prefix denotes Isometric 
model values.  
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4.2.1.3.2	   Summary	  measures	  of	  metabolic	  performance	  
4.2.1.3.2.1	   Forearm	  lactate	  
The only significant difference between the models was for peak lactate 
production, with isometric exercise producing higher peak lactate values, 
(see Table 4.2 and Figure 4.5) 
4.2.1.3.2.2	   PCO2	  
There were a number of significant differences between the exercise 
models for PCO2. Table 4.3 shows there were significant differences for 
baseline levels with isometric values being higher and for cumulative and 
cumulative minus baseline values, (see Figures 4.6 a), b) and c) 
respectively).  
Cumulative PCO2 was significantly higher for the isometric model but 
because of a higher baseline value the isometric model had lower PCO2 
values when corrected for baseline-see Figure 4.6 c). 
4.2.1.3.2.3	   Hydrogen	  ions	  
Similar to PCO2 there was a significant difference in baseline [H]+ with the 
isometric model having higher values which upon correction for baseline 
saw levels fall to below those of the cyclical model for cumulative-see 
Table 4.4 and Figures 4.7 a) & b) 
4.2.1.3.2.4	   PO2	  
Table 4.5 shows that there were three significant differences for PO2 
derived variables; cumulative, cumulative minus baseline and PO2 per 
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second, (see Figures 4.8 a), b), & c) respectively). In each case the 
values for isometric exercise were higher. 
4.2.1.3.2.5	   SO2	  
The derived variables for SO2 followed a similar pattern to PO2 with 
cumulative, cumulative minis baseline and SO2 per second all being 
significantly higher in the isometric model, (see Table 4.6 and Figures 4.9 
a), b) & c) respectively). 
4.2.1.3.2.6	   STO2	  
The only significant difference between groups was for cumulative STO2 
change, with the isometric model changing more over time, (see table 4.7 
and Figure 4.10). 
 
 154 
Table 4.2 Comparison of cyclical and isometric handgrip models for forearm lactate based summary measures of handgrip performance 
 
 
 
 
Figure 4.5 Box and whisker plot for peak lactate 
 Test Significance p value 
Lactate baseline 1 ns 0.31 
Peak Lactate 1 * 0.045 
peak lactate-baseline 1 ns 0.086 
peak % change over baseline lactate 1 ns 0.48 
Cumulative lactate 1 ns 0.097 
Cumulative lactate-baseline 1 ns 0.18 
Average Lactate per sec 1 ns 0.097 
1=unpaired t test, *=significant (p<0.05) 
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Table 4.3 Comparison of cyclical and isometric CO2 based summary measures of handgrip model 
 
  Test Significance p value 
CO2 baseline 1 * 0.014 
Peak CO2 1 ns 0.11 
Peak CO2 -baseline 1 ns 0.43 
Peak % change over baseline CO2 1 ns 0.71 
Cumulative CO2 1 * <0.0001 
Cumulative CO2 -baseline 1 * 0.0021 
CO2 per sec 1 ns 0.49 
1=unpaired t test, *=significant (p<0.05) 
 
Figure 4.6 Box and whisker plot a) baseline CO2, b) Cumulative CO2, c) Cumulative CO2 minus baseline 
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Table 4.4 Comparison of [H]+ based summary measures of handgrip model 
 
[H]+ Test Significance p value 
[H]+ baseline 1 * <0.0001 
[H]+ peak 2 ns 0.26 
[H]+ peak-baseline 2 ns 0.97 
[H]+ peak % change over baseline 2 ns 0.92 
[H]+ cumulative 1 ns 0.91 
[H]+ cumulative-baseline 1 * 0.045 
[H]+ cumulative/sec 2 ns 0.91 
1=unpaired t test, 2=Mann-Whitney,  *=significant (p<0.05)    
 
Figure 4.7 Box and whisker plot a) baseline [H]+, b) Cumulative [H]+ minus baseline 
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Table 4.5 Comparison of PO2 based summary measures of handgrip model 
 
 Test Significance p value 
PO2 baseline 1 ns 0.165 
Nadir PO2 2 ns 0.97 
Nadir-baseline PO2 2 ns 0.59 
peak % change over baseline PO2 1 ns 0.39 
Cumulative PO2 change 1 * <00001 
Cumulative PO2 change-baseline 2 * 0.018 
PO2 per sec 1 * <0.0001 
 1=unpaired t test, 2=Mann-Whitney,  *=significant (p<0.05) 
 
 
Figure 4.8 Box and whisker plot a) cumulative PO2 change b) Cumulative PO2 change minus baseline, c) PO2 per second 
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Table 4.6 Comparison of SO2 based summary measures of handgrip model 
 
 Test Significance p value 
SO2 baseline 1 ns 0.95 
Nadir SO2 2 ns 0.2 
Nadir SO2 -baseline 1 ns 0.9 
Peak % change over baseline SO2 1 ns 0.87 
Cumulative SO2 change 1 * <0.0001 
Cumulative SO2 change-baseline 1 * <0.0001 
SO2 per sec 1 * <0.0001 
1=unpaired t test, 2=Mann-Whitney,  *=significant (p<0.05)    
 
 
Figure 4.9 Box and whisker plot a) cumulative SO2 change b) Cumulative SO2 change minus baseline, c) SO2 per second 
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Table 4.7 Comparison of STO2 based summary measures of handgrip model 
 
 Test Significance p value 
STO2 baseline 1 ns 0.84 
Nadir STO2 1 ns 0.53 
Nadir STO2 -Baseline 1 ns 0.58 
Peak % change over baseline STO2 1 ns 0.67 
Cumulative STO2 change 2 * 0.0001 
Cumulative STO2 change-baseline 2 ns 0.42 
STO2 per sec 2 ns 0.86 
NIRS time to nadir STO2 2 ns 1 
NIRS STO2 slope 2 ns 1 
NIRS THI average STO2 1 ns 0.94 
NIRS VO2 2 ns 0.97 
1=unpaired t test, 2=Mann-Whitney,  *=significant (p<0.05)    
 
Figure 4.10 Box and whisker plot STO2 cumulative 
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4.2.1.4	   Forearm	  lactate	  –	  Increase	  and	  Decrease	  between	  tests	  	  
For 10 of the subjects it was possible to compare their performance in the 
cyclical versus isometric exercise models. It is clear that there are two 
distinct groups, 1) a group that produces less lactate in the isometric 
model than the cyclical model and 2) a group that produces more lactate 
in the cyclical model than they do in the isometric model, (see Figure 
4.11). 
The group was evenly split with 5 subjects seeing an increase from 
cyclical to isometric and 5 who saw a decrease in lactate production from 
cyclical to isometric, (see Figures 4.12 a) & b) respectively). 
These differences with respect to anaerobic threshold will be explored 
further in Chapter 5. 
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Figure 4.11 Total forearm lactate expression minus baseline lactate by each 
subject paired between cyclical and isometric handgrip models. 
 
Figure 4.12 Before and after plots of cumulative forearm lactate minus baseline 
expression for a) Increase between test group & b) decrease between test group. 
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4.3	   DISCUSSION	  
Both models successfully produced a measureable metabolic response to 
exercise. There were however a number of significant differences 
between the two models. 
From a practical standpoint the static isometric model was much easier to 
administer, due to the simplicity of instructions and produced a more 
defined endpoint. There was no difference between the total amount of 
work done between either model (see Figure 4.2), but subjects found the 
static isometric model much harder (Borg scale 13 (±1.25) vs. 15.91 
(±2.43), with a greater variability in subjective rating between subjects. 
The fact that subjects found the isometric test harder is probably 
explainable by the fact that maximal grip strength was much higher and 
subjects felt like they were working harder even though the exercise 
duration of the test was less as subjects fatigued quicker. This is partly 
explainable by looking at factors causing fatigue in muscle during 
exercise, although there is considerable doubt regarding the underlying 
physiology. Anaerobic exercise is known to cause more acidosis and if 
not cleared, accumulation of the end products of metabolism than aerobic 
exercise an may be a limiting factor in endurance exercise. There are a 
number of target candidates for causing fatigue during exercise and the 
most popular is the increase in acidity as the concentration of hydrogen 
ions increases. This has been recently challenged by Cairns et al who 
suggest that acidosis may have little detrimental effect on muscle 
performance in isolated muscle preparations and may even improve 
function 250. Whilst they also acknowledge this may not hold true for 
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whole body systems. Figure 4.4 suggests that there is a greater 
production of hydrogen ions and a subsequent fall in pH in the static 
isometric model but it does not reach significance, so does not confirm 
that theory. Other candidates are inorganic phosphate 251 and the 
accumulation of potassium ions in the interstitium 252, but these were not 
measured, making additional comment difficult. The most likely cause of 
fatigue is likely to be a combination of the above factors rather than a 
single variable. 
The only significant differences between the models for the fixed time 
point sampling was at 300 seconds for SO2 and PO2. The most likely 
explanation for this is the timing of exercise in each model. All subjects in 
the cyclical model exercised for 300 seconds whereas all subjects had 
completed exercise by 190.33 seconds in the isometric model. Figure 4.4 
b) to e) show this nicely with much earlier recovery to normal or 
supranormal levels seen in the isometric group. There is undoubtedly a 
significant contribution of reactive hyperaemia to the resupply of 
oxygenated blood in the isometric model, which occurs earlier than the 
cyclical model. Figure 4.4 a) also suggests that there is a higher level of 
forearm lactate production than the cyclical model, but there was no 
significant difference between the groups. There was a significant 
difference in peak lactate between the two models with the isometric 
model producing significantly higher levels of forearm lactate but not 
overall greater amounts (mean ± (SD) 4.33 (1.42) vs. 3.24 (0.79), 
p=0.045), (see Table 4.2 and Figure 4.5).  
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There were significant differences between the groups for endpoint 
summaries for forearm lactate, PO2, SO2, CO2, hydrogen ion 
concentration and STO2, but not for all endpoint summary variables. In all 
cases isometric exercise produced greater values for forearm lactate, 
CO2, and hydrogen ion concentration and lower values for PO2, SO2 and 
STO2. The most rational explanation is that despite there being no 
significant difference in the work done, the intensity of exercise performed 
was significantly higher in the isometric model and was a greater stimulus 
to anaerobic respiration, (mean ± (SD), MVC (ISO) 355.6 (80.07) vs. 
213.2 (68.17), P=0.0003). 
The most surprising difference between the two models was in the 
comparison of the performance of each individual in each test. Figure 
4.11 shows the total forearm lactate expression for each individual in the 
cyclical model and in the isometric model, what is clear from the graph is 
that the group was evenly split into those that produced higher levels of 
forearm lactate in the isometric test and those that produce lower levels 
of forearm lactate in the isometric test compared to their performance in 
the cyclical model. To the best of my knowledge this is the first time this 
has been demonstrated in the literature. It is possible that this reflects 
differing types of muscle fibres present in different individuals 211 or 
different levels of aerobic conditioning between individuals making some 
more tolerant of anaerobic conditions than others. The recent work 
describing differences between monocarboxylate transport (MCT) 
systems not only between individuals but between different muscle fibres 
may also explain the difference in performance of the two tests as this 
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system is primarily responsible for lactate transport between cells and 
blood and changes with exercise 253. This will be explored further in 
Chapter 5. 
It is important to highlight the fact that essentially the same cohort of 
volunteers was used for both studies. This has advantage in that it 
reduces variability in the study population, but may also introduce bias as 
the same confounding variables are carried across both studies i.e 
extremes of exercise capacity may skew the results and prior knowledge 
of the testing environment may influence subsequent performance. 
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4.4	   CONCLUSIONS	  
In chapters 2 and 3 I have already shown that both cyclical and isometric 
forearm exercise tests were easy to perform and produced well defined 
endpoints with respect to measurable venous markers of anaerobic 
metabolism. 
There was no discernable difference in work done by either model, but 
subjects found the isometric model harder and fatigued quicker i.e. they 
did the same amount of work but in a shorter time frame in the isometric 
model. 
As hypothesised in chapter 1 there were a number of key differences in 
the metabolic output of each model. By 300 seconds PO2 and SO2 were 
significantly higher in the isometric model than the cyclical model, 
reflecting probable restoration of oxygenated blood to the muscle, 
whereas the cyclical model was still actively exercising.  
The differences between the two models were most pronounced on 
analysis of the summary measures of metabolic performance. The 
isometric model produced significantly higher peak forearm lactate levels, 
higher cumulative PCO2, higher cumulative hydrogen ion production, 
more deoxygenation and desaturation as judged by PO2, SO2 and STO2 
changes. 
The most likely explanation for the differences being a stronger stimulus 
to anaerobic metabolism in the isometric model as opposed to the cyclical 
model, which fits with our original hypothesis. 
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Of note was a clear increase in lactate in the isometric model compared 
to the cyclical model for half of the subjects tested. The opposite was true 
for the remaining half. This will be explored further in chapter 5. 
Both models will be compared with formal exercise testing in chapter 5 to 
find which is best suited to take forward in patient testing to predict 
surgical outcome, with the hypothesis that the isometric model will show 
the strongest relationship to anaerobic threshold as measured by 
cardiopulmonary exercise testing. 
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Chapter	  5:	  The	  relationship	  of	  isometric	  and	  cyclical	  
forearm	  exercise	  models	  to	  cardiopulmonary	  exercise	  
testing	  
 
5.0	   INTRODUCTION	  
In Chapters 2-4 I have shown that both a cyclical and isometric based 
forearm exercise model is possible as a bedside test, produces a defined 
metabolic response than can be used as an endpoint for the test and that 
the isometric model appears to stimulate anaerobic metabolism to a 
greater extent. 
In addition in chapter 4 there appeared to be the emergence of two 
distinct groups. One that increased lactate production on isometric 
exercise and one that decreased lactate production on isometric exercise 
when compared with cyclical exercise. This concept will be explored 
further in relationship to anaerobic threshold of those individual’s in this 
chapter. 
In chapter 1 I have already described the utility of cardiopulmonary 
exercise testing as a marker of exercise and functional capacity and it’s 
ability to help predict surgical outcome. This chapter will compare the 
results from formal cardiopulmonary exercise testing, (from which an 
anaerobic threshold will be derived) to the endpoints of both isometric 
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and cyclical forearm exercise testing. If a significant relationship can be 
demonstrated a distinct test endpoint will be defined. 
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5.1	   MATERIALS	  AND	  METHODS	  
All eleven subjects who completed the isometric exercise program 
underwent cardiopulmonary exercise testing in a separate session and on 
a different day. 
5.1.1	   Cardiopulmonary	  exercise	  testing	  
The basis and interpretation of cardiopulmonary exercise testing has 
been described in Chapter 1, see pages 46-52. 
5.1.2	   Equipment	  and	  Protocol	  
Cardiopulmonary exercise testing was performed on a lode electronically 
braked bicycle ergometer that was controlled through Breeze 
(Medgraphics, UK) software. The bike height was set to ensure 
approximately 5 degrees of flexion in the knee at the bottom of the pedal 
crank so the subjects did not have to extend at the hip in order to reach 
the pedals. Handlebars were adjusted for comfort at the same time and 
each subject had an indication of their leg speed (rpm) displayed and 
were told to keep this between 50 and 60 rpm for the duration of the test.  
A 12 lead exercise ECG was recorded concurrently and was linked into 
the Breezesuite™ software package (Medgraphics, UK), as was non-
invasive blood pressure and continuous pulse oximetry. 
The metabolic cart (CPX Ultima metabolic monitor, Medgraphics, UK) 
was connected to the subject by way of a sealed mouthpiece which was 
then connected to a Medgraphics preVent™ pneumotach device. 
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Before each test the metabolic cart was gas and flow calibrated according 
to its internal software as was the pneumotacograph using a super 
syringe. Gas calibration was done using the two-point method. During 
calibration adjustments for barometric pressure, humidity and 
temperature were made. The metabolic cart has oxygen and carbon 
dioxide analysers with a response time of 90 m/s or less to enable breath-
by-breath measurement of carbon dioxide and oxygen. 
Results were presented in a standard 9-panel plot format and V-slope 
comparison plot compiled by Breeze (Medgraphics, UK). These were 
stored in a separate database and later analysed by an independent 
assessor who was blinded to the subjects identity and forearm exercise 
results. 
The rate of increment in work rate was predetermined using an estimate 
of expected work capacity. This was done in an objective manner to aim 
for test duration of approximately 6 to 10 minutes. Work rate was 
determined using the following equations:  
 
1) VO2 unloaded (ml/min) = 150 + (6 x weight (kg) 
2) a) Peak VO2 (ml/min) Men = height (cm) – age (years) x 20 
b) Peak VO2 (ml/min) Women = height (cm) – age (years) x 14 
3. Work Rate increment (W/min) = (Peak VO2 –VO2 Unloaded) / 100 
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Subjects were allowed to rest for 5 minutes during which data was 
recorded to ensure that the subject was comfortable with the mouthpiece. 
During this time the respiratory exchange ratio was observed until it fell 
below 1, indicating that the subject was not hyperventilating. 
The rest period was then followed by a period of 3 minutes of unloaded 
cycling. This allows for the oxygen cost of just turning the legs to be 
evaluated, provides minimum resistance and ensures that oxygen 
kinetics were not disrupted prior to the measurement of anaerobic 
threshold. After the rest cycle there was a continuous change into the 
ramp protocol that was predetermined as detailed above. Subjects were 
given verbal feedback and encouragement at all stages. 
Core data displayed and recorded were Oxygen Consumption, Carbon 
dioxide production, Ventilation, Tidal Volume, Heart Rate, Ventilatory 
equivalents for Oxygen and Carbon Dioxide, Work Rate and Respiratory 
Exchange Ratio. 
Subjects continued to exercise for 3 minutes beyond the attainment of 
perceived anaerobic threshold as judged by an independent 
cardiopulmonary testing technician to try and reduce any false positives. 
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The following criteria were used in combination to determine anaerobic 
threshold  
1) Rising ventilatory efficiency for Oxygen  
2) Plateau in Ventilatory efficiency for Carbon Dioxide 
3) RER >1 
4) Rising End Tidal Oxygen 
5) Cross over of VCO2 and VO2 when plotted on same axis 
6) Increase in gradient of VCO2 vs. VO2 
As stated the raw data was stored and later analysed by an independent 
assessor who was blinded to the subjects identity and forearm exercise 
results. 
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5.2	   RESULTS	  
5.2.1	   Demographics	  
Eleven subjects underwent formal cardiopulmonary exercise testing to 
sub maximal levels of exercise. The demographics and weekly exercise 
patterns have already been described in chapter 3, (see Table 3.1). 
Each subject completed the testing without error, except for one subject 
who had to repeat the test on the following day due to an inability to 
calibrate the gas sensors because of temperature fluctuations. 
Table 5.1 shows individual data for anaerobic threshold and resting 
oxygen consumption. There is a broad range of anaerobic thresholds 
recorded ranging from 18.2 to 36.4 mls/Kg/min, but a high group mean (± 
SD), 27.4 (± 7.23) anaerobic threshold, as would be expected form a 
young and healthy cohort. 
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Table 5.1 Individual data from cardiopulmonary exercise testing. 
 Anaerobic Threshold (At) 
Resting oxygen 
consumption (VO2) 
Subject mls/kg/min mls/min mls/kg/min mls/min 
1 18.2 1563 6.5 556 
2 27.2 2716 3.7 368 
3 19.2 1366 4.3 304 
4 21 1847 2.8 240 
5 37.2 3532 3.7 351 
6 26.2 1779 3.4 232 
7 33.4 2605 5.6 434 
8 30.9 2690 6.5 566 
9 36.4 1711 4.5 212 
10 18.9 1624 3.9 259 
11 32.9 2746 6.1 506 
Mean(SD) 27.41(7.23) 2198(686.8) 4.636(1.32) 366.2(131.7) 
 
5.2.2	   Work	  done	  vs.	  anaerobic	  threshold	  
When compared with work done during isometric and cyclical forearm 
exercise there was no clear relationship to anaerobic threshold, (see 
Figure 5.1). 
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Figure 5.1 Scatter plots of work done vs. anaerobic threshold for a) cyclical and 
b) isometric exercise models. 
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5.2.3	   Relationship	  between	  anaerobic	  threshold	  and	  resting	  oxygen	  
consumption	  (VO2)	  
 
Figure 5.2 demonstrates that there is no statistically significant 
relationship between resting oxygen consumption and anaerobic 
threshold. 
 
Figure 5.2 Scatter plot of anaerobic threshold vs. resting oxygen consumption for 
all subjects. 
 
 
5.2.4	   Difference	  in	  forearm	  lactate	  rise	  between	  isometric	  and	  cyclical	  
models	  and	  relationship	  to	  anaerobic	  threshold	  
In chapter 4 it was shown there was a clear separation of two groups that 
either increased or decreased their forearm lactate production between 
cyclical and isometric exercise, (see Figure 5.3). 
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Figure 5.3 has been reproduced here for clarity to illustrate this point. 
 
Figure 5.3 Total forearm lactate expression minus baseline lactate by each 
subject paired between cyclical and isometric handgrip models. 
 
If the groups are separated into two, based on whether they increased or 
decreased their forearm lactate production during isometric exercise 
when compared to cyclical exercise, there is a clear and significant 
difference in the anaerobic threshold of these groups, (see Figure 5.4). 
Those subjects who increased their forearm lactate production had higher 
anaerobic thresholds, the lowest of which (26.2) is just below the group 
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mean of 27.4: (median (IQR) anaerobic threshold; Increase 33.4 (26.7 - 
36.8) vs. Decrease 19.2 (18.55 – 25.95), p=0.032). 
Figure 5.4 Box and whisker plot of anaerobic threshold vs. increase or decrease 
in forearm lactate production from cyclical to isometric exercise model 
 
 
5.2.5	   Isometric	  time	  points	  and	  anaerobic	  threshold	  
There were significant associations between forearm lactate, PO2, SO2, 
CO2, and hydrogen ion concentration at all sampling intervals expect 
baseline (see Table 5.2). 
There were no significant associations for STO2 at any time point. 
The strongest associations were with forearm lactate and pH, which 
showed significant associations at all time points except baseline. 
Significant associations were seen for SO2 at 60, 120 and 180 seconds, 
for PO2 at 180 seconds and for PCO2 at 60, 120,180 and 300 seconds 
(see Figures 5.5 to 5.9 for linear regression scatter plots). 
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Those subjects with higher anaerobic thresholds produced more lactate, 
more CO2 and more hydrogen ions. They also had lower values for PO2, 
SO2.  
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Table 5.2 Linear regression r2 and significance level for Isometric handgrip exercise venous blood gas and NIRS STO2 variables vs. Anaerobic 
threshold 
 Lactate  SO2  PO2  PCO2  pH STO2 
Sample 
Time  
r2 p r2 p r2 p r2 p r2 p r2 p 
0 0.1754 ns 0.1827 ns 0.001522 ns 0.2723 ns 0.2713 ns 0.0199 ns 
60 0.4681 0.0202 0.4385 0.0264 0.04949 ns 0.572 0.0071 0.6085 0.0046 0.03252 ns 
120 0.5512 0.0089 0.5666 0.0075 0.008259 ns 0.6495 0.0027 0.6105 0.0045 0.004651 ns 
180 0.4581 0.0222 0.3873 0.0409 0.3888 0.0404 0.3949 0.0384 0.5236 0.0118 0.0001942 ns 
300 0.6779 0.0018 0.1138 ns 0.09231 ns 0.3774 0.0443 0.5393 0.0101 0.1212 ns 
600 0.5997 0.0051 0.008214 ns 0.004474 ns 0.0833 ns 0.6415 0.0031 0.346 ns 
Significant results are highlighted in yellow. Sample time-seconds, Lactate=mmo/L, SO2=Venous blood gas oxygen saturation, PO2=Venous blood gas oxygen tension 
in Kpa, PCO2=Venous blood gas carbon dioxide tension in Kpa, STO2=Tissue oxygen saturation from NIRS in % 
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 Figure 5.5 Scatter plots for Forearm lactate vs. anaerobic threshold. i) All sampling points with best fit line and ii) Significant linear regression plots with 
best fit line and 95% confidence intervals for sampling points at a) 60, b) 120, c) 180, d) 300, & e) 600 seconds. 
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Figure 5.6 Scatter plots for SO2% vs. anaerobic threshold. i) All sampling points with best fit line and ii) Significant linear regression plots with best fit 
line and 95% confidence intervals for sampling points at a) 60, b) 120, c) 180 seconds. 
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Figure 5.7 Scatter plots for PCO2 vs. anaerobic threshold. i) All sampling points with best fit line and ii) Significant linear regression plots with best fit 
line and 95% confidence intervals for sampling points at a) 60, b) 120, c) 180 & d) 300 seconds. 
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Figure 5.8 Scatter plots for pH vs. anaerobic threshold. i) All sampling points with best fit line and ii) Significant linear regression plots with best fit line 
and 95% confidence intervals for sampling points at a) 60, b) 120, c) 180 & d) 300 & e) 600 seconds. 
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Figure 5.9 Scatter plots for PO2 vs. anaerobic threshold. i) All sampling points with best fit line and ii) Significant linear regression plots with best fit line 
and 95% confidence intervals for sampling point at 180 seconds. 
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5.2.6	   Isometric	  endpoint	  summary	  measures	  and	  anaerobic	  threshold	  
There were fewer significant associations between the endpoint 
summaries for isometric exercise and anaerobic threshold.  
Forearm lactate, SO2, CO2, and hydrogen ion concentration all showed 
significant associations with anaerobic threshold, but not for all variables, 
(see Tables 5.3, 5.4, 5.6 & 5.7 and Figures 5.10, 5.11, 5.12 & 5.13 
respectively). 
There were no significant associations for PO2, STO2 or dynamometry, 
(see Tables 5.5, 5.8 & 5.9 respectively). 
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Table 5.3 Linear regression results for forearm lactate vs. anaerobic threshold 
Lactate n=11 r² P value 
Lactate baseline median(IQR) 1.409(0.6057) 0.1754 0.1999 ns 
Lactate peak  mean(SD) 4.336(1.419) 0.544 0.0096 * 
Lactate peak-baseline mean(SD) 2.927(1.336) 0.3523 0.0542 ns 
Lactate peak % change 
over baseline mean(SD) 246.2(170.9) 0.04469 0.5326 ns 
Lactate cumulative mean(SD) 2036(686.3) 0.7475 0.0006 * 
Lactate cumulative -
baseline mean(SD) 1190(560) 0.6206 0.004 * 
Lactate cumulative/sec mean(SD) 3.393(1.144) 0.7475 0.0006 * 
 
 
Figure 5.10 Linear regression scatter plots with best fit line and 95% CI for 
significant forearm lactate results 
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Table 5.4 Linear regression results for SO2 vs. anaerobic threshold 
SO2 n=11 r² P value 
SO2 baseline mean(SD) 68.69(19.63) 0.1827 0.1898 ns 
SO2 nadir mean(SD) 39.4(36.5-48.8) 0.5034 0.0145 * 
SO2-baseline median(IQR) -23.34(17.76) 0.01053 0.764 ns 
SO2 peak % change over 
baseline mean(SD) -31.03(19.93) 0.05404 0.4915 ns 
SO2 cumulative  mean(SD) 44975(4740) 0.4947 0.0157 * 
SO2 cumulative -baseline mean(SD) 3761(9226) 0.03393 0.5877 ns 
SO2/sec mean(SD) 74.96(7.9) 0.4947 0.0157 * 
 
Figure 5.11 Linear regression scatter plots with best fit line and 95% CI for 
significant SO2 results 
 
 
 
Table 5.5 Linear regression results for PO2 vs. anaerobic threshold 
PO2 n=11 r² P value 
PO2 baseline mean(SD) 6.9(4.054) 0.001522 0.9093 ns 
PO2 nadir mean(SD) 3.43(3.25-5.44 0.1342 0.2678 ns 
PO2 nadir-baseline mean(SD) 
-1.64(-5.36-(-
0.23)) 0.008611 0.7861 ns 
PO2 peak % change over 
baseline mean(SD) -29.83(22.2) 0.004594 0.843 ns 
PO2 cumulative  mean(SD) 4265(911.8) 0.00447 0.8452 ns 
PO2 cumulative-baseline mean(SD) 
782.7(-1343-
1476) 0.0003852 0.9543 ns 
PO2 /sec mean(SD) 7.108(1.52) 0.00447 0.8452 ns 
 190 
 
Table 5.6 Linear regression results for CO2 vs. anaerobic threshold 
CO2 n=11 r² P value 
CO2 baseline median(IQR) 6.582(0.7222) 0.2723 0.0997 ns 
CO2 peak mean(SD) 9.49(2.19) 0.3624 0.05 ns 
CO2 peak -baseline mean(SD) 2.908(2.017) 0.2178 0.1478 ns 
CO2 peak  % change over 
baseline  mean(SD) 44.39(31.04) 0.1792 0.1945 ns 
CO2 cumulative mean(SD) 4181(528.1) 0.5337 0.0107 * 
CO2 cumulative -baseline mean(SD) 232.1(426.2) 0.1403 0.2563 ns 
CO2 cumulative/sec mean(SD) 6.969(0.8802) 0.5337 0.0107 * 
 
Figure 5.12 Linear regression scatter plots with best fit line and 95% CI for 
significant CO2 results 
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Table 5.7 Linear regression results for Hydrogen ion concentration vs. anaerobic 
threshold 
 [H]+ n=11 r² P value 
[H]+ baseline mean(SD) 0.00000004458(3.26E-09) 0.2687 0.1023 ns 
[H]+ peak median(IQR) 0.00000006018(9.305E-09) 0.4351 0.0272 * 
[H]+ peak-baseline median(IQR) 0.0000000156(9.345E-09) 0.2265 0.1389 ns 
[H]+ peak % change over 
baseline median(IQR) 35.38(21.74) 0.1952 0.1737 ns 
[H]+ cumulative median(IQR) 0.00002973(0.000002753) 0.7721 0.0004 * 
[H]+ cumulative-baseline mean(SD) 0.000002981(0.000002211) 0.404 0.0356 * 
[H]+ cumulative/sec mean(SD) 0.00000004954(4.589E-09) 0.7721 0.0004 * 
 
Figure 5.13 Linear regression scatter plots with best fit line and 95% CI for 
significant [H]+ results 
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Table 5.8 Linear regression results for NIRS vs. anaerobic threshold 
STO2 n=11 r² P value 
STO2 baseline mean(SD) 80.09(9.428) 0.0199 0.6791 ns 
STO2 nadir mean(SD) 60.27(15.23) 0.009659 0.7737 ns 
STO2 nadir-baseline mean(SD) -19.82(11.32) 0.0002181 0.9656 ns 
STO2 peak % change over 
baseline  mean(SD) -25.31(16.53) 0.0005629 0.9448 ns 
STO2 cumulative  mean(SD) 47768(4702) 0.1455 0.247 ns 
STO2 cumulative-baseline mean(SD) -286.4(3268) 0.09284 0.3623 ns 
STO2 /sec mean(SD) 
81.25(79.25-
82.55) 0.1455 0.247 ns 
NIRS STO2 slope mean(SD) 11.94(6.481-41) 0.02826 0.6425 ns 
NIRS THI average mean(SD) 11.33(2.495) 0.09253 0.3928 ns 
NIRS V02 mean(SD) 
152.8(62.16-
475.4) 0.03315 0.6146 ns 
 
Table 5.9 Linear regression results for dynamometry vs. anaerobic threshold 
Dynamometer n=11 r² P value 
Maximum strength value mean(SD) 355.6(80.07) 0.08996 0.3702 ns 
Exercise time (secs) mean(SD) 151.9(47.89) 0.1974 0.171 ns 
Borg rating mean(SD) 15.91(2.427) 0.001378 0.9137 ns 
work done mean(SD) 26257(11388) 0.2469 0.12 ns 
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5.2.7	   Cyclical	  time	  points	  and	  anaerobic	  threshold	  
There were no significant associations for forearm lactate, PO2, SO2, 
CO2, hydrogen ion concentration or STO2 at any of the sampling 
intervals. Table 5.10 shows the linear regression results for all time 
points. 
 
5.2.8	   Cyclical	  endpoint	  summary	  measures	  and	  anaerobic	  threshold	  
There were no significant associations for any endpoint summary 
measures for forearm lactate, PO2, SO2, CO2, hydrogen ion concentration 
or STO2 and anaerobic threshold. Results are shown in the Appendix for 
completeness. 
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Table 5.10 Linear regression r2 and significance level for cyclical handgrip exercise venous blood gas and NIRS STO2 variables vs. Anaerobic 
threshold 
 Lactate  SO2  PO2  PCO2  pH STO2 
Sample 
Time  
r2 p r2 p r2 p r2 p r2 p r2 p 
0 0.1581 ns 0.2197 ns 0.2745 ns 0.05482 ns 0.05482 ns 0.07423 ns 
60 0.061 ns 0.02658 ns 0.02554 ns 0.01413 ns 0.01413 ns 0.002694 ns 
120 0.006956 ns 0.0004449 ns 0.00592 ns 0.0009365 ns 0.0009365 ns 0.02133 ns 
180 0.0013 ns 0.08377 ns 0.01777 ns 0.002931 ns 0.002931 ns 0.01702 ns 
300 0.01028 ns 0.1386 ns 0.03741 ns 0.1217 ns 0.1217 ns 0.13 ns 
600 0.03383 ns 0.03157 ns 0.04382 ns 0.07896 ns 0.07896 ns 0.1068 ns 
Significant results are highlighted in yellow. Sample time-seconds, Lactate=mmo/L, SO2=Venous blood gas oxygen saturation, PO2=Venous blood gas oxygen tension 
in Kpa, PXO2=Venous blood gas carbon dioxide tension in Kpa, STO2=Tissue oxygen saturation from NIRS in % 
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5.3	   Discussion	  
Demographically the group of subjects displayed a broad range of 
anaerobic thresholds (18.2 to 36.4 mls/Kg/min), with those at the upper 
end of the spectrum demonstrating higher than average levels of exercise 
capacity implying a partially aerobically trained cohort, with weekly 
exercise times of up to 410 minutes. 
There is no documented link between resting oxygen consumption and 
anaerobic threshold, which was confirmed in this study 254. 
As hypothesised there was no clear demonstrable relationship between 
work done in either the isometric or cyclical forearm model and anaerobic 
threshold or resting oxygen consumption. There was however a trend 
towards more work done in those with a higher anaerobic threshold for 
the isometric model. 
The difference in performance of each subject in the cyclical and 
isometric forearm models as touched upon in chapter 4 is of interest 
when examined by anaerobic threshold. There was a significant 
difference in anaerobic threshold for those subjects who saw an increase 
in their total forearm lactate in isometric compared to cyclical forearm 
exercise, median (IQR) anaerobic threshold (increase vs. decrease) 33.4 
(26.7-36.8) vs. 19.2 (18.55-25.95), P=0.032. There are a number of 
possible explanations for this of which the most probable is that isometric 
forearm is predominantly an ischemic model and relies heavily on 
anaerobic respiration for sustained muscle contraction. Those subjects 
with high anaerobic thresholds may better tolerate the lactate 
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accumulation due to conditioning and be better able to use the lactate 
produced to regenerate ATP. This is consistent with observations in elite 
athletes who may produce less lactate at a given workload than untrained 
individuals but are capable of producing larger amounts of lactate as 
workload increases, as they seemingly do not fatigue to the same extent 
and may use the lactate produced in a far more efficient way to refuel the 
metabolic processes 205.  
The most striking finding however is the consistent and significant 
relationship of fixed time point and endpoint summaries of metabolic 
performance in the isometric forearm exercise model being related to 
anaerobic threshold but not those from the cyclical forearm exercise 
model. STO2 however showed no significant association with either 
model, brining into question it’s suitability for monitoring in this model. 
As has been stated above the most probable explanation for the 
relationship to isometric testing and not to cyclical testing is the strong 
anaerobic and high intensity exercise undertaken in isometric testing. 
Although the physiological mechanism may be different between whole 
body exercise, which has equal reliance on the cardiorespiratory system 
and exercise in a small muscle group such as the forearm, they may be 
measuring a similar process of anaerobic respiration.  
It is important to state however that although the relationships were 
statistically significant the strength of the relationship was moderate at 
best with the best r2 value being 0.68 for lactate at 300 seconds.  
 197 
It is equally important to state that the numbers in this study were small 
and statistical error due to the small sample size must be noted, but the 
consistency of the result is encouraging. One of the consistent 
deficiencies in this thesis is the lack of testing in an elderly population 
with significant comorbidities. It is possible that for patients with very low 
anaerobic thresholds close to 11 mls/Kg/min that the signal may be 
stronger as they are likely to be similar to those with chronic heart failure 
who show persistently poor peripheral oxidative capacity. I plan to look at 
this population however in work that will follow this thesis. 
It is also probable that using a continuous analysis technique with 
catheters such as the Paratrend™ in the antecubital vein we may be able 
to improve the sensitivity of the test and be able to identify an inflection 
point in the venous metabolic markers of metabolism. It is unlikely that 
there will be a sharp change in any variable such as oxygen or the 
production of lactate, but the use of a continuous technique would allow 
the identification of the beginning of a rise or fall in the substrate for or the 
metabolites of aerobic respiration. There are many devices on the market 
that could have potential usefulness, for instance the improvement in 
microdialysis equipment would allow for an implantable that may extend 
its life into the Intraoperative and postoperative period, but that is not the 
subject of this thesis. Again future wok is planned to look at this 
possibility. 
Because of the relationship seen with isometric exercise testing and 
anaerobic threshold this model was taken forward to test in an 
orthopaedic group of patients which is the subject of Chapter 6. 
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5.4	   Conclusions	  
Of the two forearm exercise tests it was the isometric one that showed a 
positive and consistent relationship with anaerobic threshold as 
measured by cardiopulmonary exercise testing. 
Based on the linear regression data the most promising test endpoints 
are cumulative lactate, cumulative hydrogen ion production and forearm 
lactate at 300 seconds. These will be identified as possible predictors of 
surgical outcome in substitution of anaerobic threshold as measured by 
cardiopulmonary exercise testing and will be used in chapter 6 to try and 
predict outcome in an orthopaedic surgical population undergoing joint 
replacements. 
Of note there were no significant relationships demonstrable between 
cyclical exercise testing and cardiopulmonary exercise testing. 
Of additional and unique interest is the finding that as a group, those who 
produced more lactate in the isometric model of exercise had significantly 
higher anaerobic threshold levels. This has not been shown before but 
may reflect the phenomena shown in elite athletes that are much better 
able to utilise lactate as a fuel by transporting it to other parts of the body 
where it can be processed. 
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5.5	   Appendix	  
Cyclical	  endpoint	  summary	  measures	  and	  anaerobic	  threshold	  
Table 5.11 Cyclical endpoint summary measures vs. anaerobic threshold 
 
Lactate 
Lactate n=10 r² P value 
Lactate baseline median(IQR) 0.95(0.875-1.325) 0.1581 0.2551 ns 
Lactate peak  mean(SD) 3.24(0.7891) 0.00441 0.8554 ns 
Lactate peak-baseline mean(SD) 2.09(0.6173) 0.06296 0.4844 ns 
Lactate peak % change 
over baseline mean(SD) 203.8(82.05) 0.195 0.2014 ns 
Lactate cumulative mean(SD) 1602(398.9) 0.006053 0.8308 ns 
Lactate cumulative -
baseline mean(SD) 912(315) 0.08778 0.4058 ns 
Lactate cumulative/sec mean(SD) 2.67(0.6649) 0.006053 0.8308 ns 
 
Hydrogen ion concentration 
[H]+ n=10 r² P value 
[H]+ baseline mean(SD) 0.00000004124(1.616E-09) 0.07423 0.4463 ns 
[H]+ peak median(IQR) 0.00000005795(5.228E-08-5.677E-08) 0.1008 0.3713 ns 
[H]+ peak-baseline median(IQR) 0.00000001241(9.862E-09-1.661E-08) 0.123 0.3204 ns 
[H]+ peak % change 
over baseline median(IQR) 29(23.25-41.36) 0.1275 0.311 ns 
[H]+ cumulative median(IQR) 0.0000303(0.00002848-0.00003108) 0.1171 0.3331 ns 
[H]+ cumulative-
baseline mean(SD) 0.000004856(0.00000175) 0.06235 0.4866 ns 
[H]+ cumulative/sec mean(SD) 0.00000004933(3.414E-09) 0.1171 0.3331 ns 
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PCO2 
CO2 n=10 r² P value 
CO2 baseline median(IQR) 
5.75(5.63-
6.005) 0.05482 0.515 ns 
CO2 peak mean(SD) 8.244(0.8187) 0.0003728 0.9578 ns 
CO2 peak -baseline mean(SD) 2.378(0.5724) 0.02431 0.6671 ns 
CO2 peak  % change over baseline  mean(SD) 40.55(9.62) 0.05975 0.4961 ns 
CO2 cumulative mean(SD) 931.2(316.8) 0.08666 0.409 ns 
CO2 cumulative -baseline mean(SD) 810.5(301.9) 0.02747 0.6473 ns 
CO2 cumulative/sec mean(SD) 7.217(0.7437) 0.0642 0.48 ns 
 
PO2 
PO2 n=10 r² P value 
PO2 baseline mean(SD) 4.986(1.072) 0.2745 0.1201 ns 
PO2 nadir mean(SD) 3.738(0.4258) 0.00301 0.8803 ns 
PO2 nadir-baseline mean(SD) -1.248(0.9714) 0.3441 0.0747 ns 
PO2 peak % change over baseline mean(SD) -22.85(13.21) 0.3075 0.0962 ns 
PO2 cumulative  mean(SD) 1290(103.3) 0.08215 0.422 ns 
PO2 cumulative-baseline mean(SD) -1702(555) 0.3065 0.0968 ns 
PO2 /sec mean(SD) 2.149(0.1721) 0.08215 0.422 ns 
 
SO2 
SO2 n=10 r² P value 
SO2 baseline mean(SD) 69.15(11.33) 0.2197 0.1718 ns 
SO2 nadir mean(SD) 46.58(6.236) 0.04538 0.5546 ns 
SO2-baseline median(IQR) -21.4(-27.08-(-16.6)) 0.2766 0.1184 ns 
SO2 peak % change 
over baseline mean(SD) -32.1(6.137) 0.2202 0.1712 ns 
SO2 cumulative  mean(SD) 16425(1621) 0.1021 0.3681 ns 
SO2 cumulative -
baseline mean(SD) -25065(5462) 0.2388 0.1518 ns 
SO2/sec mean(SD) 27.37(2.702) 0.1021 0.3681 ns 
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STO2 
STO2 n=10 r² P value 
STO2 baseline mean(SD) 79.1(12.4) 0.04367 0.5623 ns 
STO2 nadir mean(SD) 56(15.28) 0.008093 0.8048 ns 
STO2 nadir-baseline mean(SD) -23.1(15.29) 0.06729 0.4692 ns 
STO2 peak % change over baseline  mean(SD) -28.56(17.94) 0.06507 0.4769 ns 
STO2 cumulative  mean(SD) 20847(3479) 0.005003 0.846 ns 
STO2 cumulative-baseline mean(SD) 720.1(559.7) 0.3422 0.0757 ns 
STO2 /sec mean(SD) 79.32(8.196) 0.133 0.3001 ns 
NIRS STO2 slope mean(SD) 33.63(35.91) 0.01308 0.7531 ns 
NIRS THI average mean(SD) 11.24(2.382) 0.05588 0.5108 ns 
NIRS V02 mean(SD) 355(344.8) 0.02319 0.6745 ns 
 
Dynamometry 
 
Dynamometer n=10 r² P value 
Maximum strength value mean(SD) 213.2(68.17) 0.03142 0.6242 ns 
Fatigue rate mean(SD) 48.76(27.91) 0.1746 0.2296 ns 
Borg rating mean(SD) 13(1.247) 0.3726 0.0609 ns 
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Chapter	  6:	  PILOT	  STUDY	  OF	  HANDGRIP	  EXERCISE	  TO	  
PREDICT	  POSTOPERATIVE	  OUTCOME	  IN	  AN	  ORTHOPAEDIC	  
POPULATION	  
 
6.0	   Introduction	  
In chapter 1 the difficulty of predicting surgical outcome, the basis of 
exercise physiology, the potential advantages of functional capacity 
testing and the perioperative use of handgrip dynamometry were detailed. 
In chapters 2 & 3 the development and performance of cyclical and 
isometric forearm exercise models were described. Each was possible 
and found to produce a biological signal worthy of further investigation. 
In chapter 4 both forearm exercise models were compared and their 
advantages and disadvantages discussed. 
In chapter 5 the clear relationship between formal cardiopulmonary 
exercise testing and the isometric handgrip model was shown and taken 
forward to test in an orthopaedic surgical population. In particular the 
strong association between cumulative lactate, cumulative hydrogen ion 
production and forearm lactate at 300 seconds. 
This chapter will present the results of the use of an isometric forearm 
exercise model to predict surgical outcome in a prospective study of 
orthopaedic patients undergoing joint replacement surgery. 
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6.1	   Materials	  and	  Methods	  
6.1.1	   Study	  design	  
A prospective observational trial of a preoperative handgrip exercise 
model in single joint replacement orthopaedic surgery to predict surgical 
outcome. Full permission for the study was obtained from the local 
research and ethics committee of UCLH. 
6.1.2	   Patient	  selection	  
6.1.2.1	   Inclusion	  criteria	  
Any adult patient (>18 years old) undergoing primary joint replacement 
surgery by one of three named surgeons. 
6.1.2.2	   Exclusion	  criteria	  
Any adult patient with hand or elbow joint deformity problems that would 
prevent handgrip exercise. 
6.1.3	   Protocol	  
Patients were approached 24 hours before their planned surgery for 
possible inclusion in the study. Full written informed consent was 
obtained from willing patient volunteers. Before entering the study a 
medical history was taken and a physical examination performed.  
All patients were admitted to the Middlesex hospital the night before 
surgery and had their operation performed at the Middlesex hospital. 
Isometric exercise testing was performed in the non-fasted state the 
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evening before surgery by myself. All patients were given instructions and 
verbal coaching prior to and during the forearm exercise period.  
A specialised trolley was constructed to allow the transport of the testing 
equipment to the patient’s bedside. Patients were tested whilst sitting up 
in bed, with the arm supported on a bedside table to mimic the same 
conditions as achieved in the healthy volunteers. A 20G cannula was 
inserted into the antecubital fossae of the patient’s non-dominant forearm 
and a baseline blood gas sample taken for analysis, five minutes after 
venous occlusion had ceased to allow for venous congestion and 
potential alterations in oxygen and forearm lactate metabolism to 
stabilise, as demonstrated in chapter 2. The patient’s MVC was 
established as described in the handgrip dynamometry section.  
Patients followed the isometric exercise regime as described in chapter 3 
with sampling at 0,60,120,180,300 and 600 seconds. The dead space of 
the cannula was discarded and the cannula flushed with 2 mls of 0.9% 
saline before and after each sampling respectively. Once the patients 
MVC had been established the computer was set to a target of 50% of 
MVC and exercise commenced in exactly the same manner as described 
in chapter 3. 
6.1.4	   Data	  collected	  
The apparatus setup and data collected were exactly the same as in the 
isometric model and have already been described in detail in chapter 3. 
In addition data on postoperative complications was recorded on days 
3,5,8 and 15 using the postoperative morbidity survey (POMS) 8. This 
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was collected by a research nurse form the surgical outcomes research 
centre and UCLH, to ensure blinding to the results of forearm exercise 
testing. 
Patients were additionally risk scored preoperatively using Detsky, Lee, 
American College of Cardiology/American Heart Association and 
POSSUM methodologies. 
Length of stay and hospital mortality was recorded retrospectively upon 
patient discharge or death. 
Anaesthesia was left to the discretion of the anaesthetist. 
6.1.5	   Statistical	  analysis	  
All analyses were done using Graphpad Prism 5 for Macintosh 
(Graphpad software, San Diego, California). All data are expressed as 
means (± standard deviation) where normally distributed unless otherwise 
stated. Statistical significance was set at p<0.05. 
The study was powered on the basis of results from the healthy volunteer 
data and a similar cohort of patients who had undergone elective 
orthopaedic surgery at University College London Hospitals, where 50% 
of patients sustained postoperative morbidity. From the healthy volunteer 
data, our primary hypothesis was that a minimum detectable difference in 
venous lactate of 2mmol/l, with an anticipated standard deviation of 
1mmol/l, would occur in the 50% patients predicted from our extensive 
previous POMS outcome studies in orthopaedic patients to sustain 
postoperative morbidity. Thus, 21 patients would be required (alpha= 
0.01; power=90%). Kaplan-Meier survival plots were also used to assess 
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the relationship between the handgrip metabolic variables and length of 
stay, stratified according to peak lactate values < >median for the whole 
patient population (log-rank test).  
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6.2	   Results	  
Twenty two patients were recruited to the study. One patient withdrew 
their consent prior to any study procedures for personal reasons; hence 
21 patients were included in the final analysis.  
6.2.1	   Demographics	  
Individual patient demographics are shown in Table 6.1. Eight patients 
had hip replacements and 14 patients had knee replacement operations. 
Three different consultant surgeons performed the operations. The 
distribution of male and female patients was approximately equal with 10 
female and 11 male patients. The average age of the population was 
69.67(±10.51) years and there was no significant difference between 
males and females, Male=69.55(±10.64) and Female=69.8-(±10.93). 
Male patients were not significantly heavier 87(70-105) vs. 74.5(70-77.5) 
Kg, p=0.23), but were significantly taller 1.73(±0.11) vs. 1.61(±0.09), 
p=0.009).  
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Table 6.1 Individual Patient Demographics 
PAT AGE SEX WT HT BMI Hand ASA Procedure OT 
1 65 M 105 1.75 34 L 1 HR(L) 160 
2 66 F 67 1.47 31 R 2 HR(R) 180 
3 88 M 63 1.55 26 R 2 KR(R) 132 
4 62 F 70 1.57 28 L 1 KR(R) 123 
5 65 M 127 1.83 38 R 2 KR(R) 136 
6 63 M 80 1.83 24 R 2 KR(L) 150 
7 54 M 114 1.78 36 R 1 KR(R) 145 
8 55 F 75 1.65 28 R 2 KR(R) 132 
9 77 F 74 1.63 28 R 2 THR(L) 206 
10 83 F 70 1.52 30 L 2 TKR(R) 167 
11 71 M 101 1.85 30 R 3 KR(R) 95 
12 75 F 73 1.65 27 R 2 TKR(L) 140 
13 88 F 75 1.57 30 R 2 THR(L) 136 
14 60 F 82 1.75 27 L 3 TKR(L) 110 
15 66 M 61 1.63 23 R 1 THR(L) 156 
16 72 F 116 1.72 39 R 2 TKR(L) 155 
17 72 M 87 1.73 29 R 1 TKR(L) 140 
18 60 F 76 1.52 33 R 2 KR(L) 140 
19 59 M 103 1.8 32 R 2 KR(R) 132 
20 87 M 76 1.7 26 R 2 THR(L) 200 
21 75 M 70 1.57 28 L 1 KR(R) 152 
 
PAT=patient, WT=weight, HT=height,  BMI=body mass index, Hand=hand dominance, ASA=ASA score, 
OT=operative time(minutes), LOS=length of stay, THR=Total Hip replacement, 
TKR=Total Knee replacement, HR=Hip replacement, KR=Knee replacement 
 
For overall complications there was an excess of female patients 
developing one or more complications as defined by POMS during their 
hospital stay (see Table 6.2). Figure 6.1 shows the decline in 
complications over time as well as the number of patients with a 
complication at any point in their stay, indicating that just over half the 
patients developed at least one complication during their stay. There was 
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a significant difference in the proportion of complications between male 
and female patients (p=0-001) with a relative risk of 0.202 for developing 
complications for male patients. Complication data for each patient is 
shown in Table 6.3. 
Table 6.2 Proportions of patients developing complications at some point during 
their hospital stay, grouped by sex. 
 
 Complications No Complications 
Male 2 9 
Female 9 1 
 
 
Figure 6.1 Number of complications per day as recorded by POMS. Blue bars 
represent the number of patients with a complication on the defined sample day. The 
red bar represents the number of patients with at least one complication during their 
stay. 
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The median hospital stay for female patients was also longer at 8(5.75-
11.75) vs. 4(2-9) but failed to reach statistical significance at p=0.05. 
No patients died within 30 days of their operation, which was the limit for 
the follow up of this study. 
6.2.2	   Risk	  scoring	  
Table 6.2 shows individual patient risk scores, length of stay and 
complications according to POMS by days 3,5,8,15 and overall. The 
Goldman, Detsky and Lee scores did not vary significantly between 
individuals or show any association with length of stay or complications 
(see Table 6.3). There was greater spread of scores for the American 
College of Cardiology/American Heart Association score but again this 
showed no relationship to length of stay or complications. 
The POSSUM morbidity and mortality scores did however show 
significant relationships with length of stay (see Table 6.4) and with 
overall compilations,. POSSUM morbidity scores for those with 
complications vs. no complications, median (IQR), 21.08 (16.24 – 26.89) 
vs. 11.81 (7.59 – 16.25), P=0.005). POSSUM mortality scores for 
complications vs. no complications, median (IQR), 0.97 (0.69– 1.36) vs. 
0.52 (0.31 – 0.7), P=0.005. 
 212 
Table 6.3 Individual patient risk scoring and outcome data 
 Risk Scores  Post operative Morbidity Survey(POMS) 
Patient 
No. 
Goldman Detsky Lee ACC/AHA POSSUM 
Morbidity 
POSSUM 
Mortality 
LOS Day 3 Day 5 Day 8 Day 15 Overall 
1 0 0 0 0 7.59 0.31 2 n n n n n 
2 0 5 1 2 21.08 0.97 26 y y y y y 
3 5 5 2 4 21.08 0.97 9 n n n n n 
4 0 0 0 0 16.25 0.69 6 y n n n y 
5 0 0 0 0 16.25 0.69 5 n n n n n 
6 0 0 0 0 7.59 0.31 2 n n n n n 
7 0 0 0 0 7.59 0.31 2 n n n n n 
8 0 0 0 0 12.68 0.49 6 y n n n y 
9 5 5 0 3 46.26 2.39 11 y n n n y 
10 5 5 0 1 26.89 1.36 8 n n y n y 
11 0 0 1 4 13.47 0.60 4 n n n n n 
12 5 5 0 1 21.08 0.97 4 y n n n y 
13 5 5 1 5 23.87 1.15 8 y y n n y 
14 0 0 1 3 16.25 0.69 14 y n y n y 
15 0 0 0 0 12.35 0.50 9 y y y n y 
16 5 0 0 0 23.87 1.15 8 y y n n y 
17 5 0 0 0 16.25 0.69 3 n n n n n 
18 0 0 0 0 10.16 0.43 5 n n n n n 
19 0 0 0 0 7.59 0.31 5 n n n n n 
20 5 0 0 3 37.29 2.23 21 y y y n y 
21 5 0 1 3 15.84 0.70 4 n n n n n 
LOS=length of stay 
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Table 6.4 Linear regression results for risk scoring and operative time vs. Length 
of stay 
 
n=21 r2 p value 
Goldman 0.01113 0.649 ns 
Detsky 0.1202 0.1236 ns 
Lee 0.07955 0.2155 ns 
ACC/AHA 0.1523 0.0803 ns 
POSSUM morbidity 0.301 0.01 * 
POSSUM mortality 0.318 0.0078 * 
ASA 0.09569 0.1724 ns 
Operation time 0.2379 0.0249 * 
 
6.2.3	   Handgrip	  dynamometry	  
 
Male patients were in addition significantly stronger with MVC of 252.1 
(±114.8) vs. 161.5 (±56.12) N, p=0.036), but did not exercise for longer 
(203(±159) vs. 163.2(±80.87) seconds, p=0.49) or perform more work 
(19283(±10584) vs. 14008(±6323) Ns, p=0.19), during handgrip exercise, 
(see table 6.5 for individual data). 
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Table 6.5 Individual handgrip dynamometry 
 
 Hand Grip Dynamometry 
Patient No. MVC Exercise time Work done 
1 425.65 90.11 18268.12 
2 130.09 127.91 9205.35 
3 109.77 38.7 2109.28 
4 155.71 145.73 12678.76 
5 352.47 135.58 2342.5 
6 222.79 334.76 34474.2 
7 406.54 105.48 20593.45 
8 218.72 166.66 21837.36 
9 253.68 89.05 11715.78 
10 143.92 185.36 13579.55 
11 150.83 268.17 20914.6 
12 186.2 240.83 21156.52 
13 130.5 308.8 18021.06 
14 46.35 20.11 824.42 
15 282.95 202.91 28099.18 
16 180.1 132.8 12163.05 
17 182.94 268.59 28601.66 
18 169.94 214.99 18896.14 
19 321.98 97.89 15599.46 
20 94.32 591.71 28324.27 
21 223.19 99 12789.06 
 
Overall MVC was significantly related to length of stay (r2 = 0.39, 
P=0.0024) and significantly lower in those with complications (median 
(IQR) complications vs. no complications, 155.71 (130.09 – 218.72) vs. 
222.99 (165.16 – 365.99), P=0.035. 
 
Table 6.10 in the Appendix shows individual exercise data and 
corresponding tissue oxygenation data for completeness. 
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6.2.3.1	   Changes	  over	  time	  in	  fixed	  time	  point	  samples	  and	  tissue	  
oxygenation	  
There were significant differences from baseline for all measured 
variables (see Figure 6.2). All variables demonstrated no statistical 
difference from baseline by 600 seconds except for lactate, which 
remained elevated. 
PO2 was the earliest variable to return to near baseline values at 180 
seconds. PCO2 and SO2 were near baseline values by 300 seconds, 
whilst hydrogen ion concentration took until 600 seconds to reach near 
baseline values (see Figure 6.2).
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Figure 6.2 Box and whisker plots for fixed time point sampling for forearm lactate, 
SO2, PO2, PCO2, Hydrogen ion concentration (mmol/L) and baseline pre and post 
exercise and nadir values for STO2 
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There were no other significant differences in any measurable metabolic 
parameter between male and female subjects except for cumulative 
forearm lactate at 300 and 600 seconds, (see Figure 6.3) 
 
Figure 6.3 Box and whisker plots for male and female groups for forearm lactate 
values at a) 300 and b) 600 seconds  
 
 
6.2.3.2	   Length	  of	  stay	  and	  complications	  
As already shown in section 6.2.1, over 50% (11/21) patients sustained 
postoperative morbidity. Those patients with postoperative morbidity also 
had a significantly longer length of stay than those without morbidity 
(P<0.01, log-rank test) as shown in Figure 6.4. 
There was also a difference in peak lactate expression between the 
group with morbidity and the groups without morbidity. As shown in 
Figure 6.5 & 6.6 the group in which morbidity occurred had significantly 
lower peak lactate levels during exercise testing (P<0.001, unpaired t-
test). 
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Figure 6.4 Impact of postoperative morbidity on length of stay. 
 
Figure 6.5 Difference in peak venous lactate levels between those with 
postoperative morbidity and those with no postoperative morbidity 
 
Figure 6.6 Box and whisker plots for forearm lactate at all fixed time sample 
points against the presence or absence of complications. 
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In addition to the relationship with morbidity those patients who 
expressed lower levels of lactate, when split by the median of lactate 
expression for the whole group had a significantly longer length of stay 
(P=0.04, log-rank test), as shown in Figure 6.7 
 
 
Figure 6.7 Prolonged length of hospital stay in patients with Lactate > median for 
the whole population 
 
 
 
 
Table 6.11 in the Appendix shows details of all significant regression 
results against length of stay for completeness. 
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6.2.3.3	   Relationship	  of	  MVC	  to	  forearm	  exercise	  model	  output	  
Tables 6.7 & Figure 6.8 show linear regression results for fixed time point 
forearm lactate sampling and endpoint summaries. There is a clear and 
strong association between these values and MVC for all points 
Table 6.7 Linear regression vs. MVC 
 
 Time point r2 p value 
0 0.4085 0.0018 * 
60 0.558 < 0.0001 * 
120 0.6614 < 0.0001 * 
180 0.6717 < 0.0001 * 
300 0.5146 0.0003 * 
600 0.4272 0.0013 * 
Peak 0.589 < 0.0001 * 
Peak-baseline 0.4808 0.0005 * 
Peak % change over baseline  0.1994 0.0424 * 
Cumulative 0.6115 < 0.0001 * 
Cumulative-baseline 0.4572 0.0008 * 
Lactate 
Per sec 0.6115 < 0.0001 * 
 
 *=Significant result 
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Figure 6.8 Linear regression plots for forearm lactate at all time points against 
MVC, best fit line and 95% CI are shown 
 
 
In addition there were significant relationships between MVC and SO2, 
PO2, PCO2 and hydrogen ion concentration against MVC, (see table 6.8). 
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Table 6.8 Significant linear regression results vs. MVC 
 Time point r² P value 
300 0.2008 0.0416 * 
Nadir-baseline 0.262 0.0177 * SO2 
Peak % under baseline 0.3428 0.0053 * 
180 0.2358 0.0256 * 
PO2 
300 0.212 0.0357 * 
60 0.3102 0.0087 * 
120 0.4655 0.0007 * 
Peak 0.397 0.0022 * 
Peak-baseline 0.6146 < 0.0001 * 
PCO2 
Peak % change over 
baseline 0.6525 < 0.0001 * 
60 0.5781 < 0.0001 * 
120 0.6608 < 0.0001 * 
180 0.2176 0.033 * 
Minimum 0.4568 0.0008 * 
Minimum-Baseline 0.4298 0.0013 * 
[H]+ 
Peak % change under 
baseline 0.3974 0.0022 * 
 
6.2.3.4	   Relationship	  of	  work	  done	  to	  forearm	  exercise	  model	  output	  
There were fewer significant relationships between exercise test output 
variables and work done, but significant results are shown in Table 6.9. 
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Table 6.9 Significant linear regression results vs. Work done 
 Time point r² P value 
Lactate 600 0.2059 0.0388 * 
180 0.3549 0.0044 * 
Cumulative 0.2515 0.0206 * SO2 
Per sec 0.2515 0.0206 * 
PO2 180 0.2863 0.0124 * 
180 0.3215 0.0073 * 
300 0.4139 0.0017 * 
600 0.2179 0.0329 * 
Cumulative 0.4304 0.0012 * 
Cumulative-
baseline 0.3843 0.0027 * 
PCO2 
Per sec 0.4304 0.0012 * 
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6.3	   Discussion	  
Overall it was possible and relatively easy to conduct isometric forearm 
testing in this population of patients in a ward based setting. The test 
showed excellent correlation between handgrip dynamometry input (MVC 
and work done) and output of metabolic markers of metabolism but was 
no better than conventional risk scoring in predicting outcome. 
The group was reasonably proportioned with 8 patients having hip and 14 
patients having knee related prosthesis and evenly split between male 
and female. The cohort was well also matched for age and weight by sex 
but male patients were taller. 
The group however showed a disproportionate number of female patients 
developing complications, with the relative risk of developing 
complications for male patients of 0.202 and female patients staying in 
hospital longer. It is difficult to explain this adequately because there was 
no significant difference in the risk scoring between males and females, 
including POSSUM morbidity and mortality scores or in their ASA status 
or operation time. There is also no consistent theme in the medical 
literature that demonstrates women have more complications than men 
and hence this study may represent a biased sample. Although strength 
(MVC) had a clear relationship to work done as shown in chapter 3 there 
was no clear relationship with lactate production, but strength alone has 
been sown to be an independent predictor of outcome. However men 
were significantly stronger in this study and may explain why the majority 
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of complications were seen in women as complications were clearly 
related to MVC. 
The utility of POSSUM to predict surgical outcome was demonstrated in 
chapter 1 and the results of this study simply confirm its ability to do that. 
It did significantly under predict the morbidity rate in the complications 
group where over 50% developed a complication. This is most likely due 
to the fact that POMS was used to measure morbidity, which probably is 
more sensitive in identifying postoperative morbidity than the datasets in 
which POSSUM was validated, hence reports more complications.  
The results of this study also add weight to the value of MVC to predict 
postoperative outcomes with it showing significant relationships between 
length of stay and being higher in the group with no complications. It is 
however possible in this study that MVC simply identified a male 
population. There was a significantly higher MVC (male vs. females 252.1 
(±114.8) vs. 161.15(±56.12) in males than females and there were 
significantly more complications in females compared to males (F:M, 9:1), 
but there was no difference in exercise time or work done between the 
sexes. The disproportionate split of complications between male and 
females is a recurring theme in this study and probably explains many of 
the anomalies seen. MVC is a strength test and has been used to predict 
surgical outcome 153, 157, 161, 168, cognitive decline 172, 255, and recovery 
after stroke 256, amongst many other outcomes. As such in this study 
males were clearly stronger and it can be assumed had a better 
nutritional state, which may be beneficial in adding surgical recovery. 
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The nature of the isometric forearm exercise test is to stimulate high 
intensity exercise and challenge the anaerobic system, which it was 
clearly able to do, as there was a significant relationship between MVC 
and the metabolic output of the study, which was in many ways more 
consistent than in the healthy volunteers. There is a known effect of 
ageing by which aerobic capacity and strength decline and it is probable 
that an isometric test in an older and less fit population of surgical 
patients will stimulate a higher anaerobic response as evidenced by this 
study. It would in retrospect have been better to have studied this 
population in greater detail for the characteristics of forearm exercise 
performance and to establish a control population, which I plan to do in a 
future study to further understand that relationship. 
There were a number of weak associations in this study including 
baseline values of STO2 and forearm lactate. They may simply be to 
statistical error or may be due to a deficiency in the methodology of this 
study. An MVC was established prior to cannulation and the same rest 
periods given as in the isometric study in healthy volunteers. It is possible 
that my assumption that this would be adequate for surgical patients may 
be wrong. They appear to be more responsive to anaerobic exercise than 
the healthy volunteers and the initial MVC may have induce a lactate and 
STO2 change that lasted longer than in healthy volunteers.  
Of note however is the consistently significant association between low 
levels of lactate expression during exercise and its association with both 
postoperative complications and increased length of stay. The inability of 
individuals with lower anaerobic thresholds, including elective orthopaedic 
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patients, to generate lactate for optimal adaptive metabolic changes may 
be an important feature of dysregulated cellular function driven by 
perioperative inflammation and increased demands for oxygen delivery. 
It can be seen in chapter 5 that those individuals with higher anaerobic 
thresholds produce statistically more lactate at any given point of exercise 
and a point particularly exaggerated in isometric testing. The small 
numbers of this study make speculation on trends fraught, and although 
we did not measure anaerobic threshold in the surgical patients it is 
possible that those with higher lactate responses and fewer complications 
have higher anaerobic thresholds, which is consistent with our original 
hypothesis. 
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6.4	   Conclusions	  
I have shown that the use of isometric forearm handgrip exercise testing 
in an orthopaedic population undergoing joint replacement surgery is 
achievable as a preoperative test. 
The test confirms work done by others that maximal voluntary contraction 
is a useful predictor of surgical outcome. In this population it was related 
to length of stay and the presence of postoperative complications. 
The test also confirmed the utility of conventional risk scoring such as 
POSSUM to predict complications and length of stay. 
The measurement of metabolic venous markers of metabolism during the 
test are consistent with it having stimulated anaerobic respiration in the 
exercising muscle and are in many ways a much clear and cleaner signal 
than those seen in the healthy volunteers during the development of this 
model. There was also a highly consistent and proportionate relationship 
between maximal voluntary contraction and the metabolic output of the 
test. 
Overall there was a consistent and significant relationship with low levels 
of lactate expression, increased length of stay and postoperative 
complications. This is consistent with the hypothesis that fitter people and 
patients appear to be able to produce larger amounts of lactate during 
exercise than those that are less fit and likely to have a worse 
postoperative outcome, possibly due to dysregulated peripheral tissue 
metabolism that was detected by our test. 
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6.5	   APPENDIX	  
Handgrip	  dynamometry	  and	  NIRS	  data	  for	  each	  patient	  
Table 6.10 Hand grip exercise and tissue oxygenation data 
 
 Hand Grip Dynamometry Tissue oxygenation 
Patient 
No. MVC 
Exercise 
time 
Work 
done 
Baseline Nadir Peak Baseline 
(PE) 
NIRS 
VO2 
1 425.65 90.11 18268.12 86 51 78 73 227 
2 130.09 127.91 9205.35 38 6 65 63 472 
3 109.77 38.7 2109.28 78 7 94 92 2908 
4 155.71 145.73 12678.76 75 56 75 71 84 
5 352.47 135.58 2342.5 54 18 63 44 134 
6 222.79 334.76 34474.2 76 63 86 78 439 
7 406.54 105.48 20593.45 42 24 43 32 110 
8 218.72 166.66 21837.36 44 27 49 42 54 
9 253.68 89.05 11715.78 82 60 76 71 179 
10 143.92 185.36 13579.55 80 47 82 79 421 
11 150.83 268.17 20914.6 72 45 74 69 219 
12 186.2 240.83 21156.52 67 53 66 59 54 
13 130.5 308.8 18021.06 74 65 73 66 201 
14 46.35 20.11 824.42 31 17 33 28 127 
15 282.95 202.91 28099.18 79 49 93 81 267 
16 180.1 132.8 12163.05 46 11 48 42 167 
17 182.94 268.59 28601.66 72 23 83 77 1655 
18 169.94 214.99 18896.14 57 15 58 45 148 
19 321.98 97.89 15599.46 81 55 82 75 270 
20 94.32 591.71 28324.27 51 41 59 59 54 
21 223.19 99 12789.06 72 62 78 73 137 
 
MVC=Maximal Voluntary contraction, Baseline (pe) = post exercise baseline, NIRS VO2=Near infra-red 
spectroscopy oxygen consumption 
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Significant	  regression	  results	  against	  length	  of	  stay	  
Table 6.11 Linear regression results for length of stay. 
Demographics 
n=21 r2 p value 
Weight 0.1405 0.094 * 
    
Risk scoring & Surgery 
n=21 r2 p value 
POSSUM morbidity 0.301 0.01 * 
POSSUM mortality 0.318 0.0078 * 
Operation time 0.2379 0.0249 * 
    
Postoperative complications 
n=21 r2 p value 
Day 3 0.3254 0.0069 * 
Day 5 0.3889 0.0025 * 
Day 8 0.541 0.0001 * 
Day 15 0.4655 0.0007 * 
Overall 0.3306 0.0064 * 
    
Dynamometry 
n=21 r2 p value 
MVC 0.277 0.0143 * 
    
Venous blood gas & Tissue oxygenation 
n=21 r2 p value 
Baseline lactate 0.3816 0.0028 * 
Nadir SO2-baseline 0.3785 0.003 * 
Peak % change over baseline SO2 0.3306 0.0064 * 
Baseline STO2 0.1988 0.0428 * 
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Chapter	  7:	  CONCLUSIONS	  AND	  FUTURE	  WORK	  
Measuring, defining and predicating surgical outcome is a major 
challenge for healthcare and remains difficult. In the first chapter of this 
thesis I have explored the methods available by which to predict surgical 
outcome, which still largely predict the risk of a population rather than an 
individual, with the most recent guidelines encouraging a stepwise 
approach to assessing perioperative risk. The use of handgrip 
dynamometry to predict clinically important outcomes including 
perioperative outcome is discussed at length. I have also highlighted and 
discussed the evidence that as a preoperative test cardiopulmonary 
exercise testing has a unique ability to be able to help in predicting 
surgical outcome, but that the test can be expensive, require trained 
personnel and is not suitable for patients with severe musculoskeletal 
problems or those undergoing emergency surgery. Hence the need to 
develop a test that may be used instead of cardiopulmonary exercise 
testing for those unable to complete the test or as a replacement for 
cardiopulmonary exercise testing for the preoperative estimation of 
perioperative risk. 
Chapter 1 also sets out my main hypotheses relating to this thesis. 
1) There is a fundamental difference in the metabolic output i.e the 
measurable venous products of metabolism; forearm lactate, SO2, 
PO2, PCO2, pH and tissue oxygenation (STO2) of a rhythmic 
isometric (Cyclical) handgrip exercise model and a static isometric 
(Isometric) handgrip exercise model. 
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In chapters 2-4 I demonstrated that this hypothesis was true. There were 
significant differences both in the quantity and timing of release of the 
measurable venous markers of metabolism. In addition I showed that the 
isometric model of forearm exercise was a stronger stimulus of anaerobic 
respiration than the cyclical model. Chapters 2-4 also confirm that both 
tests were easy to do as preoperative bedside tests. Significant questions 
that came to light during these experiments were largely related to 
improvement in technique. For instance the use of a venous catheter that 
was capable of continuously analysing markers of respiration such as 
lactate and pH may have improved the sensitivity of the test in identifying 
inflections points. I intend to adapt the model in future work to incorporate 
this technology. I attempted to overcome this by constructing summary 
and cumulative measures of these test variables, but it has to be 
recognised that they are prone to error as a result. In addition the testing 
of each model in an elderly population with a number of comorbidities 
may have given us different results to that in a healthy volunteer group, 
but I wanted to keep the model as clean as possible by studying a 
population with as few confounding variables as possible. 
2) The metabolic output from exercising forearm muscle i.e the 
measurable venous products of metabolism; forearm lactate, SO2, 
PO2, PCO2, pH and tissue oxygenation (STO2) or cumulative 
markers thereof of a standardised handgrip exercise model will 
have a direct relationship to the anaerobic threshold in the same 
individual as measured by cardiopulmonary exercise testing. 
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In chapter 5 I was able to demonstrate that the isometric forearm exercise 
model showed a consistently statistically significant relationship to 
anaerobic threshold as measured by cardiopulmonary exercise testing 
but not for the cyclical forearm exercise model. Thus this hypothesis was 
in part confirmed. Of interest was the novel finding that those with higher 
anaerobic thresholds tended to produce more lactate in the isometric 
forearm exercise model than those with lower anaerobic thresholds. 
3) The metabolic output from exercising forearm muscle i.e. the 
measurable venous products of metabolism; forearm lactate, SO2, 
PO2, PCO2, pH and tissue oxygenation (STO2) or cumulative 
markers thereof of a standardised handgrip exercise model will be 
able to identify those patients at risk of a poor surgical outcome 
and thereby allow it to be used as a preoperative test instead of 
cardiopulmonary exercise testing, or for those patients unable to 
perform a cardiopulmonary exercise test. 
Chapter 6 demonstrated the confirmation of this hypothesis. I was able to 
show that lactate was significantly higher in those patients who had fewer 
complications and shorter lengths of stay. I also confirmed the utility of 
conventional risk scoring with POSSUM and that the maximal voluntary 
contraction of handgrip dynamometry was predictive of complications and 
length of stay. 
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In summary the main findings of this thesis are: 
• Both cyclical and isometric forearm exercise models are practical 
as preoperative tests 
• The isometric forearm exercise model proved to be a much 
stronger stimulus to anaerobic respiration. 
• The isometric forearm exercise model showed a statistically 
significant and consistent relationship with anaerobic threshold as 
measured by cardiopulmonary exercise testing. 
• Maximal voluntary contraction as measured by handgrip 
dynamometry was significantly higher for patient with less 
complications and shorter lengths of stay. 
• There was a significant association with forearm lactate to be 
higher in those with fewer complications and shorter lengths of 
stay.
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